CN108728401A - The method of IVF of Oocyte in Bovine Embryo Culture and culture medium used - Google Patents
The method of IVF of Oocyte in Bovine Embryo Culture and culture medium used Download PDFInfo
- Publication number
- CN108728401A CN108728401A CN201810576764.3A CN201810576764A CN108728401A CN 108728401 A CN108728401 A CN 108728401A CN 201810576764 A CN201810576764 A CN 201810576764A CN 108728401 A CN108728401 A CN 108728401A
- Authority
- CN
- China
- Prior art keywords
- culture
- sodium
- hydrochloride
- vitro
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000283690 Bos taurus Species 0.000 title claims abstract description 80
- 210000000287 oocyte Anatomy 0.000 title claims abstract description 69
- 238000000034 method Methods 0.000 title claims abstract description 56
- 239000001963 growth medium Substances 0.000 title claims abstract description 45
- 210000001161 mammalian embryo Anatomy 0.000 title claims description 65
- 238000000338 in vitro Methods 0.000 claims abstract description 125
- 230000035800 maturation Effects 0.000 claims abstract description 99
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 88
- 230000004720 fertilization Effects 0.000 claims abstract description 71
- 210000002257 embryonic structure Anatomy 0.000 claims abstract description 51
- 239000011780 sodium chloride Substances 0.000 claims abstract description 41
- 235000002639 sodium chloride Nutrition 0.000 claims abstract description 41
- 239000007864 aqueous solution Substances 0.000 claims abstract description 37
- 239000007788 liquid Substances 0.000 claims abstract description 31
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims abstract description 21
- 239000001632 sodium acetate Substances 0.000 claims abstract description 21
- 235000017281 sodium acetate Nutrition 0.000 claims abstract description 21
- 238000005406 washing Methods 0.000 claims abstract description 18
- 238000012258 culturing Methods 0.000 claims abstract description 9
- 239000000243 solution Substances 0.000 claims description 116
- 210000002459 blastocyst Anatomy 0.000 claims description 82
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 72
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 62
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 62
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 52
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 51
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 51
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 49
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 46
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 46
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 44
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 42
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 40
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 claims description 40
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 40
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 40
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 40
- 235000013601 eggs Nutrition 0.000 claims description 40
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 40
- 238000003776 cleavage reaction Methods 0.000 claims description 39
- 230000007017 scission Effects 0.000 claims description 39
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 38
- 239000002609 medium Substances 0.000 claims description 37
- 239000001103 potassium chloride Substances 0.000 claims description 36
- 235000011164 potassium chloride Nutrition 0.000 claims description 36
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 32
- 229940098773 bovine serum albumin Drugs 0.000 claims description 32
- 229960003180 glutathione Drugs 0.000 claims description 31
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 30
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 30
- 229960003767 alanine Drugs 0.000 claims description 30
- 108010024636 Glutathione Proteins 0.000 claims description 28
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 28
- KWTQSFXGGICVPE-UHFFFAOYSA-N 2-amino-5-(diaminomethylideneamino)pentanoic acid;hydron;chloride Chemical compound Cl.OC(=O)C(N)CCCN=C(N)N KWTQSFXGGICVPE-UHFFFAOYSA-N 0.000 claims description 26
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 26
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 26
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 26
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 26
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 26
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims description 26
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 26
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 26
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 26
- 229930182844 L-isoleucine Natural products 0.000 claims description 26
- 239000004395 L-leucine Substances 0.000 claims description 26
- 235000019454 L-leucine Nutrition 0.000 claims description 26
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 claims description 26
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 26
- 229930195722 L-methionine Natural products 0.000 claims description 26
- 229930182821 L-proline Natural products 0.000 claims description 26
- HHGZUQPEIHGQST-UHFFFAOYSA-N [2-[(2-azaniumyl-2-carboxyethyl)disulfanyl]-1-carboxyethyl]azanium;dichloride Chemical compound Cl.Cl.OC(=O)C(N)CSSCC(N)C(O)=O HHGZUQPEIHGQST-UHFFFAOYSA-N 0.000 claims description 26
- 229960005261 aspartic acid Drugs 0.000 claims description 26
- 229960000310 isoleucine Drugs 0.000 claims description 26
- 229960003136 leucine Drugs 0.000 claims description 26
- 229960004452 methionine Drugs 0.000 claims description 26
- 229960002429 proline Drugs 0.000 claims description 26
- 229960004295 valine Drugs 0.000 claims description 26
- 229960001153 serine Drugs 0.000 claims description 25
- 229960004799 tryptophan Drugs 0.000 claims description 25
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 24
- 229910000365 copper sulfate Inorganic materials 0.000 claims description 24
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 claims description 24
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 23
- 239000004473 Threonine Substances 0.000 claims description 23
- 229960002989 glutamic acid Drugs 0.000 claims description 23
- 210000000582 semen Anatomy 0.000 claims description 23
- 229960002898 threonine Drugs 0.000 claims description 23
- 229960005190 phenylalanine Drugs 0.000 claims description 22
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 21
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 21
- 238000012546 transfer Methods 0.000 claims description 21
- IBAOFQIOOBQLHE-UHFFFAOYSA-N 2-amino-3,9-dihydropurin-9-ium-6-one;chloride Chemical compound Cl.N1C(N)=NC(=O)C2=C1N=CN2 IBAOFQIOOBQLHE-UHFFFAOYSA-N 0.000 claims description 20
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 claims description 20
- MKPCNMXYTMQZBE-UHFFFAOYSA-N 7h-purin-6-amine;sulfuric acid;dihydrate Chemical compound O.O.OS(O)(=O)=O.NC1=NC=NC2=C1NC=N2.NC1=NC=NC2=C1NC=N2 MKPCNMXYTMQZBE-UHFFFAOYSA-N 0.000 claims description 20
- 229930024421 Adenine Natural products 0.000 claims description 20
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 20
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 20
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims description 20
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 20
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 20
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 20
- FBKIASNRVHFWNA-USHJOAKVSA-N O.O.[Na].[Na].N[C@@H](Cc1ccc(O)cc1)C(O)=O Chemical compound O.O.[Na].[Na].N[C@@H](Cc1ccc(O)cc1)C(O)=O FBKIASNRVHFWNA-USHJOAKVSA-N 0.000 claims description 20
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 claims description 20
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims description 20
- 229960000643 adenine Drugs 0.000 claims description 20
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims description 20
- 229960004050 aminobenzoic acid Drugs 0.000 claims description 20
- 235000010323 ascorbic acid Nutrition 0.000 claims description 20
- 229960005070 ascorbic acid Drugs 0.000 claims description 20
- 239000011668 ascorbic acid Substances 0.000 claims description 20
- 229960002685 biotin Drugs 0.000 claims description 20
- 235000020958 biotin Nutrition 0.000 claims description 20
- 239000011616 biotin Substances 0.000 claims description 20
- 229940084214 calcidol Drugs 0.000 claims description 20
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 20
- 239000001110 calcium chloride Substances 0.000 claims description 20
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 20
- 235000012000 cholesterol Nutrition 0.000 claims description 20
- 229960000304 folic acid Drugs 0.000 claims description 20
- 235000019152 folic acid Nutrition 0.000 claims description 20
- 239000011724 folic acid Substances 0.000 claims description 20
- 229960000367 inositol Drugs 0.000 claims description 20
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 20
- 229960003966 nicotinamide Drugs 0.000 claims description 20
- 235000005152 nicotinamide Nutrition 0.000 claims description 20
- 239000011570 nicotinamide Substances 0.000 claims description 20
- 235000001968 nicotinic acid Nutrition 0.000 claims description 20
- 229960003512 nicotinic acid Drugs 0.000 claims description 20
- 239000011664 nicotinic acid Substances 0.000 claims description 20
- 229960003531 phenolsulfonphthalein Drugs 0.000 claims description 20
- 229920000136 polysorbate Polymers 0.000 claims description 20
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 20
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 20
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 20
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 20
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 20
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims description 20
- 229940035893 uracil Drugs 0.000 claims description 20
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims description 20
- HYPYXGZDOYTYDR-HAJWAVTHSA-N 2-methyl-3-[(2e,6e,10e,14e)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaenyl]naphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 HYPYXGZDOYTYDR-HAJWAVTHSA-N 0.000 claims description 19
- SZQUEWJRBJDHSM-UHFFFAOYSA-N iron(3+);trinitrate;nonahydrate Chemical compound O.O.O.O.O.O.O.O.O.[Fe+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O SZQUEWJRBJDHSM-UHFFFAOYSA-N 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 19
- 229960000342 retinol acetate Drugs 0.000 claims description 19
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 19
- 235000019173 retinyl acetate Nutrition 0.000 claims description 19
- 239000011770 retinyl acetate Substances 0.000 claims description 19
- 235000019143 vitamin K2 Nutrition 0.000 claims description 19
- 239000011728 vitamin K2 Substances 0.000 claims description 19
- 229940041603 vitamin k 3 Drugs 0.000 claims description 19
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 18
- 229960002477 riboflavin Drugs 0.000 claims description 18
- 235000019192 riboflavin Nutrition 0.000 claims description 18
- 239000002151 riboflavin Substances 0.000 claims description 18
- 229920006395 saturated elastomer Polymers 0.000 claims description 18
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 17
- 235000019743 Choline chloride Nutrition 0.000 claims description 17
- 229960003178 choline chloride Drugs 0.000 claims description 17
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 17
- CMXXUDSWGMGYLZ-XRIGFGBMSA-N (2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid;hydron;chloride;hydrate Chemical compound O.Cl.OC(=O)[C@@H](N)CC1=CN=CN1 CMXXUDSWGMGYLZ-XRIGFGBMSA-N 0.000 claims description 16
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 16
- 239000004471 Glycine Substances 0.000 claims description 16
- 108010046075 Thymosin Proteins 0.000 claims description 16
- 102000007501 Thymosin Human genes 0.000 claims description 16
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 16
- BBMHARZCALWXSL-UHFFFAOYSA-M sodium dihydrogenphosphate monohydrate Chemical compound O.[Na+].OP(O)([O-])=O BBMHARZCALWXSL-UHFFFAOYSA-M 0.000 claims description 16
- 239000011781 sodium selenite Substances 0.000 claims description 16
- 235000015921 sodium selenite Nutrition 0.000 claims description 16
- 229960001471 sodium selenite Drugs 0.000 claims description 16
- LCJVIYPJPCBWKS-NXPQJCNCSA-N thymosin Chemical compound SC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(O)=O)C(O)=O LCJVIYPJPCBWKS-NXPQJCNCSA-N 0.000 claims description 16
- XJZYXTWSMDRIJE-UHFFFAOYSA-N 3,7-dihydropurin-6-one;sodium Chemical compound [Na].O=C1N=CNC2=C1NC=N2 XJZYXTWSMDRIJE-UHFFFAOYSA-N 0.000 claims description 15
- 229960003001 adenosine triphosphate disodium Drugs 0.000 claims description 15
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 15
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 15
- LJPYJRMMPVFEKR-UHFFFAOYSA-N prop-2-ynylurea Chemical compound NC(=O)NCC#C LJPYJRMMPVFEKR-UHFFFAOYSA-N 0.000 claims description 15
- BQDNZTCYMLPJJM-UHFFFAOYSA-M sodium hydrogen sulfite trihydrate Chemical compound O.O.O.[Na+].OS([O-])=O BQDNZTCYMLPJJM-UHFFFAOYSA-M 0.000 claims description 15
- HKDXLLDCXWUUKY-UHFFFAOYSA-M sodium;7h-purin-3-ide-2,6-dione Chemical compound [Na+].O=C1NC(=O)NC2=C1[N-]C=N2 HKDXLLDCXWUUKY-UHFFFAOYSA-M 0.000 claims description 15
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 15
- 229960000344 thiamine hydrochloride Drugs 0.000 claims description 15
- 235000019190 thiamine hydrochloride Nutrition 0.000 claims description 15
- 239000011747 thiamine hydrochloride Substances 0.000 claims description 15
- -1 vitamin A acetic acid Ester Chemical class 0.000 claims description 14
- 239000007995 HEPES buffer Substances 0.000 claims description 13
- 210000001771 cumulus cell Anatomy 0.000 claims description 12
- 229910052757 nitrogen Inorganic materials 0.000 claims description 12
- 239000000725 suspension Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 230000013178 blastocyst hatching Effects 0.000 claims description 10
- 229940026527 glycine 50 mg Drugs 0.000 claims description 10
- 238000007710 freezing Methods 0.000 claims description 8
- 230000008014 freezing Effects 0.000 claims description 8
- 239000003761 preservation solution Substances 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- 238000005138 cryopreservation Methods 0.000 claims description 6
- 239000012531 culture fluid Substances 0.000 claims description 6
- 210000002503 granulosa cell Anatomy 0.000 claims description 6
- 239000008188 pellet Substances 0.000 claims description 6
- 239000010902 straw Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 claims description 5
- 210000001733 follicular fluid Anatomy 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 4
- 210000001672 ovary Anatomy 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- 238000001727 in vivo Methods 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims 1
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical compound OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 claims 1
- 235000019155 vitamin A Nutrition 0.000 claims 1
- 239000011719 vitamin A Substances 0.000 claims 1
- 229940045997 vitamin a Drugs 0.000 claims 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 abstract description 16
- 239000007640 basal medium Substances 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 12
- 229910000403 monosodium phosphate Inorganic materials 0.000 abstract description 5
- 235000019799 monosodium phosphate Nutrition 0.000 abstract description 5
- 238000004321 preservation Methods 0.000 abstract description 5
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 abstract description 5
- 239000012091 fetal bovine serum Substances 0.000 description 35
- 238000012360 testing method Methods 0.000 description 32
- 210000004027 cell Anatomy 0.000 description 30
- 238000005516 engineering process Methods 0.000 description 30
- 230000006907 apoptotic process Effects 0.000 description 29
- 229940024606 amino acid Drugs 0.000 description 28
- 235000001014 amino acid Nutrition 0.000 description 28
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 28
- 230000000903 blocking effect Effects 0.000 description 24
- 239000003797 essential amino acid Substances 0.000 description 24
- 235000020776 essential amino acid Nutrition 0.000 description 23
- 239000002953 phosphate buffered saline Substances 0.000 description 20
- 210000000472 morula Anatomy 0.000 description 19
- 150000001413 amino acids Chemical class 0.000 description 18
- 229960002713 calcium chloride Drugs 0.000 description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- 238000010790 dilution Methods 0.000 description 16
- 239000012895 dilution Substances 0.000 description 16
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 16
- 229930182555 Penicillin Natural products 0.000 description 15
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 15
- DHRRIBDTHFBPNG-UHFFFAOYSA-L magnesium dichloride hexahydrate Chemical compound O.O.O.O.O.O.[Mg+2].[Cl-].[Cl-] DHRRIBDTHFBPNG-UHFFFAOYSA-L 0.000 description 15
- 229940049954 penicillin Drugs 0.000 description 15
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 15
- 229940050906 magnesium chloride hexahydrate Drugs 0.000 description 14
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 14
- 235000019796 monopotassium phosphate Nutrition 0.000 description 14
- 229960005322 streptomycin Drugs 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 108010083123 CDX2 Transcription Factor Proteins 0.000 description 12
- 102000006277 CDX2 Transcription Factor Human genes 0.000 description 12
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 12
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 10
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 10
- LLSDKQJKOVVTOJ-UHFFFAOYSA-L calcium chloride dihydrate Chemical compound O.O.[Cl-].[Cl-].[Ca+2] LLSDKQJKOVVTOJ-UHFFFAOYSA-L 0.000 description 10
- 229940052299 calcium chloride dihydrate Drugs 0.000 description 10
- 229960002897 heparin Drugs 0.000 description 10
- 229920000669 heparin Polymers 0.000 description 10
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
- 102000003952 Caspase 3 Human genes 0.000 description 8
- 108090000397 Caspase 3 Proteins 0.000 description 8
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 238000012136 culture method Methods 0.000 description 8
- 238000011161 development Methods 0.000 description 8
- 230000018109 developmental process Effects 0.000 description 8
- 230000012447 hatching Effects 0.000 description 8
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 8
- 229920000053 polysorbate 80 Polymers 0.000 description 8
- 229910052711 selenium Inorganic materials 0.000 description 8
- 239000011669 selenium Substances 0.000 description 8
- 229940091258 selenium supplement Drugs 0.000 description 8
- 150000003346 selenoethers Chemical class 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 229910052708 sodium Inorganic materials 0.000 description 8
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 8
- 229940054269 sodium pyruvate Drugs 0.000 description 8
- RBMGJIZCEWRQES-DKWTVANSSA-N (2s)-2,4-diamino-4-oxobutanoic acid;hydrate Chemical compound O.OC(=O)[C@@H](N)CC(N)=O RBMGJIZCEWRQES-DKWTVANSSA-N 0.000 description 6
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 6
- 229930182816 L-glutamine Natural products 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- 229960004441 tyrosine Drugs 0.000 description 6
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 5
- JFYSPQOGGYXMRQ-UHFFFAOYSA-N 3,7-dihydropurine-2,6-dione;sodium Chemical compound [Na].O=C1NC(=O)NC2=C1NC=N2 JFYSPQOGGYXMRQ-UHFFFAOYSA-N 0.000 description 5
- 102000002322 Egg Proteins Human genes 0.000 description 5
- 108010000912 Egg Proteins Proteins 0.000 description 5
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 5
- QIJRTFXNRTXDIP-JIZZDEOASA-N L-cysteine hydrochloride hydrate Chemical compound O.Cl.SC[C@H](N)C(O)=O QIJRTFXNRTXDIP-JIZZDEOASA-N 0.000 description 5
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 5
- 229960001948 caffeine Drugs 0.000 description 5
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 5
- 229940116977 epidermal growth factor Drugs 0.000 description 5
- 229960005309 estradiol Drugs 0.000 description 5
- 229940028334 follicle stimulating hormone Drugs 0.000 description 5
- 229930182830 galactose Natural products 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 229940040129 luteinizing hormone Drugs 0.000 description 5
- 210000004681 ovum Anatomy 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000001509 sodium citrate Substances 0.000 description 5
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 5
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- 241000283707 Capra Species 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- 229930040373 Paraformaldehyde Natural products 0.000 description 4
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 4
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 4
- 235000004279 alanine Nutrition 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- 230000029803 blastocyst development Effects 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 210000003855 cell nucleus Anatomy 0.000 description 4
- 230000005754 cellular signaling Effects 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 235000013365 dairy product Nutrition 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 229920002866 paraformaldehyde Polymers 0.000 description 4
- 230000008823 permeabilization Effects 0.000 description 4
- 210000004508 polar body Anatomy 0.000 description 4
- 229940076788 pyruvate Drugs 0.000 description 4
- IRPLSAGFWHCJIQ-UHFFFAOYSA-N selanylidenecopper Chemical compound [Se]=[Cu] IRPLSAGFWHCJIQ-UHFFFAOYSA-N 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- VRZRJHGCAJPXCE-UHFFFAOYSA-M sodium hydrogen sulfate trihydrate Chemical compound O.O.O.[Na+].OS([O-])(=O)=O VRZRJHGCAJPXCE-UHFFFAOYSA-M 0.000 description 4
- 235000010288 sodium nitrite Nutrition 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 239000012192 staining solution Substances 0.000 description 4
- 229960003495 thiamine Drugs 0.000 description 4
- 235000019157 thiamine Nutrition 0.000 description 4
- 239000011721 thiamine Substances 0.000 description 4
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 4
- 210000001541 thymus gland Anatomy 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 4
- OMCVXIQHMVXMNN-DFWYDOINSA-N 2-aminoacetic acid;(2s)-2,5-diamino-5-oxopentanoic acid Chemical compound NCC(O)=O.OC(=O)[C@@H](N)CCC(N)=O OMCVXIQHMVXMNN-DFWYDOINSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- ZGBSOTLWHZQNLH-UHFFFAOYSA-N [Mg].S(O)(O)(=O)=O Chemical compound [Mg].S(O)(O)(=O)=O ZGBSOTLWHZQNLH-UHFFFAOYSA-N 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 230000013020 embryo development Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229960002433 cysteine Drugs 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 230000008143 early embryonic development Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 238000012214 genetic breeding Methods 0.000 description 2
- 229960000645 histamine hydrochloride Drugs 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 229940035544 magnesium sulfate 100 mg Drugs 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 150000004682 monohydrates Chemical class 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 230000008010 sperm capacitation Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- HNYSIKXAASZNEM-JEDNCBNOSA-N (2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid;hydrate Chemical compound O.OC(=O)[C@@H](N)CC1=CNC=N1 HNYSIKXAASZNEM-JEDNCBNOSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000337007 Oceania Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- NEEHYRZPVYRGPP-VMWPPAERSA-L calcium;(2r,3s,4s,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C([O-])=O NEEHYRZPVYRGPP-VMWPPAERSA-L 0.000 description 1
- 108091092356 cellular DNA Proteins 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000000973 gametocyte Anatomy 0.000 description 1
- 230000006543 gametophyte development Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- QZRHHEURPZONJU-UHFFFAOYSA-N iron(2+) dinitrate nonahydrate Chemical compound O.O.O.O.O.O.O.O.O.[Fe+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O QZRHHEURPZONJU-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229960004051 menadione sodium bisulfite Drugs 0.000 description 1
- XDPFHGWVCTXHDX-UHFFFAOYSA-M menadione sodium sulfonate Chemical compound [Na+].C1=CC=C2C(=O)C(C)(S([O-])(=O)=O)CC(=O)C2=C1 XDPFHGWVCTXHDX-UHFFFAOYSA-M 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000016178 sex-linked disease Diseases 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0604—Whole embryos; Culture medium therefor
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/14—Calcium; Ca chelators; Calcitonin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/16—Magnesium; Mg chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/40—Nucleotides, nucleosides or bases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/31—Pituitary sex hormones, e.g. follicle-stimulating hormone [FSH], luteinising hormone [LH]; Chorionic gonadotropins
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Reproductive Health (AREA)
- Genetics & Genomics (AREA)
- Developmental Biology & Embryology (AREA)
- Gynecology & Obstetrics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Environmental Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明涉及牛卵母细胞体外受精胚胎培养的方法和所用的培养基。这种基础培养基是包含氯化钠、磷酸二氢钠、碳酸氢钠、醋酸钠等的水溶液。还涉及一种洗卵液和成熟培养液。其中牛体外受精胚胎培养的方法,包括如下步骤:卵母细胞的采集和体外成熟;体外受精;胚胎体外培养及保存。本发明牛体外受精胚胎培养的方法具有如说明书所述优异的技术效果。The invention relates to a method for culturing bovine oocyte fertilized embryos in vitro and a used culture medium. This basal medium is an aqueous solution containing sodium chloride, sodium dihydrogenphosphate, sodium bicarbonate, sodium acetate, and the like. It also relates to an egg washing liquid and a maturation culture liquid. Wherein the method for culturing bovine in vitro fertilized embryos comprises the following steps: collection and in vitro maturation of oocytes; in vitro fertilization; in vitro culture and preservation of embryos. The method for culturing bovine IVF embryos of the present invention has excellent technical effects as described in the description.
Description
技术领域technical field
本发明属于动物繁殖技术领域,涉及一种用于农业-畜牧兽医繁殖的技术,具体涉及一种牛体外受精胚胎培养的方法,另外,本发明还涉及牛体外受精胚胎培养的相关培养液在牛体外受精胚胎培养中的应用。进一步的,本发明还涉及使用该牛体外受精胚胎培养的相关培养液进行牛体外受精胚胎培养的方法。特别是,本发明牛体外受精胚胎培养的方法具有优异的技术效果。特别是,本发明涉及一种从牛进行活体或离采集体卵母细胞进而进行体外受精以及胚胎培养的方法。The invention belongs to the technical field of animal reproduction, and relates to a technology for agricultural-animal husbandry and veterinary reproduction, in particular to a method for culturing bovine in vitro fertilized embryos. In addition, the present invention also relates to the use of related culture fluids for the cultivation of bovine in vitro fertilized embryos. Application in in vitro fertilization embryo culture. Further, the present invention also relates to a method for culturing bovine IVF embryos using the relevant culture fluid for culturing bovine IVF embryos. In particular, the method for culturing bovine IVF embryos of the present invention has excellent technical effects. In particular, the present invention relates to a method for in vitro fertilization and embryo culture of live or isolated bovine oocytes.
背景技术Background technique
体外受精(In Vitro Fertilization)或(external fertilization)是指哺乳动物的精子和卵子在体外人工控制的环境中完成受精过程的技术,英文简称为IVF。由于它与胚胎移植技术(ET)密不可分,又简称为IVF-ET。在生物学中,把体外受精胚胎移植到母体后获得的动物称试管动物(test-tube animal)。这项技术成功于20世纪50年代,在最近20年发展迅速,现已日趋成熟而成为一项重要而常规的动物繁殖生物技术。In Vitro Fertilization (In Vitro Fertilization) or (external fertilization) refers to the technology in which mammalian sperm and eggs complete the fertilization process in an artificially controlled environment outside the body. It is referred to as IVF in English. Because it is inseparable from embryo transfer technology (ET), it is also referred to as IVF-ET. In biology, animals obtained by transplanting in vitro fertilized embryos into mothers are called test-tube animals. This technology was successfully developed in the 1950s, and has developed rapidly in the past 20 years. Now it has matured and become an important and conventional animal reproduction biotechnology.
体外受精技术对动物生殖机理研究、畜牧生产、医学和濒危动物保护等具有重要意义。如用小鼠、大鼠或家兔等作实验材料,体外受精技术可用于研究哺乳动物配子发生、受精和胚胎早期发育机理。在家畜品种改良中,体外受精技术为胚胎生产提供了廉价而高效的手段,对充分利用优良品种资源,缩短家畜繁殖周期,加快品种改良速度等有重要价值。在人类,IVF-ET技术是治疗某些不孕症和克服性连锁病的重要措施之一。体外受精技术还是哺乳动物胚胎移植、克隆、转基因和性别控制等现代生物技术不可缺少的组成部分。In vitro fertilization technology is of great significance to animal reproductive mechanism research, animal husbandry production, medicine and endangered animal protection. If mice, rats or rabbits are used as experimental materials, in vitro fertilization technology can be used to study the mechanism of mammalian gametogenesis, fertilization and early embryonic development. In the improvement of livestock breeds, in vitro fertilization technology provides cheap and efficient means for embryo production, and is of great value in making full use of fine breed resources, shortening the breeding cycle of livestock, and speeding up the speed of breed improvement. In humans, IVF-ET technology is one of the important measures to treat some infertility and overcome sex-linked diseases. In vitro fertilization technology is also an indispensable part of modern biotechnology such as mammalian embryo transfer, cloning, transgenic and sex control.
随着现代农业科技的发展,为了更充分利用良种母牛的繁殖潜力,加速遗传育种进程,在生产实践中应用高效的繁殖新技术成为必然。活体采卵(Ovum pick UP,OPU)和体外受精技术(In Vitro Fertilization,IVF)是二十世纪八十年代快速发展起来的胚胎工程新技术,二者相结合可获得大量遗传系谱明确的胚胎,从而缩短世代间隔。目前,这两种技术已经成为欧美和大洋洲等畜牧业发达国家的农场主为扩大良种母牛群而采用的重要繁殖技术。然而,采用常规的牛胚胎培养体系(CR1aa和SOF液),牛体外受精的囊胚发育率较低,而且胚胎质量也远不及体内胚胎,导致胚胎移植受体后的妊娠率低,因此如何提高囊胚发育率及胚胎质量成为体外受精胚胎生产的重点和研究的焦点。With the development of modern agricultural science and technology, in order to make full use of the reproductive potential of fine-bred cows and accelerate the process of genetic breeding, it is inevitable to apply efficient new breeding technologies in production practice. Ovum pick UP (OPU) and in vitro fertilization (In Vitro Fertilization, IVF) are new technologies for embryo engineering that developed rapidly in the 1980s. The combination of the two can obtain a large number of embryos with definite genetic pedigrees. thereby shortening the generation interval. At present, these two technologies have become important breeding technologies adopted by farmers in developed animal husbandry countries such as Europe, America and Oceania to expand the herd of fine-bred cows. However, using the conventional bovine embryo culture system (CR1aa and SOF solution), the development rate of bovine in vitro fertilized blastocysts is low, and the quality of embryos is far inferior to that of in vivo embryos, resulting in low pregnancy rates after embryo transfer to recipients, so how to improve Blastocyst development rate and embryo quality have become the focus and research focus of in vitro fertilization embryo production.
早在1878年,德国人Scnenk就以家兔和豚鼠为材料,开始探索哺乳动物的体外受精技术。但直到1951年,美籍华人张民觉和Austin分别发现精子体外获能现象后,体外受精技术才获得了突破性进展。牛体外受精技术受到卵母细胞的体外成熟、精子的体外获能、受精卵的体外培养环境等多个方面的影响。As early as 1878, the German Scnenk began to explore the in vitro fertilization technology of mammals using rabbits and guinea pigs as materials. However, it was not until 1951, when Chinese-Americans Zhang Minjue and Austin discovered the phenomenon of sperm capacitation separately, that in vitro fertilization technology made a breakthrough. The bovine in vitro fertilization technique is affected by many aspects such as in vitro maturation of oocytes, in vitro capacitation of sperm, and in vitro culture environment of fertilized eggs.
胚胎的体外培养是IVF技术的一个关键环节,亦是卵母细胞体外成熟和体外受精技术最终效果的体现和检验。在体外受精后,受精卵在向囊胚发育过程中将需经历一系列重要的变化,包括合子的形成、第一次卵裂、胚胎基因组的激活、致密化以及形成囊胚。这一过程中,外界环境的变化会导致基因表达发生改变,从而影响胚胎的正常发育及质量。目前,哺乳动物早期胚胎的体外培养研究主要集中在改善培养液成分以满足不同发育阶段的胚胎营养需求。基于Rosenkrans等(Rosenkrans,C.F.,Jr.and N.L.First,Effect of freeamino acids and vitamins on cleavage and developmental rate of bovine zygotesin vitro.J Anim Sci,1994.72(2):p.434-7)开发的Charles Rosenkrans 1(CR1)培养液和Tervit等(Tervit,H.R.,D.G.Whittingham,and L.E.Rowson,Successful culture invitro of sheep and cattle ova.J Reprod Fertil,1972.30(3):p.493-7)开发的合成输卵管液(Synthetic Oviductal Fluid,SOF),经多年不断改进逐步形成了两种培养体系。据Hakan Sagirkaya等(Sagirkaya,H.,et al.,Developmental potential of bovineoocytes cultured in different maturation and culture conditions.Anim ReprodSci,2007.101(3-4):p.225-40)和Somfai等(Somfai,T.,et al.,Development of bovineembryos cultured in CR1aa and IVD101 media using different oxygen tensionsand culture systems.Acta Vet Hung,2010.58(4):p.465-74)研究成果表明,CR1aa培养液用于牛胚胎培养有较好的效果,可以广泛应用于牛的胚胎培养;Thompson,J.G.等(Thompson,J.G.,et al.,Effect of inhibitors and uncouplers of oxidativephosphorylation during compaction and blastulation of bovine embryos culturedin vitro.J Reprod Fertil,2000.118(1):p.47-55)和Jean M.Feugang等(Feugang,J.M.,O.Camargo-Rodriguez,and E.Memili,Culture systems for bovine embryos.LivestockScience,2009.121(2-3):p.141-149)的研究结果显示,SOF培养液也是一种适合于牛胚胎培养的培养体系。张志平等(张志平,安志兴,张锈,张涌,牛胚胎培养体系的优化.西北农林科技大学学报,2006.34)和桑国俊等(桑国俊,牛卵母细胞及体外胚培养技术研究.2008)研究结果也显示,经过优化的CR1aa和SOF培养液均适合于牛的体外胚胎培养,均取得良好的培养效果。哺乳动物早期胚胎发育是一个高度协调且精确调节的过程。在进化过程中,配子细胞逐步形成了一系列的分子级联网络,以保证胚胎发育周期系统地进行。在发育过程中,胚胎的内外活性氧自由基(Reactive Oxygen Species,ROS)与抗氧化剂的平衡对早期胚胎发育起着决定性作用。The in vitro culture of embryos is a key link in IVF technology, and it is also the embodiment and test of the final effect of in vitro maturation of oocytes and in vitro fertilization technology. After in vitro fertilization, the fertilized egg will undergo a series of important changes during its development to the blastocyst, including the formation of the zygote, the first cleavage, activation of the embryonic genome, compaction, and formation of the blastocyst. During this process, changes in the external environment will lead to changes in gene expression, thereby affecting the normal development and quality of embryos. At present, research on in vitro culture of mammalian early embryos is mainly focused on improving the composition of the culture medium to meet the nutritional needs of embryos at different developmental stages. Based on the Charles Rosenkrans 1 developed by Rosenkrans et al. (CR1) culture fluid and the synthetic oviduct fluid developed by Tervit et al. Synthetic Oviductal Fluid, SOF), two culture systems have been gradually formed after years of continuous improvement. According to Hakan Sagirkaya et al. (Sagirkaya, H., et al., Developmental potential of bovineocytes cultured in different maturation and culture conditions. Anim ReprodSci, 2007.101 (3-4): p.225-40) and Somfai et al. (Somfai, T. , et al., Development of bovine embryos cultured in CR1aa and IVD101 media using different oxygen tensions and culture systems. Acta Vet Hung, 2010.58 (4): p.465-74) research results show that CR1aa culture medium is used for bovine embryo culture Good effect, can be widely used in bovine embryo culture; Thompson, J.G. et al. ): p.47-55) and Jean M.Feugang et al. ) showed that SOF medium is also a suitable culture system for bovine embryo culture. Zhang Zhiping (Zhang Zhiping, An Zhixing, Zhang Ru, Zhang Yong, Optimization of Bovine Embryo Culture System. Journal of Northwest A&F University, 2006.34) and Sang Guojun et al. (Sang Guojun, Research on bovine oocyte and in vitro embryo culture technology. 2008) research results also show that the optimized CR1aa and SOF culture medium are suitable for bovine embryo culture in vitro, and both have achieved good culture effects. Early mammalian embryonic development is a highly coordinated and precisely regulated process. During evolution, gametocytes gradually formed a series of molecular cascade networks to ensure that the embryonic development cycle proceeded systematically. During development, the balance of reactive oxygen species (Reactive Oxygen Species, ROS) and antioxidants in the embryo plays a decisive role in early embryonic development.
大多生化反应均产生ROS,其在细胞内、外均有着重要的作用,一部分ROS起着信号分子的作用,但是大多数ROS对机体是有害的。Brooker,R.J.等(Brooker,R.J.,Genetics:analysis and principles(4th ed.).McGraw-Hill Science,2011)报道,ROS可以引起细胞DNA损伤、不饱和脂肪酸的氧化、蛋白质中氨基酸的氧化甚至可以导致某些酶的失活。一般来说,ROS以四种形式存在,其中H2O2氧化作用较强,是引起氧化伤害的最主要因素。Most biochemical reactions produce ROS, which play an important role inside and outside the cell. Some ROS play the role of signaling molecules, but most ROS are harmful to the body. Brooker, R.J. et al. (Brooker, R.J., Genetics: analysis and principles (4th ed.). McGraw-Hill Science, 2011) reported that ROS can cause cellular DNA damage, oxidation of unsaturated fatty acids, oxidation of amino acids in proteins can even lead to Inactivation of certain enzymes. Generally speaking, ROS exists in four forms, among which H2O2 has a strong oxidation effect and is the most important factor causing oxidative damage.
大量研究表明,谷胱甘肽(GSH)是以非蛋白质形式存在的一种抗氧化剂,能够清除多种自由基:超氧阴离子自由基、羟基自由基、过氧化氢、次氯酸和脂氧自由基,并且能够维持细胞内外氧化还原平衡。细胞内外环境GSH和ROS水平是影响受精卵发育过程中的两个重要因素。早在2000年,de Matos等(de Matos,D.G.and C.C.Furnus,The importance ofhaving high glutathione(GSH)level after bovine in vitro maturation on embryodevelopment effect of beta-mercaptoethanol,cysteine andcystine.Theriogenology,2000.53(3):p.761-71)曾通过在体外胚胎培养过程中添加β-巯基乙醇、半胱氨酸和胱氨酸来提高囊胚率。A large number of studies have shown that glutathione (GSH) is an antioxidant that exists in a non-protein form and can scavenge a variety of free radicals: superoxide anion radicals, hydroxyl radicals, hydrogen peroxide, hypochlorous acid and lipid oxygen Free radicals, and can maintain intracellular and intracellular redox balance. The levels of GSH and ROS in the internal and external environment of cells are two important factors affecting the development of fertilized eggs. As early as 2000, de Matos et al. (de Matos, D.G. and C.C. Furnus, The importance of having high glutathione (GSH) level after bovine in vitro maturation on embryodevelopment effect of beta-mercaptoethanol, cysteine and cystine. Theriogenology, 2000.53(3): p .761-71) have increased blastocyst rate by adding β-mercaptoethanol, cysteine and cystine during in vitro embryo culture.
尽管体外受精技术能成功应用于许多哺乳动物,但由于体外受精的囊胚率低而导致体外受精胚胎的生产成本高、效率低,限制了该技术在牛快速扩繁实践中的广泛应用。因此,如何能够降低成本并提高牛IVF胚胎生产效率和胚胎质量成为亟待解决的问题。Although in vitro fertilization technology can be successfully applied to many mammals, the high cost and low efficiency of in vitro fertilized embryo production due to the low blastocyst rate of in vitro fertilization limit the wide application of this technology in the practice of rapid multiplication of cattle. Therefore, how to reduce the cost and improve the production efficiency and embryo quality of bovine IVF embryos has become an urgent problem to be solved.
目前,牛体外受精的技术体系中主要以CR1aa和SOF液为胚胎体外培养液,并在此基础上进行改进,囊胚发育率均有不同程度的提高,囊胚发育率平均为30%-40%。对于囊胚质量,可以通过囊胚细胞总数、ICM细胞数/总细胞数比例、细胞凋亡率来评估。囊胚细胞总数根据囊胚所处阶段的不同而不同,S.Iwasaki等(Iwasaki,S.and T.Nakahara,Cellnumber and incidence of chromosomal anomalies in bovine blastocystsfertilized in vitro followed by culture in vitro or in vivo in rabbitoviducts.Theriogenology,1990.33(3):p.669-75)获得的牛早期囊胚总细胞数平均为44,ICM细胞数/囊胚总细胞数比例为15.8%左右;Andrew J.Watson等(Watson,A.J.,et al.,Impact of bovine oocyte maturation media on oocyte transcript levels,blastocyst development,cell number,and apoptosis.Biol Reprod,2000.62(2):p.355-64)统计牛囊胚细胞凋亡率约为7.7%-13%。At present, in the technical system of bovine in vitro fertilization, CR1aa and SOF solution are mainly used as embryo in vitro culture medium, and on this basis, the development rate of blastocysts has been improved to varying degrees, and the average rate of blastocyst development is 30%-40 %. The quality of blastocysts can be evaluated by the total number of blastocyst cells, the ratio of the number of ICM cells to the total number of cells, and the rate of apoptosis. The total number of blastocyst cells varies according to the stage of the blastocyst, S.Iwasaki et al. .Theriogenology, 1990.33 (3): p.669-75) the average number of bovine early blastocyst total cells obtained is 44, and the ICM cell number/blastocyst total cell number ratio is about 15.8%; Andrew J.Watson etc. (Watson, A.J., et al., Impact of bovine oocyte maturation media on oocyte transcript levels, blastocyst development, cell number, and apoptosis. Biol Reprod, 2000.62(2): p.355-64) statistics bovine blastocyst cell apoptosis rate is about 7.7%-13%.
CN103898046B(中国专利申请号201410073635.4)公开了一种专用于牛体外受精胚胎的培养液,所述培养液配方为:NaCl 109.5mM、KCl 3.1mM、NaHCO3 26.2mM、MgCl2·6H2O 0.8mM、KH2PO3 1.19mM、丙酮酸钠0.4mM、葡萄糖1.5mM、半乳糖酸钙5mM、10v/v%胎牛血清、L-谷氨酰胺1mM、2v/v%必需氨基酸、1v/v%非必须氨基酸和谷胱甘肽3mM,以水配制;所述必需氨基酸为以下氨基酸按比例混合后配制的水溶液,其中,各氨基酸含量为:L-盐酸精氨酸6.32g/L、L-胱氨酸二盐酸盐1.564g/L、L-盐酸组氨酸一水物2.1g/L、L-异亮氨酸2.625g/L、L-亮氨酸2.62g/L、L-赖氨酸盐酸盐3.625g/L、L-蛋氨酸0.755g/L、L-苯丙氨酸1.65g/L、L-苏氨酸2.38g/L、L-色氨酸0.51g/L、L-酪氨酸1.8g/L和L-缬氨酸2.34g/L;所述非必须氨基酸为以下氨基酸按比例混合后配制的水溶液,其中,各氨基酸含量为:L-丙氨酸0.89g/L、L-天门冬酰胺一水物1.5g/L、L-天冬氨酸1.33g/L、L-谷氨酸1.47g/L、甘氨酸0.75g/L、L-脯氨酸1.15g/L和L-丝氨酸1.05g/L。将牛体外受精胚胎置于上述培养液中进行体外培养,据信结果显示明显优于未添加GSH的对照组,提高了囊胚发育率及胚胎质量,降低体外生产胚胎的成本,为牛IVF技术应用于实践提供实验基础,可大大加速遗传育种进程。CN103898046B (Chinese Patent Application No. 201410073635.4) discloses a culture solution specially used for bovine IVF embryos. The formula of the culture solution is: NaCl 109.5mM, KCl 3.1mM, NaHCO3 26.2mM, MgCl2 6H2O 0.8mM, KH2PO3 1.19mM , sodium pyruvate 0.4mM, glucose 1.5mM, calcium galactonate 5mM, 10v/v% fetal bovine serum, L-glutamine 1mM, 2v/v% essential amino acids, 1v/v% non-essential amino acids and glutathione Peptide 3mM, prepared with water; the essential amino acid is an aqueous solution prepared by mixing the following amino acids in proportion, wherein the content of each amino acid is: L-arginine hydrochloride 6.32g/L, L-cystine dihydrochloride 1.564 g/L, L-histidine hydrochloride monohydrate 2.1g/L, L-isoleucine 2.625g/L, L-leucine 2.62g/L, L-lysine hydrochloride 3.625g/L L, L-methionine 0.755g/L, L-phenylalanine 1.65g/L, L-threonine 2.38g/L, L-tryptophan 0.51g/L, L-tyrosine 1.8g/L and L-valine 2.34g/L; the non-essential amino acid is the aqueous solution prepared after mixing the following amino acids in proportion, wherein, each amino acid content is: L-alanine 0.89g/L, L-asparagine- Water 1.5g/L, L-aspartic acid 1.33g/L, L-glutamic acid 1.47g/L, glycine 0.75g/L, L-proline 1.15g/L and L-serine 1.05g/L L. Bovine in vitro fertilized embryos are placed in the above culture medium for in vitro culture. It is believed that the results are significantly better than the control group without GSH, which improves the blastocyst development rate and embryo quality, and reduces the cost of producing embryos in vitro. It is a bovine IVF technology. The application in practice provides an experimental basis, which can greatly accelerate the process of genetic breeding.
其他参考文献:Other references:
陈大元.受精生物学.2003,北京:科学出版社;Chen Dayuan. Fertilization Biology. 2003, Beijing: Science Press;
方俊顺.牛胚胎体外生产技术研究.《中国优秀硕士学位论文全文数据库.农业科技辑》.2007,(第4期);Fang Junshun. Research on In Vitro Production Technology of Bovine Embryos. "China Excellent Master's Dissertations Full-text Database. Agricultural Science and Technology Series". 2007, (No. 4);
曹海清.卵丘细胞和培养条件对牛体外胚胎生产效率的影响.《中国优秀硕士学位论文全文数据库.农业科技辑》.2008,(第9期);Cao Haiqing. The effect of cumulus cells and culture conditions on the production efficiency of bovine in vitro embryos. "China Excellent Master's Dissertation Full-text Database. Agricultural Science and Technology Series". 2008, (No. 9);
I.H.KIM et al.Effect of exogenous glutathione on the in vitrofertilization of bovine oocytes.Theriogenology.1999,Vol.52(3)。I.H.KIM et al.Effect of exogenous glutathione on the in vitrofertilization of bovine oocytes.Theriogenology.1999,Vol.52(3).
然而,本领域仍然期待有性能改进的牛体外受精胚胎的培养的方法,例如仍然期待有提高牛体外受精胚胎培养效率的方法,例如有具有优异的成本优势的牛体外受精胚胎培养的方法。However, the art still expects a method for culturing bovine IVF embryos with improved performance, such as a method for improving the efficiency of bovine IVF embryo cultivation, for example, a method for cultivating bovine IVF embryos with excellent cost advantages.
发明内容Contents of the invention
本发明的目的在于提供一种性能改进的牛体外受精胚胎培养的方法,特别是期待提高牛IVF胚胎生产效率和胚胎质量。更具体的,本发明为达成上述目的而需要提供一种专用于牛体外受精胚胎的相关培养液和以及使用该培养液进行牛体外受精胚胎培养的方法。本发明人已经出人意料的发现,使用本发明方法呈现优异的技术效果,本发明因此发现而得以完成。The purpose of the present invention is to provide a method for cultivating bovine IVF embryos with improved performance, especially expecting to improve the production efficiency and embryo quality of bovine IVF embryos. More specifically, in order to achieve the above-mentioned purpose, the present invention needs to provide a related culture fluid specially used for bovine IVF embryos and a method for culturing bovine IVF embryos using the culture fluid. The present inventors have unexpectedly found that the use of the method of the present invention exhibits excellent technical effects, and the present invention has been accomplished by this discovery.
为此,本发明第一方面提供了一种可称为BY基础培养液的基础培养液,其是包含如下组分的水溶液:氯化钙180~220mg/L、九水硝酸铁0.70~0.75mg/L、氯化钾380~420mg/L、硫酸镁90~100mg/L、氯化钠6500~7000mg/L、一水磷酸二氢钠130~150mg/L、碳酸氢钠2000~2500mg/L、醋酸钠40~60mg/L、L-丙氨酸20~30mg/L、L-精氨酸盐酸盐60~80mg/L、L-天冬氨酸25~35mg/L、L-半胱氨酸盐酸盐一水合物0.10~0.12mg/L、L-胱氨酸二盐酸盐20~30mg/L、L-谷氨酸70~80mg/L、甘氨酸40~60mg/L、L-组氨酸盐酸盐一水合物20~25mg/L、L-羟脯氨酸8~12mg/L、L-异亮氨酸15~25mg/L、L-亮氨酸50~70mg/L、L-赖氨酸盐酸盐60~80mg/L、L-蛋氨酸10~20mg/L、L-苯丙氨酸20~30mg/L、L-脯氨酸30~50mg/L、L-丝氨酸20~30mg/L、L-苏氨酸25~35mg/L、L-色氨酸8~12mg/L、L-酪氨酸二钠二水合物55~60mg/L、L-缬氨酸20~30mg/L、抗坏血酸0.04~0.06mg/L、α-D-生育酚磷酸酯0.008~0.012mg/L、生物素0.008~0.012mg/L、骨化醇0.08~0.12mg/L、D-泛酸钙0.008~0.012mg/L、氯化胆碱0.4~0.6mg/L、叶酸0.008~0.012mg/L、肌醇0.04~0.06mg/L、三水合甲萘醌亚硫酸氢钠0.015~0.025mg/L、烟酸0.02~0.03mg/L、烟酰胺0.02~0.03mg/L、p-氨基苯甲酸0.04~0.06mg/L、盐酸吡哆辛0.04~0.06mg/L、核黄素0.008~0.012mg/L、盐酸硫胺素0.008~0.012mg/L、维生素A乙酸酯0.1~0.2mg/L、硫酸腺嘌呤8~12mg/L、腺嘌呤0.15~0.25mg/L、腺苷三磷酸二钠0.8~1.2mg/L、胆固醇0.15~0.25mg/L、2-脱氧-D-核糖0.4~0.6mg/L、D-葡萄糖800~1200mg/L、谷胱甘肽0.04~0.06mg/L、盐酸鸟嘌呤0.25~0.35mg/L、次黄嘌呤钠0.3~0.4mg/L、核糖0.4~0.6mg/L、胸腺素0.25~0.35mg/L、吐温804~6mg/L、尿嘧啶0.25~0.35mg/L、黄嘌呤钠0.3~0.4mg/L、酚红8~12mg/L。For this reason, the first aspect of the present invention provides a kind of basal culture solution that can be called BY basal culture solution, which is an aqueous solution comprising the following components: calcium chloride 180-220 mg/L, iron nitrate nonahydrate 0.70-0.75 mg /L, Potassium Chloride 380~420mg/L, Magnesium Sulfate 90~100mg/L, Sodium Chloride 6500~7000mg/L, Sodium Dihydrogen Phosphate Monohydrate 130~150mg/L, Sodium Bicarbonate 2000~2500mg/L, Sodium acetate 40~60mg/L, L-alanine 20~30mg/L, L-arginine hydrochloride 60~80mg/L, L-aspartic acid 25~35mg/L, L-cysteine Hydrochloride monohydrate 0.10~0.12mg/L, L-cystine dihydrochloride 20~30mg/L, L-glutamic acid 70~80mg/L, glycine 40~60mg/L, L-group Amino acid hydrochloride monohydrate 20~25mg/L, L-hydroxyproline 8~12mg/L, L-isoleucine 15~25mg/L, L-leucine 50~70mg/L, L -Lysine hydrochloride 60~80mg/L, L-methionine 10~20mg/L, L-phenylalanine 20~30mg/L, L-proline 30~50mg/L, L-serine 20~ 30mg/L, L-threonine 25~35mg/L, L-tryptophan 8~12mg/L, L-tyrosine disodium dihydrate 55~60mg/L, L-valine 20~30mg /L, ascorbic acid 0.04~0.06mg/L, α-D-tocopheryl phosphate 0.008~0.012mg/L, biotin 0.008~0.012mg/L, calcidol 0.08~0.12mg/L, D-calcium pantothenate 0.008 ~0.012mg/L, choline chloride 0.4~0.6mg/L, folic acid 0.008~0.012mg/L, inositol 0.04~0.06mg/L, menadione sodium bisulfite trihydrate 0.015~0.025mg/L, Niacin 0.02~0.03mg/L, Niacinamide 0.02~0.03mg/L, p-aminobenzoic acid 0.04~0.06mg/L, pyridoxine hydrochloride 0.04~0.06mg/L, riboflavin 0.008~0.012mg/L , Thiamine hydrochloride 0.008~0.012mg/L, vitamin A acetate 0.1~0.2mg/L, adenine sulfate 8~12mg/L, adenine 0.15~0.25mg/L, adenosine triphosphate disodium 0.8~ 1.2mg/L, cholesterol 0.15~0.25mg/L, 2-deoxy-D-ribose 0.4~0.6mg/L, D-glucose 800~1200mg/L, glutathione 0.04~0.06mg/L, guanine hydrochloride 0.25~0.35mg/L, sodium hypoxanthine 0.3~0.4mg/L, ribose 0.4~0.6mg/L, thymosin 0.2 5~0.35mg/L, Tween 804~6mg/L, uracil 0.25~0.35mg/L, xanthine sodium 0.3~0.4mg/L, phenol red 8~12mg/L.
根据本发明第一方面的基础培养液,其是包含如下组分的水溶液:氯化钙200mg/L、九水硝酸铁0.72mg/L、氯化钾400mg/L、硫酸镁97.7mg/L、氯化钠6800mg/L、一水磷酸二氢钠140mg/L、碳酸氢钠2200mg/L、醋酸钠50mg/L、L-丙氨酸25mg/L、L-精氨酸盐酸盐70mg/L、L-天冬氨酸30mg/L、L-半胱氨酸盐酸盐一水合物0.11mg/L、L-胱氨酸二盐酸盐26mg/L、L-谷氨酸75mg/L、甘氨酸50mg/L、L-组氨酸盐酸盐一水合物21.88mg/L、L-羟脯氨酸10mg/L、L-异亮氨酸20mg/L、L-亮氨酸60mg/L、L-赖氨酸盐酸盐70mg/L、L-蛋氨酸15mg/L、L-苯丙氨酸25mg/L、L-脯氨酸40mg/L、L-丝氨酸25mg/L、L-苏氨酸30mg/L、L-色氨酸10mg/L、L-酪氨酸二钠二水合物57.66mg/L、L-缬氨酸25mg/L、抗坏血酸0.05mg/L、α-D-生育酚磷酸酯0.01mg/L、生物素0.01mg/L、骨化醇0.1mg/L、D-泛酸钙0.01mg/L、氯化胆碱0.5mg/L、叶酸0.01mg/L、肌醇0.05mg/L、三水合甲萘醌亚硫酸氢钠0.019mg/L、烟酸0.025mg/L、烟酰胺0.025mg/L、p-氨基苯甲酸0.05mg/L、盐酸吡哆辛0.05mg/L、核黄素0.01mg/L、盐酸硫胺素0.01mg/L、维生素A乙酸酯0.14mg/L、硫酸腺嘌呤10mg/L、腺嘌呤0.2mg/L、腺苷三磷酸二钠1mg/L、胆固醇0.2mg/L、2-脱氧-D-核糖0.5mg/L、D-葡萄糖1000mg/L、谷胱甘肽0.05mg/L、盐酸鸟嘌呤0.3mg/L、次黄嘌呤钠0.354mg/L、核糖0.5mg/L、胸腺素0.3mg/L、吐温805mg/L、尿嘧啶0.3mg/L、黄嘌呤钠0.34mg/L、酚红10mg/L。The basal culture solution according to the first aspect of the present invention is an aqueous solution comprising the following components: calcium chloride 200mg/L, ferric nitrate nonahydrate 0.72mg/L, potassium chloride 400mg/L, magnesium sulfate 97.7mg/L, Sodium chloride 6800mg/L, sodium dihydrogen phosphate monohydrate 140mg/L, sodium bicarbonate 2200mg/L, sodium acetate 50mg/L, L-alanine 25mg/L, L-arginine hydrochloride 70mg/L , L-aspartic acid 30mg/L, L-cysteine hydrochloride monohydrate 0.11mg/L, L-cystine dihydrochloride 26mg/L, L-glutamic acid 75mg/L, Glycine 50mg/L, L-histidine hydrochloride monohydrate 21.88mg/L, L-hydroxyproline 10mg/L, L-isoleucine 20mg/L, L-leucine 60mg/L, L-lysine hydrochloride 70mg/L, L-methionine 15mg/L, L-phenylalanine 25mg/L, L-proline 40mg/L, L-serine 25mg/L, L-threonine 30mg/L, L-tryptophan 10mg/L, L-tyrosine disodium dihydrate 57.66mg/L, L-valine 25mg/L, ascorbic acid 0.05mg/L, α-D-tocopheryl phosphate Esters 0.01mg/L, biotin 0.01mg/L, calcidol 0.1mg/L, D-calcium pantothenate 0.01mg/L, choline chloride 0.5mg/L, folic acid 0.01mg/L, inositol 0.05mg/L L, menaquinone trihydrate sodium bisulfite 0.019mg/L, niacin 0.025mg/L, nicotinamide 0.025mg/L, p-aminobenzoic acid 0.05mg/L, pyridoxine hydrochloride 0.05mg/L, nuclear Flavin 0.01mg/L, thiamine hydrochloride 0.01mg/L, vitamin A acetate 0.14mg/L, adenine sulfate 10mg/L, adenine 0.2mg/L, adenosine triphosphate disodium 1mg/L, Cholesterol 0.2mg/L, 2-deoxy-D-ribose 0.5mg/L, D-glucose 1000mg/L, glutathione 0.05mg/L, guanine hydrochloride 0.3mg/L, hypoxanthine sodium 0.354mg/L , ribose 0.5mg/L, thymosin 0.3mg/L, Tween 805mg/L, uracil 0.3mg/L, xanthine sodium 0.34mg/L, phenol red 10mg/L.
根据本发明第一方面的基础培养液,其中还包括亚硒酸钠,其浓度为0.2~0.3mg/L,例如0.25mg/L;和/或,所述其中还包括硫酸铜,其浓度以无水物计为0.05~0.1mg/L,例如0.075mg/L。According to the basal culture solution of the first aspect of the present invention, it also includes sodium selenite at a concentration of 0.2-0.3 mg/L, such as 0.25 mg/L; and/or, it also includes copper sulfate at a concentration of The anhydrous content is 0.05-0.1 mg/L, such as 0.075 mg/L.
进一步的,本发明第二方面提供了一种洗卵液,其是添加了3mg/mL牛血清白蛋白的BY基础培养液。Furthermore, the second aspect of the present invention provides an egg washing liquid, which is BY basic culture liquid supplemented with 3 mg/mL bovine serum albumin.
根据本发明第二方面的洗卵液,其中所述BY基础培养液是包含如下组分的水溶液:氯化钙180~220mg/L、九水硝酸铁0.70~0.75mg/L、氯化钾380~420mg/L、硫酸镁90~100mg/L、氯化钠6500~7000mg/L、一水磷酸二氢钠130~150mg/L、碳酸氢钠2000~2500mg/L、醋酸钠40~60mg/L、L-丙氨酸20~30mg/L、L-精氨酸盐酸盐60~80mg/L、L-天冬氨酸25~35mg/L、L-半胱氨酸盐酸盐一水合物0.10~0.12mg/L、L-胱氨酸二盐酸盐20~30mg/L、L-谷氨酸70~80mg/L、甘氨酸40~60mg/L、L-组氨酸盐酸盐一水合物20~25mg/L、L-羟脯氨酸8~12mg/L、L-异亮氨酸15~25mg/L、L-亮氨酸50~70mg/L、L-赖氨酸盐酸盐60~80mg/L、L-蛋氨酸10~20mg/L、L-苯丙氨酸20~30mg/L、L-脯氨酸30~50mg/L、L-丝氨酸20~30mg/L、L-苏氨酸25~35mg/L、L-色氨酸8~12mg/L、L-酪氨酸二钠二水合物55~60mg/L、L-缬氨酸20~30mg/L、抗坏血酸0.04~0.06mg/L、α-D-生育酚磷酸酯0.008~0.012mg/L、生物素0.008~0.012mg/L、骨化醇0.08~0.12mg/L、D-泛酸钙0.008~0.012mg/L、氯化胆碱0.4~0.6mg/L、叶酸0.008~0.012mg/L、肌醇0.04~0.06mg/L、三水合甲萘醌亚硫酸氢钠0.015~0.025mg/L、烟酸0.02~0.03mg/L、烟酰胺0.02~0.03mg/L、p-氨基苯甲酸0.04~0.06mg/L、盐酸吡哆辛0.04~0.06mg/L、核黄素0.008~0.012mg/L、盐酸硫胺素0.008~0.012mg/L、维生素A乙酸酯0.1~0.2mg/L、硫酸腺嘌呤8~12mg/L、腺嘌呤0.15~0.25mg/L、腺苷三磷酸二钠0.8~1.2mg/L、胆固醇0.15~0.25mg/L、2-脱氧-D-核糖0.4~0.6mg/L、D-葡萄糖800~1200mg/L、谷胱甘肽0.04~0.06mg/L、盐酸鸟嘌呤0.25~0.35mg/L、次黄嘌呤钠0.3~0.4mg/L、核糖0.4~0.6mg/L、胸腺素0.25~0.35mg/L、吐温804~6mg/L、尿嘧啶0.25~0.35mg/L、黄嘌呤钠0.3~0.4mg/L、酚红8~12mg/L。According to the egg washing solution of the second aspect of the present invention, wherein the BY basic culture solution is an aqueous solution comprising the following components: 180-220 mg/L of calcium chloride, 0.70-0.75 mg/L of ferric nitrate nonahydrate, and 380 mg/L of potassium chloride ~420mg/L, magnesium sulfate 90~100mg/L, sodium chloride 6500~7000mg/L, sodium dihydrogen phosphate monohydrate 130~150mg/L, sodium bicarbonate 2000~2500mg/L, sodium acetate 40~60mg/L , L-alanine 20~30mg/L, L-arginine hydrochloride 60~80mg/L, L-aspartic acid 25~35mg/L, L-cysteine hydrochloride monohydrate 0.10~0.12mg/L, L-cystine dihydrochloride 20~30mg/L, L-glutamic acid 70~80mg/L, glycine 40~60mg/L, L-histidine hydrochloride monohydrate 20~25mg/L, L-hydroxyproline 8~12mg/L, L-isoleucine 15~25mg/L, L-leucine 50~70mg/L, L-lysine hydrochloride 60~80mg/L, L-methionine 10~20mg/L, L-phenylalanine 20~30mg/L, L-proline 30~50mg/L, L-serine 20~30mg/L, L-threo Amino acid 25~35mg/L, L-tryptophan 8~12mg/L, L-tyrosine disodium dihydrate 55~60mg/L, L-valine 20~30mg/L, ascorbic acid 0.04~0.06 mg/L, α-D-tocopheryl phosphate 0.008~0.012mg/L, biotin 0.008~0.012mg/L, calcidol 0.08~0.12mg/L, D-calcium pantothenate 0.008~0.012mg/L, chlorine Choline 0.4~0.6mg/L, folic acid 0.008~0.012mg/L, inositol 0.04~0.06mg/L, menaquinone sodium bisulfite trihydrate 0.015~0.025mg/L, niacin 0.02~0.03mg/L L. Niacinamide 0.02~0.03mg/L, p-aminobenzoic acid 0.04~0.06mg/L, pyridoxine hydrochloride 0.04~0.06mg/L, riboflavin 0.008~0.012mg/L, thiamine hydrochloride 0.008~ 0.012mg/L, vitamin A acetate 0.1~0.2mg/L, adenine sulfate 8~12mg/L, adenine 0.15~0.25mg/L, adenosine triphosphate disodium 0.8~1.2mg/L, cholesterol 0.15 ~0.25mg/L, 2-deoxy-D-ribose 0.4~0.6mg/L, D-glucose 800~1200mg/L, glutathione 0.04~0.06mg/L, guanine hydrochloride 0.25~0.35mg/L, Hypoxanthine Sodium 0.3~0.4mg/L, Ribose 0.4~0.6mg/L, Thymosin 0.25~0.35mg /L, Tween 804~6mg/L, uracil 0.25~0.35mg/L, xanthine sodium 0.3~0.4mg/L, phenol red 8~12mg/L.
根据本发明第二方面的洗卵液,其中所述BY基础培养液是包含如下组分的水溶液:氯化钙200mg/L、九水硝酸铁0.72mg/L、氯化钾400mg/L、硫酸镁97.7mg/L、氯化钠6800mg/L、一水磷酸二氢钠140mg/L、碳酸氢钠2200mg/L、醋酸钠50mg/L、L-丙氨酸25mg/L、L-精氨酸盐酸盐70mg/L、L-天冬氨酸30mg/L、L-半胱氨酸盐酸盐一水合物0.11mg/L、L-胱氨酸二盐酸盐26mg/L、L-谷氨酸75mg/L、甘氨酸50mg/L、L-组氨酸盐酸盐一水合物21.88mg/L、L-羟脯氨酸10mg/L、L-异亮氨酸20mg/L、L-亮氨酸60mg/L、L-赖氨酸盐酸盐70mg/L、L-蛋氨酸15mg/L、L-苯丙氨酸25mg/L、L-脯氨酸40mg/L、L-丝氨酸25mg/L、L-苏氨酸30mg/L、L-色氨酸10mg/L、L-酪氨酸二钠二水合物57.66mg/L、L-缬氨酸25mg/L、抗坏血酸0.05mg/L、α-D-生育酚磷酸酯0.01mg/L、生物素0.01mg/L、骨化醇0.1mg/L、D-泛酸钙0.01mg/L、氯化胆碱0.5mg/L、叶酸0.01mg/L、肌醇0.05mg/L、三水合甲萘醌亚硫酸氢钠0.019mg/L、烟酸0.025mg/L、烟酰胺0.025mg/L、p-氨基苯甲酸0.05mg/L、盐酸吡哆辛0.05mg/L、核黄素0.01mg/L、盐酸硫胺素0.01mg/L、维生素A乙酸酯0.14mg/L、硫酸腺嘌呤10mg/L、腺嘌呤0.2mg/L、腺苷三磷酸二钠1mg/L、胆固醇0.2mg/L、2-脱氧-D-核糖0.5mg/L、D-葡萄糖1000mg/L、谷胱甘肽0.05mg/L、盐酸鸟嘌呤0.3mg/L、次黄嘌呤钠0.354mg/L、核糖0.5mg/L、胸腺素0.3mg/L、吐温805mg/L、尿嘧啶0.3mg/L、黄嘌呤钠0.34mg/L、酚红10mg/L。According to the egg washing solution of the second aspect of the present invention, wherein the BY basic culture solution is an aqueous solution comprising the following components: calcium chloride 200mg/L, ferric nitrate nonahydrate 0.72mg/L, potassium chloride 400mg/L, sulfuric acid Magnesium 97.7mg/L, Sodium Chloride 6800mg/L, Sodium Dihydrogen Phosphate Monohydrate 140mg/L, Sodium Bicarbonate 2200mg/L, Sodium Acetate 50mg/L, L-Alanine 25mg/L, L-Arginine Hydrochloride 70mg/L, L-aspartic acid 30mg/L, L-cysteine hydrochloride monohydrate 0.11mg/L, L-cystine dihydrochloride 26mg/L, L-glutamine Glycine 75mg/L, Glycine 50mg/L, L-Histidine Hydrochloride Monohydrate 21.88mg/L, L-Hydroxyproline 10mg/L, L-Isoleucine 20mg/L, L-Leucine Amino acid 60mg/L, L-lysine hydrochloride 70mg/L, L-methionine 15mg/L, L-phenylalanine 25mg/L, L-proline 40mg/L, L-serine 25mg/L , L-Threonine 30mg/L, L-Tryptophan 10mg/L, L-Tyrosine Disodium Dihydrate 57.66mg/L, L-Valine 25mg/L, Ascorbic Acid 0.05mg/L, α -D-tocopheryl phosphate 0.01mg/L, biotin 0.01mg/L, calcidol 0.1mg/L, D-calcium pantothenate 0.01mg/L, choline chloride 0.5mg/L, folic acid 0.01mg/L , Inositol 0.05mg/L, Menaquinone Sodium Bisulfite Trihydrate 0.019mg/L, Nicotinic Acid 0.025mg/L, Niacinamide 0.025mg/L, p-Aminobenzoic Acid 0.05mg/L, Pyridoxine Hydrochloride 0.05mg/L, riboflavin 0.01mg/L, thiamine hydrochloride 0.01mg/L, vitamin A acetate 0.14mg/L, adenine sulfate 10mg/L, adenine 0.2mg/L, adenosine triphosphate Disodium 1mg/L, Cholesterol 0.2mg/L, 2-Deoxy-D-ribose 0.5mg/L, D-glucose 1000mg/L, Glutathione 0.05mg/L, Guanine Hydrochloride 0.3mg/L, Hypoxanthin Purine sodium 0.354mg/L, ribose 0.5mg/L, thymosin 0.3mg/L, Tween 805mg/L, uracil 0.3mg/L, xanthine sodium 0.34mg/L, phenol red 10mg/L.
根据本发明第二方面的洗卵液,其中所述BY基础培养液中还包括亚硒酸钠,其浓度为0.2~0.3mg/L,例如0.25mg/L;和/或,所述BY基础培养液中还包括硫酸铜,其浓度以无水物计为0.05~0.1mg/L,例如0.075mg/L。According to the egg washing solution according to the second aspect of the present invention, wherein the BY base culture solution also includes sodium selenite, the concentration of which is 0.2-0.3 mg/L, such as 0.25 mg/L; and/or, the BY base The culture solution also includes copper sulfate, the concentration of which is 0.05-0.1 mg/L in terms of anhydrous matter, such as 0.075 mg/L.
进一步的,本发明第三方面提供了一种成熟培养液,其是添加了100mL/L FBS、10μg/mL FSH、10μg/mL LH、1μg/mL E2、20ng/mL EGF的BY基础培养液。Further, the third aspect of the present invention provides a mature culture medium, which is BY basal culture medium supplemented with 100mL/L FBS, 10μg/mL FSH, 10μg/mL LH, 1μg/mL E2, and 20ng/mL EGF.
根据本发明第三方面的成熟培养液,其中所述BY基础培养液是包含如下组分的水溶液:氯化钙180~220mg/L、九水硝酸铁0.70~0.75mg/L、氯化钾380~420mg/L、硫酸镁90~100mg/L、氯化钠6500~7000mg/L、一水磷酸二氢钠130~150mg/L、碳酸氢钠2000~2500mg/L、醋酸钠40~60mg/L、L-丙氨酸20~30mg/L、L-精氨酸盐酸盐60~80mg/L、L-天冬氨酸25~35mg/L、L-半胱氨酸盐酸盐一水合物0.10~0.12mg/L、L-胱氨酸二盐酸盐20~30mg/L、L-谷氨酸70~80mg/L、甘氨酸40~60mg/L、L-组氨酸盐酸盐一水合物20~25mg/L、L-羟脯氨酸8~12mg/L、L-异亮氨酸15~25mg/L、L-亮氨酸50~70mg/L、L-赖氨酸盐酸盐60~80mg/L、L-蛋氨酸10~20mg/L、L-苯丙氨酸20~30mg/L、L-脯氨酸30~50mg/L、L-丝氨酸20~30mg/L、L-苏氨酸25~35mg/L、L-色氨酸8~12mg/L、L-酪氨酸二钠二水合物55~60mg/L、L-缬氨酸20~30mg/L、抗坏血酸0.04~0.06mg/L、α-D-生育酚磷酸酯0.008~0.012mg/L、生物素0.008~0.012mg/L、骨化醇0.08~0.12mg/L、D-泛酸钙0.008~0.012mg/L、氯化胆碱0.4~0.6mg/L、叶酸0.008~0.012mg/L、肌醇0.04~0.06mg/L、三水合甲萘醌亚硫酸氢钠0.015~0.025mg/L、烟酸0.02~0.03mg/L、烟酰胺0.02~0.03mg/L、p-氨基苯甲酸0.04~0.06mg/L、盐酸吡哆辛0.04~0.06mg/L、核黄素0.008~0.012mg/L、盐酸硫胺素0.008~0.012mg/L、维生素A乙酸酯0.1~0.2mg/L、硫酸腺嘌呤8~12mg/L、腺嘌呤0.15~0.25mg/L、腺苷三磷酸二钠0.8~1.2mg/L、胆固醇0.15~0.25mg/L、2-脱氧-D-核糖0.4~0.6mg/L、D-葡萄糖800~1200mg/L、谷胱甘肽0.04~0.06mg/L、盐酸鸟嘌呤0.25~0.35mg/L、次黄嘌呤钠0.3~0.4mg/L、核糖0.4~0.6mg/L、胸腺素0.25~0.35mg/L、吐温804~6mg/L、尿嘧啶0.25~0.35mg/L、黄嘌呤钠0.3~0.4mg/L、酚红8~12mg/L。According to the mature culture solution of the third aspect of the present invention, wherein the BY basic culture solution is an aqueous solution comprising the following components: 180-220 mg/L of calcium chloride, 0.70-0.75 mg/L of ferric nitrate nonahydrate, and 380 mg/L of potassium chloride ~420mg/L, magnesium sulfate 90~100mg/L, sodium chloride 6500~7000mg/L, sodium dihydrogen phosphate monohydrate 130~150mg/L, sodium bicarbonate 2000~2500mg/L, sodium acetate 40~60mg/L , L-alanine 20~30mg/L, L-arginine hydrochloride 60~80mg/L, L-aspartic acid 25~35mg/L, L-cysteine hydrochloride monohydrate 0.10~0.12mg/L, L-cystine dihydrochloride 20~30mg/L, L-glutamic acid 70~80mg/L, glycine 40~60mg/L, L-histidine hydrochloride monohydrate 20~25mg/L, L-hydroxyproline 8~12mg/L, L-isoleucine 15~25mg/L, L-leucine 50~70mg/L, L-lysine hydrochloride 60~80mg/L, L-methionine 10~20mg/L, L-phenylalanine 20~30mg/L, L-proline 30~50mg/L, L-serine 20~30mg/L, L-threo Amino acid 25~35mg/L, L-tryptophan 8~12mg/L, L-tyrosine disodium dihydrate 55~60mg/L, L-valine 20~30mg/L, ascorbic acid 0.04~0.06 mg/L, α-D-tocopheryl phosphate 0.008~0.012mg/L, biotin 0.008~0.012mg/L, calcidol 0.08~0.12mg/L, D-calcium pantothenate 0.008~0.012mg/L, chlorine Choline 0.4~0.6mg/L, folic acid 0.008~0.012mg/L, inositol 0.04~0.06mg/L, menaquinone sodium bisulfite trihydrate 0.015~0.025mg/L, niacin 0.02~0.03mg/L L. Niacinamide 0.02~0.03mg/L, p-aminobenzoic acid 0.04~0.06mg/L, pyridoxine hydrochloride 0.04~0.06mg/L, riboflavin 0.008~0.012mg/L, thiamine hydrochloride 0.008~ 0.012mg/L, vitamin A acetate 0.1~0.2mg/L, adenine sulfate 8~12mg/L, adenine 0.15~0.25mg/L, adenosine triphosphate disodium 0.8~1.2mg/L, cholesterol 0.15 ~0.25mg/L, 2-deoxy-D-ribose 0.4~0.6mg/L, D-glucose 800~1200mg/L, glutathione 0.04~0.06mg/L, guanine hydrochloride 0.25~0.35mg/L, Hypoxanthine Sodium 0.3~0.4mg/L, Ribose 0.4~0.6mg/L, Thymosin 0.25~0.35 mg/L, Tween 804~6mg/L, uracil 0.25~0.35mg/L, xanthine sodium 0.3~0.4mg/L, phenol red 8~12mg/L.
根据本发明第三方面的成熟培养液,其中所述BY基础培养液是包含如下组分的水溶液:氯化钙200mg/L、九水硝酸铁0.72mg/L、氯化钾400mg/L、硫酸镁97.7mg/L、氯化钠6800mg/L、一水磷酸二氢钠140mg/L、碳酸氢钠2200mg/L、醋酸钠50mg/L、L-丙氨酸25mg/L、L-精氨酸盐酸盐70mg/L、L-天冬氨酸30mg/L、L-半胱氨酸盐酸盐一水合物0.11mg/L、L-胱氨酸二盐酸盐26mg/L、L-谷氨酸75mg/L、甘氨酸50mg/L、L-组氨酸盐酸盐一水合物21.88mg/L、L-羟脯氨酸10mg/L、L-异亮氨酸20mg/L、L-亮氨酸60mg/L、L-赖氨酸盐酸盐70mg/L、L-蛋氨酸15mg/L、L-苯丙氨酸25mg/L、L-脯氨酸40mg/L、L-丝氨酸25mg/L、L-苏氨酸30mg/L、L-色氨酸10mg/L、L-酪氨酸二钠二水合物57.66mg/L、L-缬氨酸25mg/L、抗坏血酸0.05mg/L、α-D-生育酚磷酸酯0.01mg/L、生物素0.01mg/L、骨化醇0.1mg/L、D-泛酸钙0.01mg/L、氯化胆碱0.5mg/L、叶酸0.01mg/L、肌醇0.05mg/L、三水合甲萘醌亚硫酸氢钠0.019mg/L、烟酸0.025mg/L、烟酰胺0.025mg/L、p-氨基苯甲酸0.05mg/L、盐酸吡哆辛0.05mg/L、核黄素0.01mg/L、盐酸硫胺素0.01mg/L、维生素A乙酸酯0.14mg/L、硫酸腺嘌呤10mg/L、腺嘌呤0.2mg/L、腺苷三磷酸二钠1mg/L、胆固醇0.2mg/L、2-脱氧-D-核糖0.5mg/L、D-葡萄糖1000mg/L、谷胱甘肽0.05mg/L、盐酸鸟嘌呤0.3mg/L、次黄嘌呤钠0.354mg/L、核糖0.5mg/L、胸腺素0.3mg/L、吐温805mg/L、尿嘧啶0.3mg/L、黄嘌呤钠0.34mg/L、酚红10mg/L。According to the mature culture solution of the third aspect of the present invention, wherein the BY basic culture solution is an aqueous solution comprising the following components: calcium chloride 200mg/L, ferric nitrate nonahydrate 0.72mg/L, potassium chloride 400mg/L, sulfuric acid Magnesium 97.7mg/L, Sodium Chloride 6800mg/L, Sodium Dihydrogen Phosphate Monohydrate 140mg/L, Sodium Bicarbonate 2200mg/L, Sodium Acetate 50mg/L, L-Alanine 25mg/L, L-Arginine Hydrochloride 70mg/L, L-aspartic acid 30mg/L, L-cysteine hydrochloride monohydrate 0.11mg/L, L-cystine dihydrochloride 26mg/L, L-glutamine Glycine 75mg/L, Glycine 50mg/L, L-Histidine Hydrochloride Monohydrate 21.88mg/L, L-Hydroxyproline 10mg/L, L-Isoleucine 20mg/L, L-Leucine Amino acid 60mg/L, L-lysine hydrochloride 70mg/L, L-methionine 15mg/L, L-phenylalanine 25mg/L, L-proline 40mg/L, L-serine 25mg/L , L-Threonine 30mg/L, L-Tryptophan 10mg/L, L-Tyrosine Disodium Dihydrate 57.66mg/L, L-Valine 25mg/L, Ascorbic Acid 0.05mg/L, α -D-tocopheryl phosphate 0.01mg/L, biotin 0.01mg/L, calcidol 0.1mg/L, D-calcium pantothenate 0.01mg/L, choline chloride 0.5mg/L, folic acid 0.01mg/L , Inositol 0.05mg/L, Menaquinone Sodium Bisulfite Trihydrate 0.019mg/L, Nicotinic Acid 0.025mg/L, Niacinamide 0.025mg/L, p-Aminobenzoic Acid 0.05mg/L, Pyridoxine Hydrochloride 0.05mg/L, riboflavin 0.01mg/L, thiamine hydrochloride 0.01mg/L, vitamin A acetate 0.14mg/L, adenine sulfate 10mg/L, adenine 0.2mg/L, adenosine triphosphate Disodium 1mg/L, Cholesterol 0.2mg/L, 2-Deoxy-D-ribose 0.5mg/L, D-glucose 1000mg/L, Glutathione 0.05mg/L, Guanine Hydrochloride 0.3mg/L, Hypoxanthin Purine sodium 0.354mg/L, ribose 0.5mg/L, thymosin 0.3mg/L, Tween 805mg/L, uracil 0.3mg/L, xanthine sodium 0.34mg/L, phenol red 10mg/L.
根据本发明第三方面的成熟培养液,其中所述BY基础培养液中还包括亚硒酸钠,其浓度为0.2~0.3mg/L,例如0.25mg/L;和/或,所述BY基础培养液中还包括硫酸铜,其浓度以无水物计为0.05~0.1mg/L,例如0.075mg/L。According to the mature culture solution of the third aspect of the present invention, wherein the BY base culture solution also includes sodium selenite at a concentration of 0.2-0.3 mg/L, such as 0.25 mg/L; and/or, the BY base The culture solution also includes copper sulfate, the concentration of which is 0.05-0.1 mg/L in terms of anhydrous matter, such as 0.075 mg/L.
进一步的,本发明第四方面提供了一种成熟培养液,其是添加了10~20mmol/L(例如15mmol/L)4-羟乙基哌嗪乙磺酸、100mL/L FBS、10μg/mL FSH、10μg/mL LH、1μg/mL E2、20ng/mL EGF的BY基础培养液。Further, the fourth aspect of the present invention provides a mature culture medium, which is added with 10-20mmol/L (for example, 15mmol/L) 4-hydroxyethylpiperazineethanesulfonic acid, 100mL/L FBS, 10μg/mL BY basal culture medium of FSH, 10 μg/mL LH, 1 μg/mL E2, 20 ng/mL EGF.
根据本发明第四方面的成熟培养液,其中所述BY基础培养液是包含如下组分的水溶液:氯化钙180~220mg/L、九水硝酸铁0.70~0.75mg/L、氯化钾380~420mg/L、硫酸镁90~100mg/L、氯化钠6500~7000mg/L、一水磷酸二氢钠130~150mg/L、碳酸氢钠2000~2500mg/L、醋酸钠40~60mg/L、L-丙氨酸20~30mg/L、L-精氨酸盐酸盐60~80mg/L、L-天冬氨酸25~35mg/L、L-半胱氨酸盐酸盐一水合物0.10~0.12mg/L、L-胱氨酸二盐酸盐20~30mg/L、L-谷氨酸70~80mg/L、甘氨酸40~60mg/L、L-组氨酸盐酸盐一水合物20~25mg/L、L-羟脯氨酸8~12mg/L、L-异亮氨酸15~25mg/L、L-亮氨酸50~70mg/L、L-赖氨酸盐酸盐60~80mg/L、L-蛋氨酸10~20mg/L、L-苯丙氨酸20~30mg/L、L-脯氨酸30~50mg/L、L-丝氨酸20~30mg/L、L-苏氨酸25~35mg/L、L-色氨酸8~12mg/L、L-酪氨酸二钠二水合物55~60mg/L、L-缬氨酸20~30mg/L、抗坏血酸0.04~0.06mg/L、α-D-生育酚磷酸酯0.008~0.012mg/L、生物素0.008~0.012mg/L、骨化醇0.08~0.12mg/L、D-泛酸钙0.008~0.012mg/L、氯化胆碱0.4~0.6mg/L、叶酸0.008~0.012mg/L、肌醇0.04~0.06mg/L、三水合甲萘醌亚硫酸氢钠0.015~0.025mg/L、烟酸0.02~0.03mg/L、烟酰胺0.02~0.03mg/L、p-氨基苯甲酸0.04~0.06mg/L、盐酸吡哆辛0.04~0.06mg/L、核黄素0.008~0.012mg/L、盐酸硫胺素0.008~0.012mg/L、维生素A乙酸酯0.1~0.2mg/L、硫酸腺嘌呤8~12mg/L、腺嘌呤0.15~0.25mg/L、腺苷三磷酸二钠0.8~1.2mg/L、胆固醇0.15~0.25mg/L、2-脱氧-D-核糖0.4~0.6mg/L、D-葡萄糖800~1200mg/L、谷胱甘肽0.04~0.06mg/L、盐酸鸟嘌呤0.25~0.35mg/L、次黄嘌呤钠0.3~0.4mg/L、核糖0.4~0.6mg/L、胸腺素0.25~0.35mg/L、吐温804~6mg/L、尿嘧啶0.25~0.35mg/L、黄嘌呤钠0.3~0.4mg/L、酚红8~12mg/L。According to the mature culture solution of the fourth aspect of the present invention, wherein the BY basic culture solution is an aqueous solution comprising the following components: 180-220 mg/L of calcium chloride, 0.70-0.75 mg/L of ferric nitrate nonahydrate, and 380 mg/L of potassium chloride ~420mg/L, magnesium sulfate 90~100mg/L, sodium chloride 6500~7000mg/L, sodium dihydrogen phosphate monohydrate 130~150mg/L, sodium bicarbonate 2000~2500mg/L, sodium acetate 40~60mg/L , L-alanine 20~30mg/L, L-arginine hydrochloride 60~80mg/L, L-aspartic acid 25~35mg/L, L-cysteine hydrochloride monohydrate 0.10~0.12mg/L, L-cystine dihydrochloride 20~30mg/L, L-glutamic acid 70~80mg/L, glycine 40~60mg/L, L-histidine hydrochloride monohydrate 20~25mg/L, L-hydroxyproline 8~12mg/L, L-isoleucine 15~25mg/L, L-leucine 50~70mg/L, L-lysine hydrochloride 60~80mg/L, L-methionine 10~20mg/L, L-phenylalanine 20~30mg/L, L-proline 30~50mg/L, L-serine 20~30mg/L, L-threo Amino acid 25~35mg/L, L-tryptophan 8~12mg/L, L-tyrosine disodium dihydrate 55~60mg/L, L-valine 20~30mg/L, ascorbic acid 0.04~0.06 mg/L, α-D-tocopheryl phosphate 0.008~0.012mg/L, biotin 0.008~0.012mg/L, calcidol 0.08~0.12mg/L, D-calcium pantothenate 0.008~0.012mg/L, chlorine Choline 0.4~0.6mg/L, folic acid 0.008~0.012mg/L, inositol 0.04~0.06mg/L, menaquinone sodium bisulfite trihydrate 0.015~0.025mg/L, niacin 0.02~0.03mg/L L. Niacinamide 0.02~0.03mg/L, p-aminobenzoic acid 0.04~0.06mg/L, pyridoxine hydrochloride 0.04~0.06mg/L, riboflavin 0.008~0.012mg/L, thiamine hydrochloride 0.008~ 0.012mg/L, vitamin A acetate 0.1~0.2mg/L, adenine sulfate 8~12mg/L, adenine 0.15~0.25mg/L, adenosine triphosphate disodium 0.8~1.2mg/L, cholesterol 0.15 ~0.25mg/L, 2-deoxy-D-ribose 0.4~0.6mg/L, D-glucose 800~1200mg/L, glutathione 0.04~0.06mg/L, guanine hydrochloride 0.25~0.35mg/L, Hypoxanthine Sodium 0.3~0.4mg/L, Ribose 0.4~0.6mg/L, Thymosin 0.25~0.35 mg/L, Tween 804~6mg/L, uracil 0.25~0.35mg/L, xanthine sodium 0.3~0.4mg/L, phenol red 8~12mg/L.
根据本发明第四方面的成熟培养液,其中所述BY基础培养液是包含如下组分的水溶液:氯化钙200mg/L、九水硝酸铁0.72mg/L、氯化钾400mg/L、硫酸镁97.7mg/L、氯化钠6800mg/L、一水磷酸二氢钠140mg/L、碳酸氢钠2200mg/L、醋酸钠50mg/L、L-丙氨酸25mg/L、L-精氨酸盐酸盐70mg/L、L-天冬氨酸30mg/L、L-半胱氨酸盐酸盐一水合物0.11mg/L、L-胱氨酸二盐酸盐26mg/L、L-谷氨酸75mg/L、甘氨酸50mg/L、L-组氨酸盐酸盐一水合物21.88mg/L、L-羟脯氨酸10mg/L、L-异亮氨酸20mg/L、L-亮氨酸60mg/L、L-赖氨酸盐酸盐70mg/L、L-蛋氨酸15mg/L、L-苯丙氨酸25mg/L、L-脯氨酸40mg/L、L-丝氨酸25mg/L、L-苏氨酸30mg/L、L-色氨酸10mg/L、L-酪氨酸二钠二水合物57.66mg/L、L-缬氨酸25mg/L、抗坏血酸0.05mg/L、α-D-生育酚磷酸酯0.01mg/L、生物素0.01mg/L、骨化醇0.1mg/L、D-泛酸钙0.01mg/L、氯化胆碱0.5mg/L、叶酸0.01mg/L、肌醇0.05mg/L、三水合甲萘醌亚硫酸氢钠0.019mg/L、烟酸0.025mg/L、烟酰胺0.025mg/L、p-氨基苯甲酸0.05mg/L、盐酸吡哆辛0.05mg/L、核黄素0.01mg/L、盐酸硫胺素0.01mg/L、维生素A乙酸酯0.14mg/L、硫酸腺嘌呤10mg/L、腺嘌呤0.2mg/L、腺苷三磷酸二钠1mg/L、胆固醇0.2mg/L、2-脱氧-D-核糖0.5mg/L、D-葡萄糖1000mg/L、谷胱甘肽0.05mg/L、盐酸鸟嘌呤0.3mg/L、次黄嘌呤钠0.354mg/L、核糖0.5mg/L、胸腺素0.3mg/L、吐温805mg/L、尿嘧啶0.3mg/L、黄嘌呤钠0.34mg/L、酚红10mg/L。According to the mature culture solution of the fourth aspect of the present invention, wherein the BY basic culture solution is an aqueous solution comprising the following components: calcium chloride 200mg/L, ferric nitrate nonahydrate 0.72mg/L, potassium chloride 400mg/L, sulfuric acid Magnesium 97.7mg/L, Sodium Chloride 6800mg/L, Sodium Dihydrogen Phosphate Monohydrate 140mg/L, Sodium Bicarbonate 2200mg/L, Sodium Acetate 50mg/L, L-Alanine 25mg/L, L-Arginine Hydrochloride 70mg/L, L-aspartic acid 30mg/L, L-cysteine hydrochloride monohydrate 0.11mg/L, L-cystine dihydrochloride 26mg/L, L-glutamine Glycine 75mg/L, Glycine 50mg/L, L-Histidine Hydrochloride Monohydrate 21.88mg/L, L-Hydroxyproline 10mg/L, L-Isoleucine 20mg/L, L-Leucine Amino acid 60mg/L, L-lysine hydrochloride 70mg/L, L-methionine 15mg/L, L-phenylalanine 25mg/L, L-proline 40mg/L, L-serine 25mg/L , L-Threonine 30mg/L, L-Tryptophan 10mg/L, L-Tyrosine Disodium Dihydrate 57.66mg/L, L-Valine 25mg/L, Ascorbic Acid 0.05mg/L, α -D-tocopheryl phosphate 0.01mg/L, biotin 0.01mg/L, calcidol 0.1mg/L, D-calcium pantothenate 0.01mg/L, choline chloride 0.5mg/L, folic acid 0.01mg/L , Inositol 0.05mg/L, Menaquinone Sodium Bisulfite Trihydrate 0.019mg/L, Nicotinic Acid 0.025mg/L, Niacinamide 0.025mg/L, p-Aminobenzoic Acid 0.05mg/L, Pyridoxine Hydrochloride 0.05mg/L, riboflavin 0.01mg/L, thiamine hydrochloride 0.01mg/L, vitamin A acetate 0.14mg/L, adenine sulfate 10mg/L, adenine 0.2mg/L, adenosine triphosphate Disodium 1mg/L, Cholesterol 0.2mg/L, 2-Deoxy-D-ribose 0.5mg/L, D-glucose 1000mg/L, Glutathione 0.05mg/L, Guanine Hydrochloride 0.3mg/L, Hypoxanthin Purine sodium 0.354mg/L, ribose 0.5mg/L, thymosin 0.3mg/L, Tween 805mg/L, uracil 0.3mg/L, xanthine sodium 0.34mg/L, phenol red 10mg/L.
根据本发明第四方面的成熟培养液,其中所述BY基础培养液中还包括亚硒酸钠,其浓度为0.2~0.3mg/L,例如0.25mg/L;和/或,所述BY基础培养液中还包括硫酸铜,其浓度以无水物计为0.05~0.1mg/L,例如0.075mg/L。According to the mature culture solution of the fourth aspect of the present invention, wherein the BY basal culture solution further includes sodium selenite at a concentration of 0.2-0.3 mg/L, such as 0.25 mg/L; and/or, the BY basal The culture solution also includes copper sulfate, the concentration of which is 0.05-0.1 mg/L in terms of anhydrous matter, such as 0.075 mg/L.
进一步,本发明第五方面提供了一种牛体外受精胚胎培养的方法,其包括如下步骤:Further, the fifth aspect of the present invention provides a method for culturing bovine in vitro fertilized embryos, which includes the following steps:
(1)卵母细胞的采集和体外成熟(1) Oocyte collection and in vitro maturation
离体采集:取屠宰场卵巢盛放于加双抗生理盐水的保温桶中,30.5-33℃条件下,4h内运回实验室;抽取表面2-8mm的卵泡,收集沉淀,在体视显微镜下捡出至少含有3层卵丘细胞包裹的卵母细胞COCs(即,卵丘-卵母细胞复合体),在洗卵液中洗涤2遍,去除多余杂质;In vitro collection: Take the ovary from the slaughterhouse and put it in an insulated barrel with double-antibiotic saline, and transport it back to the laboratory within 4 hours under the condition of 30.5-33°C; extract the follicles with a surface size of 2-8mm, collect the precipitate, and examine it under a stereo microscope Next, pick out oocyte COCs (that is, cumulus-oocyte complexes) that contain at least three layers of cumulus cells, and wash them twice in egg washing liquid to remove excess impurities;
活体采集:对牛进行活体采卵,将所得卵泡液在体视显微镜下捡出至少含3层卵丘细胞包裹的卵丘-卵母细胞复合体(COCs),放入包含HEPES的成熟培养液中38.8℃、3h内运回实验室;Live collection: live bovine eggs are collected, and the resulting follicular fluid is picked out under a stereomicroscope to pick out cumulus-oocyte complexes (COCs) that contain at least 3 layers of cumulus cells, and put them into the mature culture medium containing HEPES Temperature 38.8 ℃, transported back to the laboratory within 3 hours;
将以上离体采集或者活体采集所得COCs在卵母细胞成熟培养液中洗涤1次,再转移到新的成熟培养液中培养22-24h,培养条件为38.8℃、5.5-6.5%CO2、饱和湿度;Wash the COCs collected above in vitro or in vivo in the oocyte maturation culture medium once, and then transfer to a new maturation culture medium for 22-24 hours. The culture conditions are 38.8°C, 5.5-6.5% CO2, and saturated humidity. ;
(2)体外受精(2) In vitro fertilization
将成熟的COCs在受精培养液中洗涤1次,再转移到受精培养液中,放入培养箱中,备用;Wash the mature COCs once in the fertilization medium, then transfer them to the fertilization medium, put them in the incubator, and set aside;
从液氮中取一支冻精细管,37℃水浴解冻;无菌操作剪开细管两端,使精液注入盛有精液制备培养液的15mL离心管中,328×g离心2次,每次5min,离心后弃上清;将300μL精液制备培养液加入上述离心管,重悬精子沉淀,取适当的精子悬液进行精子计数;Take a frozen fine tube from liquid nitrogen and thaw it in a water bath at 37°C; cut both ends of the thin tube aseptically, inject the semen into a 15mL centrifuge tube filled with the semen preparation culture medium, and centrifuge twice at 328×g, each time After centrifuging for 5 minutes, discard the supernatant; add 300 μL of semen preparation culture medium to the above centrifuge tube, resuspend the sperm pellet, and take an appropriate sperm suspension for sperm counting;
将计算好体积的精子悬液加入盛有卵母细胞的受精培养液滴中,并将培养盘放入培养箱,使精卵共孵育16-20h,培养条件为38.8℃、5.5-6.5%CO2、饱和湿度;Add the calculated volume of sperm suspension into the fertilization culture drop filled with oocytes, put the culture plate into the incubator, and incubate the sperm and eggs for 16-20 hours. The culture conditions are 38.8°C, 5.5-6.5% CO2 , saturated humidity;
(3)胚胎体外培养及保存(3) In vitro culture and storage of embryos
体外受精操作完毕后,将胚胎周围的颗粒细胞用剥卵针去除干净,放入胚胎培养液中培养,此时记为胚胎培养的第1天,培养条件为38.8℃、6%O2、88%N2、饱和湿度,第3天记录卵裂率;第7天记录囊胚率,至第9天时统计囊胚孵化率(其为孵化囊胚数除以囊胚数所得百分数),并进行质量鉴定;After the in vitro fertilization operation, remove the granulosa cells around the embryo with the egg stripping needle, and put them into the embryo culture medium for culture. At this time, it is recorded as the first day of embryo culture. The culture conditions are 38.8°C, 6% O2, 88% N2, saturated humidity, record the cleavage rate on the 3rd day; record the blastocyst rate on the 7th day, and count the blastocyst hatching rate (it is the percentage obtained by dividing the number of hatched blastocysts by the number of blastocysts) on the 9th day, and carry out quality identification ;
将可用胚胎在保存液中洗涤3次,在平衡液中平衡10min后转移入冷冻液,按5段装液法装入胚胎,做好标记,再放入程序降温仪中按照0.5℃/min的速度降至-35℃后,将胚胎细管迅速取出,置入液氮中冷冻保存。Wash the usable embryos in the preservation solution for 3 times, equilibrate in the balance solution for 10 minutes, transfer to the freezing solution, load the embryos according to the 5-stage liquid filling method, mark them well, and then put them into the programmed cooling device at a temperature of 0.5°C/min. After the speed dropped to -35°C, the embryo straw was quickly taken out and placed in liquid nitrogen for cryopreservation.
根据本发明第五方面的方法,其中步骤(1)中,所述加双抗生理盐水是包含青霉素400IU/mL、链霉素400μg/mL的生理盐水。According to the method of the fifth aspect of the present invention, wherein in step (1), the double-antibiotic-added normal saline is normal saline containing 400 IU/mL of penicillin and 400 μg/mL of streptomycin.
根据本发明第五方面的方法,其中步骤(1)中,所述洗卵液是添加了3mg/mL牛血清白蛋白的BY基础培养液。According to the method of the fifth aspect of the present invention, wherein in step (1), the egg washing solution is BY basal culture solution added with 3 mg/mL bovine serum albumin.
本发明的洗卵液或者其它培养液的配制方法是本领域技术人员容易实现的,例如对于洗卵液而言,通常是在预先配制好的本发明BY基础培养液中添加牛血清白蛋白至其相应要求的浓度,这种配制方法也是本领域技术人员常用的。The preparation method of egg washing liquid or other culture fluid of the present invention is easily realized by those skilled in the art, for example, for egg washing liquid, it is usually to add bovine serum albumin to The corresponding required concentration, this preparation method is also commonly used by those skilled in the art.
根据本发明第五方面的方法,其中步骤(1)中,所述成熟培养液是添加了100mL/LFBS、10μg/mL FSH、10μg/mL LH、1μg/mL E2、20ng/mL EGF的BY基础培养液。According to the method of the fifth aspect of the present invention, wherein in step (1), the mature culture solution is the BY base added with 100mL/LFBS, 10μg/mL FSH, 10μg/mL LH, 1μg/mL E2, 20ng/mL EGF culture medium.
根据本发明第五方面的方法,其中HEPES即4-羟乙基哌嗪乙磺酸在所述成熟培养液中的浓度为10~20mmol/L,例如15mmol/L。在本发明中,EGF——表皮生长因子,FSH——卵泡刺激素,FBS——胎牛血清,E2——雌二醇,LH——促黄体生成素。The method according to the fifth aspect of the present invention, wherein the concentration of HEPES, namely 4-hydroxyethylpiperazineethanesulfonic acid, in the maturation culture solution is 10-20 mmol/L, for example 15 mmol/L. In the present invention, EGF—epidermal growth factor, FSH—follicle stimulating hormone, FBS—fetal bovine serum, E2—estradiol, LH—luteinizing hormone.
根据本发明第五方面的方法,其中步骤(2)中,所述受精培养液是包含112.0mM氯化钠、4.02mM氯化钾、2.25mM的氯化钙二水合物、0.52mM六水氯化镁、0.83mM磷酸二氢钾、37.0mM碳酸氢钠、1.25mM丙酮酸钠、10μg/ml肝素、4mg/ml牛血清白蛋白(BSA)、100U/ml青霉素、100μg/ml链霉素的水溶液。According to the method of the fifth aspect of the present invention, wherein in step (2), the fertilization culture liquid is calcium chloride dihydrate comprising 112.0mM sodium chloride, 4.02mM potassium chloride, 2.25mM, 0.52mM magnesium chloride hexahydrate , 0.83mM potassium dihydrogen phosphate, 37.0mM sodium bicarbonate, 1.25mM sodium pyruvate, 10μg/ml heparin, 4mg/ml bovine serum albumin (BSA), 100U/ml penicillin, 100μg/ml streptomycin in water.
根据本发明第五方面的方法,其中步骤(2)中,所述精液制备培养液是包含112.0mM氯化钠、4.02mM氯化钾、2.25mM的氯化钙二水合物、0.52mM六水氯化镁、0.83mM磷酸二氢钾、37.0mM碳酸氢钠、1.25mM丙酮酸钠、10μg/ml肝素、4mg/ml牛血清白蛋白(BSA)、10mM咖啡因、100U/ml青霉素、100μg/ml链霉素的水溶液。According to the method of the fifth aspect of the present invention, wherein in step (2), the seminal fluid preparation culture fluid is calcium chloride dihydrate containing 112.0mM sodium chloride, 4.02mM potassium chloride, 2.25mM, 0.52mM hexahydrate Magnesium chloride, 0.83mM potassium dihydrogen phosphate, 37.0mM sodium bicarbonate, 1.25mM sodium pyruvate, 10μg/ml heparin, 4mg/ml bovine serum albumin (BSA), 10mM caffeine, 100U/ml penicillin, 100μg/ml chain Aqueous solution of mycin.
根据本发明第五方面的方法,其中步骤(3)中,所述胚胎培养液包含:109.5mM氯化钠、3.1mM氯化钾、26.2mM碳酸氢钠、0.8mM六水氯化镁、1.19mM磷酸二氢钾、0.4mM丙酮酸钠、1.5mM葡萄糖、5mM半乳糖酸钙、2.5v/v%胎牛血清(FBS)、L-谷氨酰胺1mM、2v/v%必需氨基酸、1v/v%非必须氨基酸、3mM的谷胱甘肽、枸橼酸钠0.04w/v%、麦芽糖0.02w/v%的水溶液;所述必需氨基酸为以下氨基酸按重量比例添加:L-盐酸精氨酸6.32g、L-胱氨酸二盐酸盐1.564g、L-盐酸组氨酸一水物2.1g、L-异亮氨酸2.625g、L-亮氨酸2.62g、L-赖氨酸盐酸盐3.625g、L-蛋氨酸0.755g、L-苯丙氨酸1.65g、L-苏氨酸2.38g、L-色氨酸0.51g、L-酪氨酸1.8g和L-缬氨酸2.34g,所述非必须氨基酸为以下氨基酸按重量比例添加:L-丙氨酸0.89g、L-天门冬酰胺一水物1.5g、L-天冬氨酸1.33g、L-谷氨酸1.47g、甘氨酸0.75g、L-脯氨酸1.15g和L-丝氨酸1.05g。According to the method of the fifth aspect of the present invention, wherein in step (3), the embryo culture solution comprises: 109.5mM sodium chloride, 3.1mM potassium chloride, 26.2mM sodium bicarbonate, 0.8mM magnesium chloride hexahydrate, 1.19mM phosphoric acid Potassium dihydrogen, 0.4mM sodium pyruvate, 1.5mM glucose, 5mM calcium galactose, 2.5v/v% fetal bovine serum (FBS), L-glutamine 1mM, 2v/v% essential amino acids, 1v/v% Non-essential amino acids, 3mM glutathione, sodium citrate 0.04w/v%, maltose 0.02w/v% aqueous solution; the essential amino acids are the following amino acids added in proportion by weight: L-arginine hydrochloride 6.32g , L-cystine dihydrochloride 1.564g, L-histidine hydrochloride monohydrate 2.1g, L-isoleucine 2.625g, L-leucine 2.62g, L-lysine hydrochloride 3.625g, L-methionine 0.755g, L-phenylalanine 1.65g, L-threonine 2.38g, L-tryptophan 0.51g, L-tyrosine 1.8g and L-valine 2.34g, The non-essential amino acids are the following amino acids added in proportion by weight: L-alanine 0.89g, L-asparagine monohydrate 1.5g, L-aspartic acid 1.33g, L-glutamic acid 1.47g, glycine 0.75g, L-proline 1.15g and L-serine 1.05g.
根据本发明第五方面的方法,其中步骤(1)中,所述BY基础培养液是包含如下组分的水溶液:氯化钙180~220mg/L、九水硝酸铁0.70~0.75mg/L、氯化钾380~420mg/L、硫酸镁90~100mg/L、氯化钠6500~7000mg/L、一水磷酸二氢钠130~150mg/L、碳酸氢钠2000~2500mg/L、醋酸钠40~60mg/L、L-丙氨酸20~30mg/L、L-精氨酸盐酸盐60~80mg/L、L-天冬氨酸25~35mg/L、L-半胱氨酸盐酸盐一水合物0.10~0.12mg/L、L-胱氨酸二盐酸盐20~30mg/L、L-谷氨酸70~80mg/L、甘氨酸40~60mg/L、L-组氨酸盐酸盐一水合物20~25mg/L、L-羟脯氨酸8~12mg/L、L-异亮氨酸15~25mg/L、L-亮氨酸50~70mg/L、L-赖氨酸盐酸盐60~80mg/L、L-蛋氨酸10~20mg/L、L-苯丙氨酸20~30mg/L、L-脯氨酸30~50mg/L、L-丝氨酸20~30mg/L、L-苏氨酸25~35mg/L、L-色氨酸8~12mg/L、L-酪氨酸二钠二水合物55~60mg/L、L-缬氨酸20~30mg/L、抗坏血酸0.04~0.06mg/L、α-D-生育酚磷酸酯0.008~0.012mg/L、生物素0.008~0.012mg/L、骨化醇0.08~0.12mg/L、D-泛酸钙0.008~0.012mg/L、氯化胆碱0.4~0.6mg/L、叶酸0.008~0.012mg/L、肌醇0.04~0.06mg/L、三水合甲萘醌亚硫酸氢钠0.015~0.025mg/L、烟酸0.02~0.03mg/L、烟酰胺0.02~0.03mg/L、p-氨基苯甲酸0.04~0.06mg/L、盐酸吡哆辛0.04~0.06mg/L、核黄素0.008~0.012mg/L、盐酸硫胺素0.008~0.012mg/L、维生素A乙酸酯0.1~0.2mg/L、硫酸腺嘌呤8~12mg/L、腺嘌呤0.15~0.25mg/L、腺苷三磷酸二钠0.8~1.2mg/L、胆固醇0.15~0.25mg/L、2-脱氧-D-核糖0.4~0.6mg/L、D-葡萄糖800~1200mg/L、谷胱甘肽0.04~0.06mg/L、盐酸鸟嘌呤0.25~0.35mg/L、次黄嘌呤钠0.3~0.4mg/L、核糖0.4~0.6mg/L、胸腺素0.25~0.35mg/L、吐温804~6mg/L、尿嘧啶0.25~0.35mg/L、黄嘌呤钠0.3~0.4mg/L、酚红8~12mg/L。According to the method of the fifth aspect of the present invention, wherein in step (1), the BY basal culture solution is an aqueous solution comprising the following components: 180-220 mg/L of calcium chloride, 0.70-0.75 mg/L of ferric nitrate nonahydrate, Potassium chloride 380~420mg/L, magnesium sulfate 90~100mg/L, sodium chloride 6500~7000mg/L, sodium dihydrogen phosphate monohydrate 130~150mg/L, sodium bicarbonate 2000~2500mg/L, sodium acetate 40 ~60mg/L, L-alanine 20~30mg/L, L-arginine hydrochloride 60~80mg/L, L-aspartic acid 25~35mg/L, L-cysteine hydrochloride Salt monohydrate 0.10~0.12mg/L, L-cystine dihydrochloride 20~30mg/L, L-glutamic acid 70~80mg/L, glycine 40~60mg/L, L-histidine Salt monohydrate 20~25mg/L, L-hydroxyproline 8~12mg/L, L-isoleucine 15~25mg/L, L-leucine 50~70mg/L, L-lysine Hydrochloride 60~80mg/L, L-methionine 10~20mg/L, L-phenylalanine 20~30mg/L, L-proline 30~50mg/L, L-serine 20~30mg/L , L-threonine 25~35mg/L, L-tryptophan 8~12mg/L, L-tyrosine disodium dihydrate 55~60mg/L, L-valine 20~30mg/L, Ascorbic acid 0.04~0.06mg/L, α-D-tocopheryl phosphate 0.008~0.012mg/L, biotin 0.008~0.012mg/L, calcidol 0.08~0.12mg/L, D-calcium pantothenate 0.008~0.012mg /L, choline chloride 0.4~0.6mg/L, folic acid 0.008~0.012mg/L, inositol 0.04~0.06mg/L, menaquinone sodium bisulfite trihydrate 0.015~0.025mg/L, niacin 0.02 ~0.03mg/L, nicotinamide 0.02~0.03mg/L, p-aminobenzoic acid 0.04~0.06mg/L, pyridoxine hydrochloride 0.04~0.06mg/L, riboflavin 0.008~0.012mg/L, sulfur hydrochloride Amine 0.008~0.012mg/L, vitamin A acetate 0.1~0.2mg/L, adenine sulfate 8~12mg/L, adenine 0.15~0.25mg/L, adenosine triphosphate disodium 0.8~1.2mg/L L. Cholesterol 0.15~0.25mg/L, 2-deoxy-D-ribose 0.4~0.6mg/L, D-glucose 800~1200mg/L, glutathione 0.04~0.06mg/L, guanine hydrochloride 0.25~0.35 mg/L, hypoxanthine sodium 0.3~0.4mg/L, ribose 0.4~0.6mg/L, thymosin 0.25~ 0.35mg/L, Tween 804~6mg/L, uracil 0.25~0.35mg/L, xanthine sodium 0.3~0.4mg/L, phenol red 8~12mg/L.
根据本发明第五方面的方法,其中步骤(1)中,所述BY基础培养液是包含如下组分的水溶液:氯化钙200mg/L、九水硝酸铁0.72mg/L、氯化钾400mg/L、硫酸镁97.7mg/L、氯化钠6800mg/L、一水磷酸二氢钠140mg/L、碳酸氢钠2200mg/L、醋酸钠50mg/L、L-丙氨酸25mg/L、L-精氨酸盐酸盐70mg/L、L-天冬氨酸30mg/L、L-半胱氨酸盐酸盐一水合物0.11mg/L、L-胱氨酸二盐酸盐26mg/L、L-谷氨酸75mg/L、甘氨酸50mg/L、L-组氨酸盐酸盐一水合物21.88mg/L、L-羟脯氨酸10mg/L、L-异亮氨酸20mg/L、L-亮氨酸60mg/L、L-赖氨酸盐酸盐70mg/L、L-蛋氨酸15mg/L、L-苯丙氨酸25mg/L、L-脯氨酸40mg/L、L-丝氨酸25mg/L、L-苏氨酸30mg/L、L-色氨酸10mg/L、L-酪氨酸二钠二水合物57.66mg/L、L-缬氨酸25mg/L、抗坏血酸0.05mg/L、α-D-生育酚磷酸酯0.01mg/L、生物素0.01mg/L、骨化醇0.1mg/L、D-泛酸钙0.01mg/L、氯化胆碱0.5mg/L、叶酸0.01mg/L、肌醇0.05mg/L、三水合甲萘醌亚硫酸氢钠0.019mg/L、烟酸0.025mg/L、烟酰胺0.025mg/L、p-氨基苯甲酸0.05mg/L、盐酸吡哆辛0.05mg/L、核黄素0.01mg/L、盐酸硫胺素0.01mg/L、维生素A乙酸酯0.14mg/L、硫酸腺嘌呤10mg/L、腺嘌呤0.2mg/L、腺苷三磷酸二钠1mg/L、胆固醇0.2mg/L、2-脱氧-D-核糖0.5mg/L、D-葡萄糖1000mg/L、谷胱甘肽0.05mg/L、盐酸鸟嘌呤0.3mg/L、次黄嘌呤钠0.354mg/L、核糖0.5mg/L、胸腺素0.3mg/L、吐温805mg/L、尿嘧啶0.3mg/L、黄嘌呤钠0.34mg/L、酚红10mg/L。According to the method of the fifth aspect of the present invention, wherein in step (1), the BY basic culture solution is an aqueous solution comprising the following components: calcium chloride 200mg/L, ferric nitrate nonahydrate 0.72mg/L, potassium chloride 400mg /L, magnesium sulfate 97.7mg/L, sodium chloride 6800mg/L, sodium dihydrogen phosphate monohydrate 140mg/L, sodium bicarbonate 2200mg/L, sodium acetate 50mg/L, L-alanine 25mg/L, L -Arginine hydrochloride 70mg/L, L-aspartic acid 30mg/L, L-cysteine hydrochloride monohydrate 0.11mg/L, L-cystine dihydrochloride 26mg/L , L-glutamic acid 75mg/L, glycine 50mg/L, L-histidine hydrochloride monohydrate 21.88mg/L, L-hydroxyproline 10mg/L, L-isoleucine 20mg/L , L-leucine 60mg/L, L-lysine hydrochloride 70mg/L, L-methionine 15mg/L, L-phenylalanine 25mg/L, L-proline 40mg/L, L- Serine 25mg/L, L-Threonine 30mg/L, L-Tryptophan 10mg/L, L-Tyrosine Disodium Dihydrate 57.66mg/L, L-Valine 25mg/L, Ascorbic Acid 0.05mg /L, α-D-tocopheryl phosphate 0.01mg/L, biotin 0.01mg/L, calcidol 0.1mg/L, D-calcium pantothenate 0.01mg/L, choline chloride 0.5mg/L, folic acid 0.01mg/L, inositol 0.05mg/L, menaquinone trihydrate sodium bisulfite 0.019mg/L, niacin 0.025mg/L, niacinamide 0.025mg/L, p-aminobenzoic acid 0.05mg/L, Pyridoxine hydrochloride 0.05mg/L, riboflavin 0.01mg/L, thiamine hydrochloride 0.01mg/L, vitamin A acetate 0.14mg/L, adenine sulfate 10mg/L, adenine 0.2mg/L, Adenosine triphosphate disodium 1mg/L, cholesterol 0.2mg/L, 2-deoxy-D-ribose 0.5mg/L, D-glucose 1000mg/L, glutathione 0.05mg/L, guanine hydrochloride 0.3mg/L L, Sodium Hypoxanthine 0.354mg/L, Ribose 0.5mg/L, Thymosin 0.3mg/L, Tween 805mg/L, Uracil 0.3mg/L, Sodium Xanthine 0.34mg/L, Phenol Red 10mg/L .
根据本发明第五方面的方法,其中步骤(1)中,所述BY基础培养液中还包括亚硒酸钠,其浓度为0.2~0.3mg/L,例如0.25mg/L;和/或,所述BY基础培养液中还包括硫酸铜,其浓度以无水物计为0.05~0.1mg/L,例如0.075mg/L。According to the method of the fifth aspect of the present invention, wherein in step (1), the BY basal culture solution further includes sodium selenite at a concentration of 0.2-0.3 mg/L, such as 0.25 mg/L; and/or, The BY basal culture solution also includes copper sulfate, the concentration of which is 0.05-0.1 mg/L in terms of anhydrous matter, such as 0.075 mg/L.
在本发明中,例如在步骤(3)中,胚胎所用的保存液、平衡液、冷冻液等均是本领域公知的并且是可以容易从市售途径获得的,例如冷冻液可以是瑞典Vitrolife公司在国内销售的FreezeKitTM Cleave。In the present invention, for example, in step (3), the preservation solution, balance solution, freezing solution, etc. used by the embryo are well known in the art and can be easily obtained from commercially available channels. For example, the freezing solution can be obtained from Vitrolife, Sweden FreezeKit TM Cleave sold domestically.
本发明任一方面或该任一方面的任一实施方案所具有的任一技术特征同样适用其它任一实施方案或其它任一方面的任一实施方案,只要它们不会相互矛盾,当然在相互之间适用时,必要的话可对相应特征作适当修饰。下面对本发明的各个方面和特点作进一步的描述。Any aspect of the present invention or any technical feature of any implementation of this any aspect is also applicable to any other implementation or any implementation of any other aspect, as long as they do not contradict each other, of course When applicable, the corresponding features can be appropriately modified if necessary. Various aspects and features of the present invention are further described below.
本发明所引述的所有文献,它们的全部内容通过引用并入本文,并且如果这些文献所表达的含义与本发明不一致时,以本发明的表述为准。此外,本发明使用的各种术语和短语具有本领域技术人员公知的一般含义,即便如此,本发明仍然希望在此对这些术语和短语作更详尽的说明和解释,提及的术语和短语如有与公知含义不一致的,以本发明所表述的含义为准。All the documents cited in the present invention are incorporated herein by reference in their entirety, and if the meaning expressed in these documents is inconsistent with the present invention, the expression of the present invention shall prevail. In addition, various terms and phrases used in the present invention have common meanings known to those skilled in the art. Even so, the present invention still hopes to make a more detailed description and explanation of these terms and phrases here. The terms and phrases mentioned are as follows: If there is any inconsistency with the known meaning, the meaning expressed in the present invention shall prevail.
本发明使用的胎牛血清可以容易的从市场购得其标准化商品形式,例如可以从各种代理商处购得Gibco公司的澳洲胎牛血清(货号:10099141)、新西兰胎牛血清(货号:10091148)、北美胎牛血清(货号:16000044)、墨西哥胎牛血清(货号:10437028)等,这些商品化胎牛血清的价格500ml大多在8000元以上,用于本发明牛体外受精胚胎培养液中时胎牛血清是成本主要贡献者。在本发明上下文的试验中,如未特别说明,所用的胎牛血清是Gibco公司的澳洲胎牛血清(货号:10099141)。The fetal bovine serum used in the present invention can be easily purchased from the market in its standardized commodity form, for example, Australian fetal bovine serum (article number: 10099141), New Zealand fetal bovine serum (article number: 10091148) can be purchased from various agents. ), North American fetal bovine serum (article number: 16000044), Mexican fetal bovine serum (article number: 10437028), etc., the price of these commercial fetal bovine serum is mostly more than 8000 yuan for 500ml, when used in the bovine in vitro fertilization embryo culture medium of the present invention Fetal bovine serum is a major contributor to costs. In the tests in the context of the present invention, unless otherwise specified, the fetal bovine serum used was Australian fetal bovine serum from Gibco (Product No.: 10099141).
具体实施方式Detailed ways
通过下面的实施例可以对本发明进行进一步的描述,然而,本发明的范围并不限于下述实施例。本领域的专业人员能够理解,在不背离本发明的精神和范围的前提下,可以对本发明进行各种变化和修饰。本发明对试验中所使用到的材料以及试验方法进行一般性和/或具体的描述。虽然为实现本发明目的所使用的许多材料和操作方法是本领域公知的,但是本发明仍然在此作尽可能详细描述。若未特别指明,实施例中所用的技术手段为本领域技术人员所熟知的常规手段,所用原料均为市售商品。The present invention can be further described by the following examples, however, the scope of the present invention is not limited to the following examples. Those skilled in the art can understand that various changes and modifications can be made in the present invention without departing from the spirit and scope of the present invention. The present invention provides general and/or specific descriptions of the materials and test methods used in the tests. While many of the materials and methods of manipulation which are employed for the purposes of the invention are well known in the art, the invention has been described here in as much detail as possible. Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art, and the raw materials used are all commercially available products.
实施例1:牛体外受精胚胎的培养方法(离体无硒)Embodiment 1: the culture method of bovine in vitro fertilization embryo (no selenium in vitro)
一、试剂1. Reagents
本发明的具体试验中,如未另外说明,使用的相关试剂详述如下:In the specific test of the present invention, if not otherwise specified, the relevant reagents used are described in detail as follows:
加双抗生理盐水:包含青霉素400IU/mL、链霉素400μg/mL的生理盐水。Add double-antibody normal saline: normal saline containing 400 IU/mL penicillin and 400 μg/mL streptomycin.
洗卵液:添加了3mg/mL牛血清白蛋白的BY基础培养液。Egg washing solution: BY basal culture solution supplemented with 3mg/mL bovine serum albumin.
成熟培养液:添加了100mL/L FBS、10μg/mL FSH、10μg/mL LH、1μg/mL E2、20ng/mLEGF的BY基础培养液。Maturation medium: BY basal medium supplemented with 100 mL/L FBS, 10 μg/mL FSH, 10 μg/mL LH, 1 μg/mL E2, and 20 ng/mL EGF.
HEPES成熟培养液:添加了15mmol/L HEPES、100mL/L FBS、10μg/mL FSH、10μg/mLLH、1μg/mL E2、20ng/mL EGF的BY基础培养液。HEPES maturation medium: BY basal medium supplemented with 15mmol/L HEPES, 100mL/L FBS, 10μg/mL FSH, 10μg/mL LLH, 1μg/mL E2, and 20ng/mL EGF.
其中,EGF——表皮生长因子,FSH——卵泡刺激素,FBS——胎牛血清,E2——雌二醇,LH——促黄体生成素。Among them, EGF—epidermal growth factor, FSH—follicle stimulating hormone, FBS—fetal bovine serum, E2—estradiol, LH—luteinizing hormone.
受精培养液:包含112.0mM氯化钠、4.02mM氯化钾、2.25mM的氯化钙二水合物、0.52mM六水氯化镁、0.83mM磷酸二氢钾、37.0mM碳酸氢钠、1.25mM丙酮酸钠、10μg/ml肝素、4mg/ml牛血清白蛋白(BSA)、100U/ml青霉素、100μg/ml链霉素的水溶液。Fertilization medium: containing 112.0mM sodium chloride, 4.02mM potassium chloride, 2.25mM calcium chloride dihydrate, 0.52mM magnesium chloride hexahydrate, 0.83mM potassium dihydrogen phosphate, 37.0mM sodium bicarbonate, 1.25mM pyruvate Aqueous solution of sodium, 10 μg/ml heparin, 4 mg/ml bovine serum albumin (BSA), 100 U/ml penicillin, 100 μg/ml streptomycin.
精液制备培养液:包含112.0mM氯化钠、4.02mM氯化钾、2.25mM的氯化钙二水合物、0.52mM六水氯化镁、0.83mM磷酸二氢钾、37.0mM碳酸氢钠、1.25mM丙酮酸钠、10μg/ml肝素、4mg/ml牛血清白蛋白(BSA)、10mM咖啡因、100U/ml青霉素、100μg/ml链霉素的水溶液。Semen preparation medium: containing 112.0mM sodium chloride, 4.02mM potassium chloride, 2.25mM calcium chloride dihydrate, 0.52mM magnesium chloride hexahydrate, 0.83mM potassium dihydrogen phosphate, 37.0mM sodium bicarbonate, 1.25mM acetone An aqueous solution of sodium nitrite, 10 μg/ml heparin, 4 mg/ml bovine serum albumin (BSA), 10 mM caffeine, 100 U/ml penicillin, and 100 μg/ml streptomycin.
胚胎培养液:包含:109.5mM氯化钠、3.1mM氯化钾、26.2mM碳酸氢钠、0.8mM六水氯化镁、1.19mM磷酸二氢钾、0.4mM丙酮酸钠、1.5mM葡萄糖、5mM半乳糖酸钙、2.5v/v%胎牛血清(FBS)、L-谷氨酰胺1mM、2v/v%必需氨基酸、1v/v%非必须氨基酸、3mM的谷胱甘肽、枸橼酸钠0.04w/v%、麦芽糖0.02w/v%的水溶液;所述必需氨基酸为以下氨基酸按重量比例添加:L-盐酸精氨酸6.32g、L-胱氨酸二盐酸盐1.564g、L-盐酸组氨酸一水物2.1g、L-异亮氨酸2.625g、L-亮氨酸2.62g、L-赖氨酸盐酸盐3.625g、L-蛋氨酸0.755g、L-苯丙氨酸1.65g、L-苏氨酸2.38g、L-色氨酸0.51g、L-酪氨酸1.8g和L-缬氨酸2.34g,所述非必须氨基酸为以下氨基酸按重量比例添加:L-丙氨酸0.89g、L-天门冬酰胺一水物1.5g、L-天冬氨酸1.33g、L-谷氨酸1.47g、甘氨酸0.75g、L-脯氨酸1.15g和L-丝氨酸1.05g。Embryo culture medium: contains: 109.5mM sodium chloride, 3.1mM potassium chloride, 26.2mM sodium bicarbonate, 0.8mM magnesium chloride hexahydrate, 1.19mM potassium dihydrogen phosphate, 0.4mM sodium pyruvate, 1.5mM glucose, 5mM galactose calcium carbonate, 2.5v/v% fetal bovine serum (FBS), L-glutamine 1mM, 2v/v% essential amino acids, 1v/v% non-essential amino acids, 3mM glutathione, sodium citrate 0.04w /v%, maltose 0.02w/v% aqueous solution; the essential amino acids are the following amino acids added in proportion by weight: L-arginine hydrochloride 6.32g, L-cystine dihydrochloride 1.564g, L-hydrochloride group Amino acid monohydrate 2.1g, L-isoleucine 2.625g, L-leucine 2.62g, L-lysine hydrochloride 3.625g, L-methionine 0.755g, L-phenylalanine 1.65g , L-threonine 2.38g, L-tryptophan 0.51g, L-tyrosine 1.8g and L-valine 2.34g, described non-essential amino acid is that following amino acid is added by weight ratio: L-alanine 0.89 g of acid, 1.5 g of L-asparagine monohydrate, 1.33 g of L-aspartic acid, 1.47 g of L-glutamic acid, 0.75 g of glycine, 1.15 g of L-proline, and 1.05 g of L-serine.
BY基础培养液是包含如下组分的水溶液:氯化钙200mg/L、九水硝酸铁0.72mg/L、氯化钾400mg/L、硫酸镁97.7mg/L、氯化钠6800mg/L、一水磷酸二氢钠140mg/L、碳酸氢钠2200mg/L、醋酸钠50mg/L、L-丙氨酸25mg/L、L-精氨酸盐酸盐70mg/L、L-天冬氨酸30mg/L、L-半胱氨酸盐酸盐一水合物0.11mg/L、L-胱氨酸二盐酸盐26mg/L、L-谷氨酸75mg/L、甘氨酸50mg/L、L-组氨酸盐酸盐一水合物21.88mg/L、L-羟脯氨酸10mg/L、L-异亮氨酸20mg/L、L-亮氨酸60mg/L、L-赖氨酸盐酸盐70mg/L、L-蛋氨酸15mg/L、L-苯丙氨酸25mg/L、L-脯氨酸40mg/L、L-丝氨酸25mg/L、L-苏氨酸30mg/L、L-色氨酸10mg/L、L-酪氨酸二钠二水合物57.66mg/L、L-缬氨酸25mg/L、抗坏血酸0.05mg/L、α-D-生育酚磷酸酯0.01mg/L、生物素0.01mg/L、骨化醇0.1mg/L、D-泛酸钙0.01mg/L、氯化胆碱0.5mg/L、叶酸0.01mg/L、肌醇0.05mg/L、三水合甲萘醌亚硫酸氢钠0.019mg/L、烟酸0.025mg/L、烟酰胺0.025mg/L、p-氨基苯甲酸0.05mg/L、盐酸吡哆辛0.05mg/L、核黄素0.01mg/L、盐酸硫胺素0.01mg/L、维生素A乙酸酯0.14mg/L、硫酸腺嘌呤10mg/L、腺嘌呤0.2mg/L、腺苷三磷酸二钠1mg/L、胆固醇0.2mg/L、2-脱氧-D-核糖0.5mg/L、D-葡萄糖1000mg/L、谷胱甘肽0.05mg/L、盐酸鸟嘌呤0.3mg/L、次黄嘌呤钠0.354mg/L、核糖0.5mg/L、胸腺素0.3mg/L、吐温805mg/L、尿嘧啶0.3mg/L、黄嘌呤钠0.34mg/L、酚红10mg/L。BY basic culture solution is an aqueous solution containing the following components: calcium chloride 200mg/L, ferric nitrate nonahydrate 0.72mg/L, potassium chloride 400mg/L, magnesium sulfate 97.7mg/L, sodium chloride 6800mg/L, a Sodium dihydrogen phosphate water 140mg/L, sodium bicarbonate 2200mg/L, sodium acetate 50mg/L, L-alanine 25mg/L, L-arginine hydrochloride 70mg/L, L-aspartic acid 30mg /L, L-cysteine hydrochloride monohydrate 0.11mg/L, L-cystine dihydrochloride 26mg/L, L-glutamic acid 75mg/L, glycine 50mg/L, L-group Amino acid hydrochloride monohydrate 21.88mg/L, L-hydroxyproline 10mg/L, L-isoleucine 20mg/L, L-leucine 60mg/L, L-lysine hydrochloride 70mg/L, L-methionine 15mg/L, L-phenylalanine 25mg/L, L-proline 40mg/L, L-serine 25mg/L, L-threonine 30mg/L, L-tryptophan Acid 10mg/L, L-tyrosine disodium dihydrate 57.66mg/L, L-valine 25mg/L, ascorbic acid 0.05mg/L, α-D-tocopheryl phosphate 0.01mg/L, biotin 0.01mg/L, calcidol 0.1mg/L, D-calcium pantothenate 0.01mg/L, choline chloride 0.5mg/L, folic acid 0.01mg/L, inositol 0.05mg/L, menaquinone trihydrate Sodium bisulfate 0.019mg/L, niacin 0.025mg/L, nicotinamide 0.025mg/L, p-aminobenzoic acid 0.05mg/L, pyridoxine hydrochloride 0.05mg/L, riboflavin 0.01mg/L, hydrochloric acid Thiamine 0.01mg/L, vitamin A acetate 0.14mg/L, adenine sulfate 10mg/L, adenine 0.2mg/L, adenosine triphosphate disodium 1mg/L, cholesterol 0.2mg/L, 2- Deoxy-D-ribose 0.5mg/L, D-glucose 1000mg/L, glutathione 0.05mg/L, guanine hydrochloride 0.3mg/L, hypoxanthine sodium 0.354mg/L, ribose 0.5mg/L, thymus Su 0.3mg/L, Tween 805mg/L, uracil 0.3mg/L, xanthine sodium 0.34mg/L, phenol red 10mg/L.
二、牛体外受精和胚胎培养:2. Cattle in vitro fertilization and embryo culture:
步骤(1)、卵母细胞的采集和体外成熟Step (1), collection and in vitro maturation of oocytes
取屠宰场卵巢盛放于加双抗生理盐水的保温桶中,30.5-33℃条件下,4h内运回实验室;抽取表面2-8mm的卵泡,收集沉淀,在体视显微镜下捡出至少含有3层卵丘细胞包裹的卵母细胞COCs(即,卵丘-卵母细胞复合体),在洗卵液中洗涤2遍,去除多余杂质;Take the ovaries from the slaughterhouse and put them in an insulated bucket with double-antibiotic saline, and transport them back to the laboratory within 4 hours at 30.5-33°C; extract follicles with a surface size of 2-8mm, collect the precipitate, and pick out under a stereo microscope at least Oocyte COCs (i.e., cumulus-oocyte complex) wrapped by three layers of cumulus cells are washed twice in egg washing liquid to remove excess impurities;
将所得COCs在卵母细胞成熟培养液中洗涤1次,再转移到新的成熟培养液中培养22-24h(实际操作24小时),培养条件为38.8℃、5.5-6.5%CO2、饱和湿度;The obtained COCs were washed once in the oocyte maturation medium, and then transferred to a new maturation medium for 22-24 hours (actual operation 24 hours). The culture conditions were 38.8°C, 5.5-6.5% CO2, and saturated humidity;
步骤(2)、体外受精Step (2), in vitro fertilization
将成熟的COCs在受精培养液中洗涤1次,再转移到受精培养液中,放入培养箱中,备用;Wash the mature COCs once in the fertilization medium, then transfer them to the fertilization medium, put them in the incubator, and set aside;
从液氮中取一支冻精细管,37℃水浴解冻;无菌操作剪开细管两端,使精液注入盛有精液制备培养液的15mL离心管中,328×g离心2次,每次5min,离心后弃上清;将300μL精液制备培养液加入上述离心管,重悬精子沉淀,取适当的精子悬液进行精子计数;Take a frozen fine tube from liquid nitrogen and thaw it in a water bath at 37°C; cut both ends of the thin tube aseptically, inject the semen into a 15mL centrifuge tube filled with the semen preparation culture medium, and centrifuge twice at 328×g, each time After centrifuging for 5 minutes, discard the supernatant; add 300 μL of semen preparation culture medium to the above centrifuge tube, resuspend the sperm pellet, and take an appropriate sperm suspension for sperm counting;
将计算好体积的精子悬液加入盛有卵母细胞的受精培养液滴中,并将培养盘放入培养箱,使精卵共孵育16-20h(实际操作18小时),培养条件为38.8℃、5.5-6.5%CO2、饱和湿度;Add the calculated volume of sperm suspension into the fertilization culture drop filled with oocytes, put the culture plate into the incubator, and incubate the sperm and eggs for 16-20 hours (the actual operation is 18 hours), and the culture condition is 38.8°C , 5.5-6.5% CO2, saturated humidity;
步骤(3)、胚胎体外培养及保存Step (3), in vitro culture and preservation of embryos
体外受精操作完毕后,将胚胎周围的颗粒细胞用剥卵针去除干净,放入胚胎培养液中培养,此时记为胚胎培养的第1天,培养条件为38.8℃、6%O2、88%N2、饱和湿度,第3天记录卵裂率;第7天记录囊胚率,至第9天时统计囊胚孵化率(其为孵化囊胚数除以囊胚数所得百分数),并进行质量鉴定;After the in vitro fertilization operation, remove the granulosa cells around the embryo with the egg stripping needle, and put them into the embryo culture medium for culture. At this time, it is recorded as the first day of embryo culture. The culture conditions are 38.8°C, 6% O2, 88% N2, saturated humidity, record the cleavage rate on the 3rd day; record the blastocyst rate on the 7th day, and count the blastocyst hatching rate (it is the percentage obtained by dividing the number of hatched blastocysts by the number of blastocysts) on the 9th day, and carry out quality identification ;
将可用胚胎在保存液中洗涤3次,在平衡液中平衡10min后转移入冷冻液,按5段装液法装入胚胎,做好标记,再放入程序降温仪中按照0.5℃/min的速度降至-35℃后,将胚胎细管迅速取出,置入液氮中冷冻保存。Wash the usable embryos in the preservation solution for 3 times, equilibrate in the balance solution for 10 minutes, transfer to the freezing solution, load the embryos according to the 5-stage liquid filling method, mark them well, and then put them into the programmed cooling device at a temperature of 0.5°C/min. After the speed dropped to -35°C, the embryo straw was quickly taken out and placed in liquid nitrogen for cryopreservation.
三、胚胎差异染色的方法3. Method of Differential Staining of Embryos
1.选取体外培养第7天的囊胚,使用2%多聚甲醛固定20min。1. Select blastocysts on day 7 of in vitro culture and fix them with 2% paraformaldehyde for 20 minutes.
2.使用含0.5%BSA的磷酸盐缓冲液(PBS-BSA)洗两次,放入透化液(50μl Triton、5μl吐温80和9.945ml PBS)中,室温放置30min。2. Wash twice with phosphate buffered saline (PBS-BSA) containing 0.5% BSA, put into permeabilization solution (50 μl Triton, 5 μl Tween 80 and 9.945 ml PBS), and stand at room temperature for 30 min.
3.使用2M盐酸室温处理20min,然后使用100mM的Tris-HCl室温处理10min,使CDX2蛋白能够与一抗结合。3. Use 2M hydrochloric acid to treat at room temperature for 20 minutes, and then use 100 mM Tris-HCl to treat at room temperature for 10 minutes, so that the CDX2 protein can bind to the primary antibody.
4.使用PBS-BSA清洗三次,将囊胚放入封闭液(1ml山羊血清、5μl吐温80和8.995mlPBS)中,室温封闭1h,然后转入4℃冰箱封闭过夜。4. Wash three times with PBS-BSA, put the blastocyst into blocking solution (1ml goat serum, 5μl Tween 80 and 8.995ml PBS), seal at room temperature for 1h, and then transfer to 4°C refrigerator to seal overnight.
5.弃去封闭液,CDX2一抗用封闭液按1:200稀释,室温孵育2h,弃去一抗稀释液,用PBS-BSA清洗3次,每次5min。5. Discard the blocking solution, dilute the CDX2 primary antibody with blocking solution at 1:200, incubate at room temperature for 2 hours, discard the primary antibody dilution, and wash with PBS-BSA 3 times, 5 minutes each time.
6.caspase-3一抗(购自Cell Signaling Technology公司)用封闭液按1:200稀释,室温孵育2h,弃去一抗稀释液,用PBS-BSA清洗3次,每次5min。6. The caspase-3 primary antibody (purchased from Cell Signaling Technology Company) was diluted 1:200 with blocking solution, incubated at room temperature for 2 hours, discarded the primary antibody dilution, and washed 3 times with PBS-BSA, 5 minutes each time.
7.在避光条件下用封闭液按1:200稀释CDX2特异性二抗(购自Sigma公司),室温下避光放置1h。避光条件下弃去二抗稀释液,用PBS清洗3次,每次5min。7. Dilute the CDX2-specific secondary antibody (purchased from Sigma) at a ratio of 1:200 with blocking solution in the dark, and place it in the dark at room temperature for 1 hour. The secondary antibody dilution was discarded under dark conditions, and washed 3 times with PBS, 5 min each time.
8.在避光条件下用封闭液按1:200稀释caspase-3特异性二抗(购自LifeTechnologies公司),室温下避光放置1h。避光条件下弃去二抗稀释液,用PBS清洗3次,每次5min。8. Dilute the caspase-3-specific secondary antibody (purchased from Life Technologies) at a ratio of 1:200 with blocking solution under dark conditions, and place in the dark at room temperature for 1 hour. The secondary antibody dilution was discarded under dark conditions, and washed 3 times with PBS, 5 min each time.
9.加入10μg/mL的Hochest 33342染液染细胞核,室温作用5min,在荧光显微镜下观察并拍照。9. Add 10 μg/mL Hochest 33342 staining solution to stain cell nuclei, react at room temperature for 5 minutes, observe and take pictures under a fluorescent microscope.
10.实验重复三次,每次随机选取10个囊胚,计算凋亡率、ICM细胞数/总细胞数来评估囊胚质量。10. The experiment was repeated three times, and 10 blastocysts were randomly selected each time, and the apoptosis rate, ICM cell number/total cell number were calculated to evaluate the blastocyst quality.
数据统计方法:实验数据采用统计软件SAS V8中的ANOVA程序进行分析,Duncan’smultiple-range检验方法判定处理间的差异显著性,当p<0.05时认为差异显著。Data statistics method: The experimental data was analyzed using the ANOVA program in the statistical software SAS V8, and the Duncan’s multiple-range test method was used to determine the significance of the difference between treatments. When p<0.05, the difference was considered significant.
在本发明中,卵裂率=受精卵裂数/受精卵数。在本发明中,囊胚率=囊胚数/卵裂胚胎数。In the present invention, cleavage rate=number of fertilized cleavage/number of fertilized eggs. In the present invention, the blastocyst rate=the number of blastocysts/the number of cleavage embryos.
四、卵母细胞的体外成熟(IVM)效果——成熟率4. In vitro maturation (IVM) effect of oocytes - maturation rate
在本实施例的步骤(1)中,经体外成熟培养完毕后,在倒置显微镜下观察,将卵母细胞有第一极体释放、保持卵丘细胞间分泌粘稠的基质、细胞层显著膨大,细胞以卵子为中心,大体呈放射状向四周扩散者判定为已成熟,记录成熟的卵母细胞数,计算成熟率。In the step (1) of this embodiment, after in vitro maturation and culture, observe under an inverted microscope, the oocyte has the first polar body released, the viscous matrix secreted between the cumulus cells is maintained, and the cell layer is significantly enlarged. , The cells are centered on the ovum, and the cells that spread radially to the surroundings are judged to be mature, record the number of mature oocytes, and calculate the maturity rate.
五、结果5. Results
本实施例对中国黄牛(南阳牛,役用品种)进行试验。结果,卵裂率88.7%、桑葚胚率为63.7%、囊胚率为51.2%、凋亡率5.1%;另外,在第9天时囊胚孵化率达72.3%。卵母细胞体外成熟的成熟率达75.6%。In this example, a test is carried out on Chinese yellow cattle (Nanyang cattle, a service breed). As a result, the cleavage rate was 88.7%, the morula rate was 63.7%, the blastocyst rate was 51.2%, and the apoptosis rate was 5.1%. In addition, the blastocyst hatching rate reached 72.3% on the 9th day. The maturation rate of in vitro maturation of oocytes reached 75.6%.
在一个补充试验中,参照本实施例1的方法,分别针对荷斯坦牛(乳牛品种)、西门塔尔牛(肉牛品种)、中国水牛(役用品种)三种牛进行试验,结果:卵裂率均在84~89%范围内、桑葚胚率均在62~65%范围内、囊胚率均在50~53%范围内、凋亡率均在4~7%范围内、第9天囊胚孵化率均在71~75%范围内;荷斯坦牛、西门塔尔牛、中国水牛三种牛的卵母细胞体外成熟的成熟率分别为69.3%、65.6%、57.8%。In a supplementary test, with reference to the method of Example 1, tests were carried out on Holstein cattle (dairy breed), Simmental cattle (beef breed), and Chinese buffalo (service breed), and the results: cleavage The rate of morula was in the range of 84-89%, the rate of morula was in the range of 62-65%, the rate of blastocyst was in the range of 50-53%, the rate of apoptosis was in the range of 4-7%. The hatching rates of embryos were all in the range of 71-75%. The maturation rates of in vitro maturation of oocytes from Holstein, Simmental and Chinese buffalo were 69.3%, 65.6% and 57.8% respectively.
实施例2:牛体外受精胚胎的培养方法(活体无硒)Embodiment 2: the culture method of bovine in vitro fertilization embryo (living body without selenium)
一、试剂1. Reagents
本发明的具体试验中,如未另外说明,使用的相关试剂详述如下:In the specific test of the present invention, if not otherwise specified, the relevant reagents used are described in detail as follows:
加双抗生理盐水:包含青霉素400IU/mL、链霉素400μg/mL的生理盐水。Add double-antibody normal saline: normal saline containing 400 IU/mL penicillin and 400 μg/mL streptomycin.
洗卵液:添加了3mg/mL牛血清白蛋白的BY基础培养液。Egg washing solution: BY basal culture solution supplemented with 3mg/mL bovine serum albumin.
成熟培养液:添加了100mL/L FBS、10μg/mL FSH、10μg/mL LH、1μg/mL E2、20ng/mLEGF的BY基础培养液。Maturation medium: BY basal medium supplemented with 100 mL/L FBS, 10 μg/mL FSH, 10 μg/mL LH, 1 μg/mL E2, and 20 ng/mL EGF.
HEPES成熟培养液:添加了15mmol/L HEPES、100mL/L FBS、10μg/mL FSH、10μg/mLLH、1μg/mL E2、20ng/mL EGF的BY基础培养液。HEPES maturation medium: BY basal medium supplemented with 15mmol/L HEPES, 100mL/L FBS, 10μg/mL FSH, 10μg/mL LLH, 1μg/mL E2, and 20ng/mL EGF.
其中,EGF——表皮生长因子,FSH——卵泡刺激素,FBS——胎牛血清,E2——雌二醇,LH——促黄体生成素。Among them, EGF—epidermal growth factor, FSH—follicle stimulating hormone, FBS—fetal bovine serum, E2—estradiol, LH—luteinizing hormone.
受精培养液:包含112.0mM氯化钠、4.02mM氯化钾、2.25mM的氯化钙二水合物、0.52mM六水氯化镁、0.83mM磷酸二氢钾、37.0mM碳酸氢钠、1.25mM丙酮酸钠、10μg/ml肝素、4mg/ml牛血清白蛋白(BSA)、100U/ml青霉素、100μg/ml链霉素的水溶液。Fertilization medium: containing 112.0mM sodium chloride, 4.02mM potassium chloride, 2.25mM calcium chloride dihydrate, 0.52mM magnesium chloride hexahydrate, 0.83mM potassium dihydrogen phosphate, 37.0mM sodium bicarbonate, 1.25mM pyruvate Aqueous solution of sodium, 10 μg/ml heparin, 4 mg/ml bovine serum albumin (BSA), 100 U/ml penicillin, 100 μg/ml streptomycin.
精液制备培养液:包含112.0mM氯化钠、4.02mM氯化钾、2.25mM的氯化钙二水合物、0.52mM六水氯化镁、0.83mM磷酸二氢钾、37.0mM碳酸氢钠、1.25mM丙酮酸钠、10μg/ml肝素、4mg/ml牛血清白蛋白(BSA)、10mM咖啡因、100U/ml青霉素、100μg/ml链霉素的水溶液。Semen preparation medium: containing 112.0mM sodium chloride, 4.02mM potassium chloride, 2.25mM calcium chloride dihydrate, 0.52mM magnesium chloride hexahydrate, 0.83mM potassium dihydrogen phosphate, 37.0mM sodium bicarbonate, 1.25mM acetone An aqueous solution of sodium nitrite, 10 μg/ml heparin, 4 mg/ml bovine serum albumin (BSA), 10 mM caffeine, 100 U/ml penicillin, and 100 μg/ml streptomycin.
胚胎培养液:包含:109.5mM氯化钠、3.1mM氯化钾、26.2mM碳酸氢钠、0.8mM六水氯化镁、1.19mM磷酸二氢钾、0.4mM丙酮酸钠、1.5mM葡萄糖、5mM半乳糖酸钙、2.5v/v%胎牛血清(FBS)、L-谷氨酰胺1mM、2v/v%必需氨基酸、1v/v%非必须氨基酸、3mM的谷胱甘肽、枸橼酸钠0.04w/v%、麦芽糖0.02w/v%的水溶液;所述必需氨基酸为以下氨基酸按重量比例添加:L-盐酸精氨酸6.32g、L-胱氨酸二盐酸盐1.564g、L-盐酸组氨酸一水物2.1g、L-异亮氨酸2.625g、L-亮氨酸2.62g、L-赖氨酸盐酸盐3.625g、L-蛋氨酸0.755g、L-苯丙氨酸1.65g、L-苏氨酸2.38g、L-色氨酸0.51g、L-酪氨酸1.8g和L-缬氨酸2.34g,所述非必须氨基酸为以下氨基酸按重量比例添加:L-丙氨酸0.89g、L-天门冬酰胺一水物1.5g、L-天冬氨酸1.33g、L-谷氨酸1.47g、甘氨酸0.75g、L-脯氨酸1.15g和L-丝氨酸1.05g。Embryo culture medium: contains: 109.5mM sodium chloride, 3.1mM potassium chloride, 26.2mM sodium bicarbonate, 0.8mM magnesium chloride hexahydrate, 1.19mM potassium dihydrogen phosphate, 0.4mM sodium pyruvate, 1.5mM glucose, 5mM galactose calcium carbonate, 2.5v/v% fetal bovine serum (FBS), L-glutamine 1mM, 2v/v% essential amino acids, 1v/v% non-essential amino acids, 3mM glutathione, sodium citrate 0.04w /v%, maltose 0.02w/v% aqueous solution; the essential amino acids are the following amino acids added in proportion by weight: L-arginine hydrochloride 6.32g, L-cystine dihydrochloride 1.564g, L-hydrochloride group Amino acid monohydrate 2.1g, L-isoleucine 2.625g, L-leucine 2.62g, L-lysine hydrochloride 3.625g, L-methionine 0.755g, L-phenylalanine 1.65g , L-threonine 2.38g, L-tryptophan 0.51g, L-tyrosine 1.8g and L-valine 2.34g, described non-essential amino acid is that following amino acid is added by weight ratio: L-alanine 0.89 g of acid, 1.5 g of L-asparagine monohydrate, 1.33 g of L-aspartic acid, 1.47 g of L-glutamic acid, 0.75 g of glycine, 1.15 g of L-proline, and 1.05 g of L-serine.
BY基础培养液是包含如下组分的水溶液:氯化钙200mg/L、九水硝酸铁0.72mg/L、氯化钾400mg/L、硫酸镁97.7mg/L、氯化钠6800mg/L、一水磷酸二氢钠140mg/L、碳酸氢钠2200mg/L、醋酸钠50mg/L、L-丙氨酸25mg/L、L-精氨酸盐酸盐70mg/L、L-天冬氨酸30mg/L、L-半胱氨酸盐酸盐一水合物0.11mg/L、L-胱氨酸二盐酸盐26mg/L、L-谷氨酸75mg/L、甘氨酸50mg/L、L-组氨酸盐酸盐一水合物21.88mg/L、L-羟脯氨酸10mg/L、L-异亮氨酸20mg/L、L-亮氨酸60mg/L、L-赖氨酸盐酸盐70mg/L、L-蛋氨酸15mg/L、L-苯丙氨酸25mg/L、L-脯氨酸40mg/L、L-丝氨酸25mg/L、L-苏氨酸30mg/L、L-色氨酸10mg/L、L-酪氨酸二钠二水合物57.66mg/L、L-缬氨酸25mg/L、抗坏血酸0.05mg/L、α-D-生育酚磷酸酯0.01mg/L、生物素0.01mg/L、骨化醇0.1mg/L、D-泛酸钙0.01mg/L、氯化胆碱0.5mg/L、叶酸0.01mg/L、肌醇0.05mg/L、三水合甲萘醌亚硫酸氢钠0.019mg/L、烟酸0.025mg/L、烟酰胺0.025mg/L、p-氨基苯甲酸0.05mg/L、盐酸吡哆辛0.05mg/L、核黄素0.01mg/L、盐酸硫胺素0.01mg/L、维生素A乙酸酯0.14mg/L、硫酸腺嘌呤10mg/L、腺嘌呤0.2mg/L、腺苷三磷酸二钠1mg/L、胆固醇0.2mg/L、2-脱氧-D-核糖0.5mg/L、D-葡萄糖1000mg/L、谷胱甘肽0.05mg/L、盐酸鸟嘌呤0.3mg/L、次黄嘌呤钠0.354mg/L、核糖0.5mg/L、胸腺素0.3mg/L、吐温805mg/L、尿嘧啶0.3mg/L、黄嘌呤钠0.34mg/L、酚红10mg/L。BY basic culture solution is an aqueous solution containing the following components: calcium chloride 200mg/L, ferric nitrate nonahydrate 0.72mg/L, potassium chloride 400mg/L, magnesium sulfate 97.7mg/L, sodium chloride 6800mg/L, a Sodium dihydrogen phosphate water 140mg/L, sodium bicarbonate 2200mg/L, sodium acetate 50mg/L, L-alanine 25mg/L, L-arginine hydrochloride 70mg/L, L-aspartic acid 30mg /L, L-cysteine hydrochloride monohydrate 0.11mg/L, L-cystine dihydrochloride 26mg/L, L-glutamic acid 75mg/L, glycine 50mg/L, L-group Amino acid hydrochloride monohydrate 21.88mg/L, L-hydroxyproline 10mg/L, L-isoleucine 20mg/L, L-leucine 60mg/L, L-lysine hydrochloride 70mg/L, L-methionine 15mg/L, L-phenylalanine 25mg/L, L-proline 40mg/L, L-serine 25mg/L, L-threonine 30mg/L, L-tryptophan Acid 10mg/L, L-tyrosine disodium dihydrate 57.66mg/L, L-valine 25mg/L, ascorbic acid 0.05mg/L, α-D-tocopheryl phosphate 0.01mg/L, biotin 0.01mg/L, calcidol 0.1mg/L, D-calcium pantothenate 0.01mg/L, choline chloride 0.5mg/L, folic acid 0.01mg/L, inositol 0.05mg/L, menaquinone trihydrate Sodium bisulfate 0.019mg/L, niacin 0.025mg/L, nicotinamide 0.025mg/L, p-aminobenzoic acid 0.05mg/L, pyridoxine hydrochloride 0.05mg/L, riboflavin 0.01mg/L, hydrochloric acid Thiamine 0.01mg/L, vitamin A acetate 0.14mg/L, adenine sulfate 10mg/L, adenine 0.2mg/L, adenosine triphosphate disodium 1mg/L, cholesterol 0.2mg/L, 2- Deoxy-D-ribose 0.5mg/L, D-glucose 1000mg/L, glutathione 0.05mg/L, guanine hydrochloride 0.3mg/L, hypoxanthine sodium 0.354mg/L, ribose 0.5mg/L, thymus Su 0.3mg/L, Tween 805mg/L, uracil 0.3mg/L, xanthine sodium 0.34mg/L, phenol red 10mg/L.
二、牛体外受精和胚胎培养:2. Cattle in vitro fertilization and embryo culture:
步骤(1)、卵母细胞的采集和体外成熟Step (1), collection of oocytes and in vitro maturation
对牛进行活体采卵,将所得卵泡液在体视显微镜下捡出至少含3层卵丘细胞包裹的卵丘-卵母细胞复合体(COCs),放入包含HEPES的成熟培养液中38.8℃、3h内运回实验室;Live bovine eggs were collected, and the obtained follicular fluid was picked out under a stereo microscope to find cumulus-oocyte complexes (COCs) that contained at least 3 layers of cumulus cells, and put them into the mature culture medium containing HEPES at 38.8°C 、Transport back to the laboratory within 3 hours;
将所得COCs在卵母细胞成熟培养液中洗涤1次,再转移到新的成熟培养液中培养22-24h(实际操作24小时),培养条件为38.8℃、5.5-6.5%CO2、饱和湿度;The obtained COCs were washed once in the oocyte maturation medium, and then transferred to a new maturation medium for 22-24 hours (actual operation 24 hours). The culture conditions were 38.8°C, 5.5-6.5% CO2, and saturated humidity;
步骤(2)、体外受精Step (2), in vitro fertilization
将成熟的COCs在受精培养液中洗涤1次,再转移到受精培养液中,放入培养箱中,备用;Wash the mature COCs once in the fertilization medium, then transfer them to the fertilization medium, put them in the incubator, and set aside;
从液氮中取一支冻精细管,37℃水浴解冻;无菌操作剪开细管两端,使精液注入盛有精液制备培养液的15mL离心管中,328×g离心2次,每次5min,离心后弃上清;将300μL精液制备培养液加入上述离心管,重悬精子沉淀,取适当的精子悬液进行精子计数;Take a frozen fine tube from liquid nitrogen and thaw it in a water bath at 37°C; cut both ends of the thin tube aseptically, inject the semen into a 15mL centrifuge tube filled with the semen preparation culture medium, and centrifuge twice at 328×g, each time After centrifuging for 5 minutes, discard the supernatant; add 300 μL of semen preparation culture medium to the above centrifuge tube, resuspend the sperm pellet, and take an appropriate sperm suspension for sperm counting;
将计算好体积的精子悬液加入盛有卵母细胞的受精培养液滴中,并将培养盘放入培养箱,使精卵共孵育16-20h(实际操作18小时),培养条件为38.8℃、5.5-6.5%CO2、饱和湿度;Add the calculated volume of sperm suspension into the fertilization culture drop filled with oocytes, put the culture plate into the incubator, and incubate the sperm and eggs for 16-20 hours (the actual operation is 18 hours), and the culture condition is 38.8°C , 5.5-6.5% CO2, saturated humidity;
步骤(3)、胚胎体外培养及保存Step (3), in vitro culture and preservation of embryos
体外受精操作完毕后,将胚胎周围的颗粒细胞用剥卵针去除干净,放入胚胎培养液中培养,此时记为胚胎培养的第1天,培养条件为38.8℃、6%O2、88%N2、饱和湿度,第3天记录卵裂率;第7天记录囊胚率,至第9天时统计囊胚孵化率(其为孵化囊胚数除以囊胚数所得百分数),并进行质量鉴定;After the in vitro fertilization operation, remove the granulosa cells around the embryo with the egg stripping needle, and put them into the embryo culture medium for culture. At this time, it is recorded as the first day of embryo culture. The culture conditions are 38.8°C, 6% O2, 88% N2, saturated humidity, record the cleavage rate on the 3rd day; record the blastocyst rate on the 7th day, and count the blastocyst hatching rate (it is the percentage obtained by dividing the number of hatched blastocysts by the number of blastocysts) on the 9th day, and carry out quality identification ;
将可用胚胎在保存液中洗涤3次,在平衡液中平衡10min后转移入冷冻液,按5段装液法装入胚胎,做好标记,再放入程序降温仪中按照0.5℃/min的速度降至-35℃后,将胚胎细管迅速取出,置入液氮中冷冻保存。Wash the usable embryos in the preservation solution for 3 times, equilibrate in the balance solution for 10 minutes, transfer to the freezing solution, load the embryos according to the 5-stage liquid filling method, mark them well, and then put them into the programmed cooling device at a temperature of 0.5°C/min. After the speed dropped to -35°C, the embryo straw was quickly taken out and placed in liquid nitrogen for cryopreservation.
三、胚胎差异染色的方法3. Method of Differential Staining of Embryos
1.选取体外培养第7天的囊胚,使用2%多聚甲醛固定20min。1. Select blastocysts on day 7 of in vitro culture and fix them with 2% paraformaldehyde for 20 minutes.
2.使用含0.5%BSA的磷酸盐缓冲液(PBS-BSA)洗两次,放入透化液(50μl Triton、5μl吐温80和9.945ml PBS)中,室温放置30min。2. Wash twice with phosphate buffered saline (PBS-BSA) containing 0.5% BSA, put into permeabilization solution (50 μl Triton, 5 μl Tween 80 and 9.945 ml PBS), and stand at room temperature for 30 min.
3.使用2M盐酸室温处理20min,然后使用100mM的Tris-HCl室温处理10min,使CDX2蛋白能够与一抗结合。3. Use 2M hydrochloric acid to treat at room temperature for 20 minutes, and then use 100 mM Tris-HCl to treat at room temperature for 10 minutes, so that the CDX2 protein can bind to the primary antibody.
4.使用PBS-BSA清洗三次,将囊胚放入封闭液(1ml山羊血清、5μl吐温80和8.995mlPBS)中,室温封闭1h,然后转入4℃冰箱封闭过夜。4. Wash three times with PBS-BSA, put the blastocyst into blocking solution (1ml goat serum, 5μl Tween 80 and 8.995ml PBS), seal at room temperature for 1h, and then transfer to 4°C refrigerator to seal overnight.
5.弃去封闭液,CDX2一抗用封闭液按1:200稀释,室温孵育2h,弃去一抗稀释液,用PBS-BSA清洗3次,每次5min。5. Discard the blocking solution, dilute the CDX2 primary antibody with blocking solution at 1:200, incubate at room temperature for 2 hours, discard the primary antibody dilution, and wash with PBS-BSA 3 times, 5 minutes each time.
6.caspase-3一抗(购自Cell Signaling Technology公司)用封闭液按1:200稀释,室温孵育2h,弃去一抗稀释液,用PBS-BSA清洗3次,每次5min。6. The caspase-3 primary antibody (purchased from Cell Signaling Technology Company) was diluted 1:200 with blocking solution, incubated at room temperature for 2 hours, discarded the primary antibody dilution, and washed 3 times with PBS-BSA, 5 minutes each time.
7.在避光条件下用封闭液按1:200稀释CDX2特异性二抗(购自Sigma公司),室温下避光放置1h。避光条件下弃去二抗稀释液,用PBS清洗3次,每次5min。7. Dilute the CDX2-specific secondary antibody (purchased from Sigma) at a ratio of 1:200 with blocking solution in the dark, and place it in the dark at room temperature for 1 hour. The secondary antibody dilution was discarded under dark conditions, and washed 3 times with PBS, 5 min each time.
8.在避光条件下用封闭液按1:200稀释caspase-3特异性二抗(购自LifeTechnologies公司),室温下避光放置1h。避光条件下弃去二抗稀释液,用PBS清洗3次,每次5min。8. Dilute the caspase-3-specific secondary antibody (purchased from Life Technologies) at a ratio of 1:200 with blocking solution under dark conditions, and place in the dark at room temperature for 1 hour. The secondary antibody dilution was discarded under dark conditions, and washed 3 times with PBS, 5 min each time.
9.加入10μg/mL的Hochest 33342染液染细胞核,室温作用5min,在荧光显微镜下观察并拍照。9. Add 10 μg/mL Hochest 33342 staining solution to stain cell nuclei, react at room temperature for 5 minutes, observe and take pictures under a fluorescent microscope.
10.实验重复三次,每次随机选取10个囊胚,计算凋亡率、ICM细胞数/总细胞数来评估囊胚质量。10. The experiment was repeated three times, and 10 blastocysts were randomly selected each time, and the apoptosis rate, ICM cell number/total cell number were calculated to evaluate the blastocyst quality.
数据统计方法:实验数据采用统计软件SAS V8中的ANOVA程序进行分析,Duncan’smultiple-range检验方法判定处理间的差异显著性,当p<0.05时认为差异显著。Data statistics method: The experimental data was analyzed using the ANOVA program in the statistical software SAS V8, and the Duncan’s multiple-range test method was used to determine the significance of the difference between treatments. When p<0.05, the difference was considered significant.
在本发明中,卵裂率=受精卵裂数/受精卵数。在本发明中,囊胚率=囊胚数/卵裂胚胎数。In the present invention, cleavage rate=number of fertilized cleavage/number of fertilized eggs. In the present invention, the blastocyst rate=the number of blastocysts/the number of cleavage embryos.
四、卵母细胞的体外成熟(IVM)效果——成熟率4. In vitro maturation (IVM) effect of oocytes - maturation rate
在本实施例的步骤(1)中,经体外成熟培养完毕后,在倒置显微镜下观察,将卵母细胞有第一极体释放、保持卵丘细胞间分泌粘稠的基质、细胞层显著膨大,细胞以卵子为中心,大体呈放射状向四周扩散者判定为已成熟,记录成熟的卵母细胞数,计算成熟率。In the step (1) of this embodiment, after in vitro maturation and culture, observe under an inverted microscope, the oocyte has the first polar body released, the viscous matrix secreted between the cumulus cells is maintained, and the cell layer is significantly enlarged. , The cells are centered on the ovum, and the cells that spread radially to the surroundings are judged to be mature, record the number of mature oocytes, and calculate the maturity rate.
五、结果5. Results
本实施例对中国黄牛(南阳牛,役用品种)进行试验。结果,卵裂率87.4%、桑葚胚率为64.2%、囊胚率为51.8%、凋亡率4.8%;另外,在第9天时囊胚孵化率达71.1%。卵母细胞体外成熟的成熟率达76.3%。In this example, a test is carried out on Chinese yellow cattle (Nanyang cattle, a service breed). As a result, the cleavage rate was 87.4%, the morula rate was 64.2%, the blastocyst rate was 51.8%, and the apoptosis rate was 4.8%. In addition, the blastocyst hatching rate reached 71.1% on the 9th day. The maturation rate of in vitro maturation of oocytes was 76.3%.
在一个补充试验中,参照上文实施例2的方法,分别针对荷斯坦牛(乳牛品种)、西门塔尔牛(肉牛品种)、中国水牛(役用品种)三种牛进行试验,结果:卵裂率均在83~89%范围内、桑葚胚率均在61~65%范围内、囊胚率均在50~54%范围内、凋亡率均在4~6%范围内、第9天囊胚孵化率均在72~75%范围内;荷斯坦牛、西门塔尔牛、中国水牛三种牛的卵母细胞体外成熟的成熟率分别为68.8%、66.3%、58.3%。In a supplementary test, with reference to the method in Example 2 above, tests were carried out on Holstein cattle (dairy breed), Simmental cattle (beef breed), and Chinese buffalo (service breed), and the results: The cleavage rates were all in the range of 83-89%, the morula rates were all in the range of 61-65%, the blastocyst rates were all in the range of 50-54%, and the apoptosis rates were all in the range of 4-6%. The hatching rates of blastocysts were all in the range of 72-75%. The maturation rates of oocytes matured in vitro from Holstein, Simmental and Chinese buffalo were 68.8%, 66.3% and 58.3% respectively.
实施例3:牛体外受精胚胎的培养方法(离体硒铜)Embodiment 3: the culture method of bovine in vitro fertilization embryo (isolated selenium copper)
本实施例与上文实施例1的主要区别是在BY基础培养液中还额外添加0.25mg/L亚硒酸钠和0.075mg/L无水硫酸铜。The main difference between this example and the above example 1 is that 0.25 mg/L sodium selenite and 0.075 mg/L anhydrous copper sulfate are additionally added to the BY basal culture solution.
一、试剂1. Reagents
本发明的具体试验中,如未另外说明,使用的相关试剂详述如下:In the specific test of the present invention, if not otherwise specified, the relevant reagents used are described in detail as follows:
加双抗生理盐水:包含青霉素400IU/mL、链霉素400μg/mL的生理盐水。Add double-antibody normal saline: normal saline containing 400 IU/mL penicillin and 400 μg/mL streptomycin.
洗卵液:添加了3mg/mL牛血清白蛋白的BY基础培养液。Egg washing solution: BY basal culture solution supplemented with 3mg/mL bovine serum albumin.
成熟培养液:添加了100mL/L FBS、10μg/mL FSH、10μg/mL LH、1μg/mL E2、20ng/mLEGF的BY基础培养液。Maturation medium: BY basal medium supplemented with 100 mL/L FBS, 10 μg/mL FSH, 10 μg/mL LH, 1 μg/mL E2, and 20 ng/mL EGF.
HEPES成熟培养液:添加了15mmol/L HEPES、100mL/L FBS、10μg/mL FSH、10μg/mLLH、1μg/mL E2、20ng/mL EGF的BY基础培养液。HEPES maturation medium: BY basal medium supplemented with 15mmol/L HEPES, 100mL/L FBS, 10μg/mL FSH, 10μg/mL LLH, 1μg/mL E2, and 20ng/mL EGF.
其中,EGF——表皮生长因子,FSH——卵泡刺激素,FBS——胎牛血清,E2——雌二醇,LH——促黄体生成素。Among them, EGF—epidermal growth factor, FSH—follicle stimulating hormone, FBS—fetal bovine serum, E2—estradiol, LH—luteinizing hormone.
受精培养液:包含112.0mM氯化钠、4.02mM氯化钾、2.25mM的氯化钙二水合物、0.52mM六水氯化镁、0.83mM磷酸二氢钾、37.0mM碳酸氢钠、1.25mM丙酮酸钠、10μg/ml肝素、4mg/ml牛血清白蛋白(BSA)、100U/ml青霉素、100μg/ml链霉素的水溶液。Fertilization medium: containing 112.0mM sodium chloride, 4.02mM potassium chloride, 2.25mM calcium chloride dihydrate, 0.52mM magnesium chloride hexahydrate, 0.83mM potassium dihydrogen phosphate, 37.0mM sodium bicarbonate, 1.25mM pyruvate Aqueous solution of sodium, 10 μg/ml heparin, 4 mg/ml bovine serum albumin (BSA), 100 U/ml penicillin, 100 μg/ml streptomycin.
精液制备培养液:包含112.0mM氯化钠、4.02mM氯化钾、2.25mM的氯化钙二水合物、0.52mM六水氯化镁、0.83mM磷酸二氢钾、37.0mM碳酸氢钠、1.25mM丙酮酸钠、10μg/ml肝素、4mg/ml牛血清白蛋白(BSA)、10mM咖啡因、100U/ml青霉素、100μg/ml链霉素的水溶液。Semen preparation medium: containing 112.0mM sodium chloride, 4.02mM potassium chloride, 2.25mM calcium chloride dihydrate, 0.52mM magnesium chloride hexahydrate, 0.83mM potassium dihydrogen phosphate, 37.0mM sodium bicarbonate, 1.25mM acetone An aqueous solution of sodium nitrite, 10 μg/ml heparin, 4 mg/ml bovine serum albumin (BSA), 10 mM caffeine, 100 U/ml penicillin, and 100 μg/ml streptomycin.
胚胎培养液:包含:109.5mM氯化钠、3.1mM氯化钾、26.2mM碳酸氢钠、0.8mM六水氯化镁、1.19mM磷酸二氢钾、0.4mM丙酮酸钠、1.5mM葡萄糖、5mM半乳糖酸钙、10v/v%胎牛血清(FBS)、L-谷氨酰胺1mM、2v/v%必需氨基酸、1v/v%非必须氨基酸、3mM的谷胱甘肽、枸橼酸钠0.04w/v%、麦芽糖0.02w/v%的水溶液;所述必需氨基酸为以下氨基酸按重量比例添加:L-盐酸精氨酸6.32g、L-胱氨酸二盐酸盐1.564g、L-盐酸组氨酸一水物2.1g、L-异亮氨酸2.625g、L-亮氨酸2.62g、L-赖氨酸盐酸盐3.625g、L-蛋氨酸0.755g、L-苯丙氨酸1.65g、L-苏氨酸2.38g、L-色氨酸0.51g、L-酪氨酸1.8g和L-缬氨酸2.34g,所述非必须氨基酸为以下氨基酸按重量比例添加:L-丙氨酸0.89g、L-天门冬酰胺一水物1.5g、L-天冬氨酸1.33g、L-谷氨酸1.47g、甘氨酸0.75g、L-脯氨酸1.15g和L-丝氨酸1.05g。Embryo culture medium: contains: 109.5mM sodium chloride, 3.1mM potassium chloride, 26.2mM sodium bicarbonate, 0.8mM magnesium chloride hexahydrate, 1.19mM potassium dihydrogen phosphate, 0.4mM sodium pyruvate, 1.5mM glucose, 5mM galactose calcium carbonate, 10v/v% fetal bovine serum (FBS), L-glutamine 1mM, 2v/v% essential amino acids, 1v/v% non-essential amino acids, 3mM glutathione, sodium citrate 0.04w/ v%, maltose 0.02w/v% aqueous solution; the essential amino acid is the following amino acids added in proportion by weight: L-arginine hydrochloride 6.32g, L-cystine dihydrochloride 1.564g, L-histamine hydrochloride Acid monohydrate 2.1g, L-isoleucine 2.625g, L-leucine 2.62g, L-lysine hydrochloride 3.625g, L-methionine 0.755g, L-phenylalanine 1.65g, L-Threonine 2.38g, L-Tryptophan 0.51g, L-Tyrosine 1.8g and L-Valine 2.34g, described non-essential amino acids are the following amino acids added in proportion by weight: L-Alanine 0.89g, L-asparagine monohydrate 1.5g, L-aspartic acid 1.33g, L-glutamic acid 1.47g, glycine 0.75g, L-proline 1.15g and L-serine 1.05g.
BY基础培养液是包含如下组分的水溶液:氯化钙200mg/L、九水硝酸铁0.72mg/L、氯化钾400mg/L、硫酸镁97.7mg/L、氯化钠6800mg/L、一水磷酸二氢钠140mg/L、碳酸氢钠2200mg/L、醋酸钠50mg/L、L-丙氨酸25mg/L、L-精氨酸盐酸盐70mg/L、L-天冬氨酸30mg/L、L-半胱氨酸盐酸盐一水合物0.11mg/L、L-胱氨酸二盐酸盐26mg/L、L-谷氨酸75mg/L、甘氨酸50mg/L、L-组氨酸盐酸盐一水合物21.88mg/L、L-羟脯氨酸10mg/L、L-异亮氨酸20mg/L、L-亮氨酸60mg/L、L-赖氨酸盐酸盐70mg/L、L-蛋氨酸15mg/L、L-苯丙氨酸25mg/L、L-脯氨酸40mg/L、L-丝氨酸25mg/L、L-苏氨酸30mg/L、L-色氨酸10mg/L、L-酪氨酸二钠二水合物57.66mg/L、L-缬氨酸25mg/L、抗坏血酸0.05mg/L、α-D-生育酚磷酸酯0.01mg/L、生物素0.01mg/L、骨化醇0.1mg/L、D-泛酸钙0.01mg/L、氯化胆碱0.5mg/L、叶酸0.01mg/L、肌醇0.05mg/L、三水合甲萘醌亚硫酸氢钠0.019mg/L、烟酸0.025mg/L、烟酰胺0.025mg/L、p-氨基苯甲酸0.05mg/L、盐酸吡哆辛0.05mg/L、核黄素0.01mg/L、盐酸硫胺素0.01mg/L、维生素A乙酸酯0.14mg/L、硫酸腺嘌呤10mg/L、腺嘌呤0.2mg/L、腺苷三磷酸二钠1mg/L、胆固醇0.2mg/L、2-脱氧-D-核糖0.5mg/L、D-葡萄糖1000mg/L、谷胱甘肽0.05mg/L、盐酸鸟嘌呤0.3mg/L、次黄嘌呤钠0.354mg/L、核糖0.5mg/L、胸腺素0.3mg/L、吐温805mg/L、尿嘧啶0.3mg/L、黄嘌呤钠0.34mg/L、酚红10mg/L、0.25mg/L亚硒酸钠和0.075mg/L无水硫酸铜。BY basic culture solution is an aqueous solution containing the following components: calcium chloride 200mg/L, ferric nitrate nonahydrate 0.72mg/L, potassium chloride 400mg/L, magnesium sulfate 97.7mg/L, sodium chloride 6800mg/L, a Sodium dihydrogen phosphate water 140mg/L, sodium bicarbonate 2200mg/L, sodium acetate 50mg/L, L-alanine 25mg/L, L-arginine hydrochloride 70mg/L, L-aspartic acid 30mg /L, L-cysteine hydrochloride monohydrate 0.11mg/L, L-cystine dihydrochloride 26mg/L, L-glutamic acid 75mg/L, glycine 50mg/L, L-group Amino acid hydrochloride monohydrate 21.88mg/L, L-hydroxyproline 10mg/L, L-isoleucine 20mg/L, L-leucine 60mg/L, L-lysine hydrochloride 70mg/L, L-methionine 15mg/L, L-phenylalanine 25mg/L, L-proline 40mg/L, L-serine 25mg/L, L-threonine 30mg/L, L-tryptophan Acid 10mg/L, L-tyrosine disodium dihydrate 57.66mg/L, L-valine 25mg/L, ascorbic acid 0.05mg/L, α-D-tocopheryl phosphate 0.01mg/L, biotin 0.01mg/L, calcidol 0.1mg/L, D-calcium pantothenate 0.01mg/L, choline chloride 0.5mg/L, folic acid 0.01mg/L, inositol 0.05mg/L, menaquinone trihydrate Sodium bisulfate 0.019mg/L, niacin 0.025mg/L, nicotinamide 0.025mg/L, p-aminobenzoic acid 0.05mg/L, pyridoxine hydrochloride 0.05mg/L, riboflavin 0.01mg/L, hydrochloric acid Thiamine 0.01mg/L, vitamin A acetate 0.14mg/L, adenine sulfate 10mg/L, adenine 0.2mg/L, adenosine triphosphate disodium 1mg/L, cholesterol 0.2mg/L, 2- Deoxy-D-ribose 0.5mg/L, D-glucose 1000mg/L, glutathione 0.05mg/L, guanine hydrochloride 0.3mg/L, hypoxanthine sodium 0.354mg/L, ribose 0.5mg/L, thymus Sodium 0.3mg/L, Tween 805mg/L, Uracil 0.3mg/L, Sodium Xanthine 0.34mg/L, Phenol Red 10mg/L, Sodium Selenite 0.25mg/L and Copper Sulfate Anhydrous 0.075mg/L .
二、牛体外受精和胚胎培养:2. Cattle in vitro fertilization and embryo culture:
步骤(1)、卵母细胞的采集和体外成熟Step (1), collection and in vitro maturation of oocytes
取屠宰场卵巢盛放于加双抗生理盐水的保温桶中,30.5-33℃条件下,4h内运回实验室;抽取表面2-8mm的卵泡,收集沉淀,在体视显微镜下捡出至少含有3层卵丘细胞包裹的卵母细胞COCs(即,卵丘-卵母细胞复合体),在洗卵液中洗涤2遍,去除多余杂质;Take the ovaries from the slaughterhouse and put them in an insulated bucket with double-antibiotic saline, and transport them back to the laboratory within 4 hours at 30.5-33°C; extract follicles with a surface size of 2-8mm, collect the precipitate, and pick out under a stereo microscope at least Oocyte COCs (i.e., cumulus-oocyte complex) wrapped by three layers of cumulus cells are washed twice in egg washing liquid to remove excess impurities;
将所得COCs在卵母细胞成熟培养液中洗涤1次,再转移到新的成熟培养液中培养22-24h(实际操作24小时),培养条件为38.8℃、5.5-6.5%CO2、饱和湿度;The obtained COCs were washed once in the oocyte maturation medium, and then transferred to a new maturation medium for 22-24 hours (actual operation 24 hours). The culture conditions were 38.8°C, 5.5-6.5% CO2, and saturated humidity;
步骤(2)、体外受精Step (2), in vitro fertilization
将成熟的COCs在受精培养液中洗涤1次,再转移到受精培养液中,放入培养箱中,备用;Wash the mature COCs once in the fertilization medium, then transfer them to the fertilization medium, put them in the incubator, and set aside;
从液氮中取一支冻精细管,37℃水浴解冻;无菌操作剪开细管两端,使精液注入盛有精液制备培养液的15mL离心管中,328×g离心2次,每次5min,离心后弃上清;将300μL精液制备培养液加入上述离心管,重悬精子沉淀,取适当的精子悬液进行精子计数;Take a frozen fine tube from liquid nitrogen and thaw it in a water bath at 37°C; cut both ends of the thin tube aseptically, inject the semen into a 15mL centrifuge tube filled with the semen preparation culture medium, and centrifuge twice at 328×g, each time After centrifuging for 5 minutes, discard the supernatant; add 300 μL of semen preparation culture medium to the above centrifuge tube, resuspend the sperm pellet, and take an appropriate sperm suspension for sperm counting;
将计算好体积的精子悬液加入盛有卵母细胞的受精培养液滴中,并将培养盘放入培养箱,使精卵共孵育16-20h(实际操作18小时),培养条件为38.8℃、5.5-6.5%CO2、饱和湿度;Add the calculated volume of sperm suspension into the fertilization culture drop filled with oocytes, put the culture plate into the incubator, and incubate the sperm and eggs for 16-20 hours (the actual operation is 18 hours), and the culture condition is 38.8°C , 5.5-6.5% CO2, saturated humidity;
步骤(3)、胚胎体外培养及保存Step (3), in vitro culture and preservation of embryos
体外受精操作完毕后,将胚胎周围的颗粒细胞用剥卵针去除干净,放入胚胎培养液中培养,此时记为胚胎培养的第1天,培养条件为38.8℃、6%O2、88%N2、饱和湿度,第3天记录卵裂率;第7天记录囊胚率,至第9天时统计囊胚孵化率(其为孵化囊胚数除以囊胚数所得百分数),并进行质量鉴定;After the in vitro fertilization operation, remove the granulosa cells around the embryo with the egg stripping needle, and put them into the embryo culture medium for culture. At this time, it is recorded as the first day of embryo culture. The culture conditions are 38.8°C, 6% O2, 88% N2, saturated humidity, record the cleavage rate on the 3rd day; record the blastocyst rate on the 7th day, and count the blastocyst hatching rate (it is the percentage obtained by dividing the number of hatched blastocysts by the number of blastocysts) on the 9th day, and carry out quality identification ;
将可用胚胎在保存液中洗涤3次,在平衡液中平衡10min后转移入冷冻液,按5段装液法装入胚胎,做好标记,再放入程序降温仪中按照0.5℃/min的速度降至-35℃后,将胚胎细管迅速取出,置入液氮中冷冻保存。Wash the usable embryos in the preservation solution for 3 times, equilibrate in the balance solution for 10 minutes, transfer to the freezing solution, load the embryos according to the 5-stage liquid filling method, mark them well, and then put them into the programmed cooling device at a temperature of 0.5°C/min. After the speed dropped to -35°C, the embryo straw was quickly taken out and placed in liquid nitrogen for cryopreservation.
三、胚胎差异染色的方法3. Method of Differential Staining of Embryos
1.选取体外培养第7天的囊胚,使用2%多聚甲醛固定20min。1. Select blastocysts on day 7 of in vitro culture and fix them with 2% paraformaldehyde for 20 minutes.
2.使用含0.5%BSA的磷酸盐缓冲液(PBS-BSA)洗两次,放入透化液(50μl Triton、5μl吐温80和9.945ml PBS)中,室温放置30min。2. Wash twice with phosphate buffered saline (PBS-BSA) containing 0.5% BSA, put into permeabilization solution (50 μl Triton, 5 μl Tween 80 and 9.945 ml PBS), and stand at room temperature for 30 min.
3.使用2M盐酸室温处理20min,然后使用100mM的Tris-HCl室温处理10min,使CDX2蛋白能够与一抗结合。3. Use 2M hydrochloric acid to treat at room temperature for 20 minutes, and then use 100 mM Tris-HCl to treat at room temperature for 10 minutes, so that the CDX2 protein can bind to the primary antibody.
4.使用PBS-BSA清洗三次,将囊胚放入封闭液(1ml山羊血清、5μl吐温80和8.995mlPBS)中,室温封闭1h,然后转入4℃冰箱封闭过夜。4. Wash three times with PBS-BSA, put the blastocyst into blocking solution (1ml goat serum, 5μl Tween 80 and 8.995ml PBS), seal at room temperature for 1h, and then transfer to 4°C refrigerator to seal overnight.
5.弃去封闭液,CDX2一抗用封闭液按1:200稀释,室温孵育2h,弃去一抗稀释液,用PBS-BSA清洗3次,每次5min。5. Discard the blocking solution, dilute the CDX2 primary antibody with blocking solution at 1:200, incubate at room temperature for 2 hours, discard the primary antibody dilution, and wash with PBS-BSA 3 times, 5 minutes each time.
6.caspase-3一抗(购自Cell Signaling Technology公司)用封闭液按1:200稀释,室温孵育2h,弃去一抗稀释液,用PBS-BSA清洗3次,每次5min。6. The caspase-3 primary antibody (purchased from Cell Signaling Technology Company) was diluted 1:200 with blocking solution, incubated at room temperature for 2 hours, discarded the primary antibody dilution, and washed 3 times with PBS-BSA, 5 minutes each time.
7.在避光条件下用封闭液按1:200稀释CDX2特异性二抗(购自Sigma公司),室温下避光放置1h。避光条件下弃去二抗稀释液,用PBS清洗3次,每次5min。7. Dilute the CDX2-specific secondary antibody (purchased from Sigma) at a ratio of 1:200 with blocking solution in the dark, and place it in the dark at room temperature for 1 hour. The secondary antibody dilution was discarded under dark conditions, and washed 3 times with PBS, 5 min each time.
8.在避光条件下用封闭液按1:200稀释caspase-3特异性二抗(购自LifeTechnologies公司),室温下避光放置1h。避光条件下弃去二抗稀释液,用PBS清洗3次,每次5min。8. Dilute the caspase-3-specific secondary antibody (purchased from Life Technologies) at a ratio of 1:200 with blocking solution under dark conditions, and place in the dark at room temperature for 1 hour. The secondary antibody dilution was discarded under dark conditions, and washed 3 times with PBS, 5 min each time.
9.加入10μg/mL的Hochest 33342染液染细胞核,室温作用5min,在荧光显微镜下观察并拍照。9. Add 10 μg/mL Hochest 33342 staining solution to stain cell nuclei, react at room temperature for 5 minutes, observe and take pictures under a fluorescent microscope.
10.实验重复三次,每次随机选取10个囊胚,计算凋亡率、ICM细胞数/总细胞数来评估囊胚质量。10. The experiment was repeated three times, and 10 blastocysts were randomly selected each time, and the apoptosis rate, ICM cell number/total cell number were calculated to evaluate the blastocyst quality.
数据统计方法:实验数据采用统计软件SAS V8中的ANOVA程序进行分析,Duncan’smultiple-range检验方法判定处理间的差异显著性,当p<0.05时认为差异显著。Data statistics method: The experimental data was analyzed using the ANOVA program in the statistical software SAS V8, and the Duncan’s multiple-range test method was used to determine the significance of the difference between treatments. When p<0.05, the difference was considered significant.
在本发明中,卵裂率=受精卵裂数/受精卵数。在本发明中,囊胚率=囊胚数/卵裂胚胎数。In the present invention, cleavage rate=number of fertilized cleavage/number of fertilized eggs. In the present invention, the blastocyst rate=the number of blastocysts/the number of cleavage embryos.
四、卵母细胞的体外成熟(IVM)效果——成熟率4. In vitro maturation (IVM) effect of oocytes - maturation rate
在本实施例的步骤(1)中,经体外成熟培养完毕后,在倒置显微镜下观察,将卵母细胞有第一极体释放、保持卵丘细胞间分泌粘稠的基质、细胞层显著膨大,细胞以卵子为中心,大体呈放射状向四周扩散者判定为已成熟,记录成熟的卵母细胞数,计算成熟率。In the step (1) of this embodiment, after in vitro maturation and culture, observe under an inverted microscope, the oocyte has the first polar body released, the viscous matrix secreted between the cumulus cells is maintained, and the cell layer is significantly enlarged. , The cells are centered on the ovum, and the cells that spread radially to the surroundings are judged to be mature, record the number of mature oocytes, and calculate the maturity rate.
五、结果5. Results
本实施例对中国黄牛(南阳牛,役用品种)进行试验。结果,卵裂率88.2%、桑葚胚率为64.2%、囊胚率为50.8%、凋亡率5.6%;另外,在第9天时囊胚孵化率达73.4%。卵母细胞体外成熟的成熟率达88.3%,相对于实施例1方法的成熟率增加约13个百分点。In this example, a test is carried out on Chinese yellow cattle (Nanyang cattle, a service breed). As a result, the cleavage rate was 88.2%, the morula rate was 64.2%, the blastocyst rate was 50.8%, and the apoptosis rate was 5.6%. In addition, the blastocyst hatching rate reached 73.4% on the 9th day. The maturation rate of the in vitro maturation of oocytes reached 88.3%, an increase of about 13 percentage points relative to the maturation rate of the method in Example 1.
在一个补充试验中,参照上文实施例3的方法,分别针对荷斯坦牛(乳牛品种)、西门塔尔牛(肉牛品种)、中国水牛(役用品种)三种牛进行试验,结果:卵裂率均在84~90%范围内、桑葚胚率均在61~65%范围内、囊胚率均在50~54%范围内、凋亡率均在3~6%范围内、第9天囊胚孵化率均在71~76%范围内;荷斯坦牛、西门塔尔牛、中国水牛三种牛的卵母细胞体外成熟的成熟率分别为84.5%、79.5%、73.2%,相对于实施例1方法的成熟率均分别增加约14~15个百分点。上述结果,尽管本发明实施例1方法能够获得完全令人满意的结果,然而,出人意料的发现是,当在本发明BY基础培养液中添加微量硒化物和硫酸铜时能够显著增加卵母细胞体外成熟的成熟率,这是非常有意义的,特别是没有任何现有技术教导上述硒化物和硫酸铜的添加能够显著增加卵母细胞体外成熟的成熟率的技术教导。In a supplementary test, with reference to the method in Example 3 above, tests were carried out on Holstein cattle (dairy breed), Simmental cattle (beef breed), and Chinese buffalo (service breed), and the results: The cleavage rates were all in the range of 84-90%, the morula rates were all in the range of 61-65%, the blastocyst rates were all in the range of 50-54%, and the apoptosis rates were all in the range of 3-6%. The hatching rates of blastocysts were all in the range of 71-76%; the maturation rates of in vitro maturation of oocytes from Holstein, Simmental, and Chinese buffalo were 84.5%, 79.5%, and 73.2%, respectively. The maturity rates of the methods in Example 1 all increased by about 14 to 15 percentage points. The above-mentioned results, although the method of Example 1 of the present invention can obtain completely satisfactory results, however, it is unexpectedly found that when trace selenide and copper sulfate are added to the BY basal culture solution of the present invention, it can significantly increase the oocyte in vitro. The maturation rate of maturation, which is very meaningful, especially there is no technical teaching in any prior art that the above-mentioned addition of selenide and copper sulfate can significantly increase the maturation rate of in vitro maturation of oocytes.
在一个补充试验中,参考本实施例3,在BY基础培养基中不添加亚硒酸钠(而仅增补相应量的硫酸铜)或者不添加硫酸铜(而仅增补相应量的亚硒酸钠)时,在四种牛种中,卵裂率、桑葚胚率、囊胚率、凋亡率四参数在两种情况下与实施例3结果基本一致,对四种牛种的卵裂率均在84~89%范围内、桑葚胚率均在63~65%范围内、囊胚率均在52~55%范围内、凋亡率均在3~6%范围内、第9天囊胚孵化率均在70~75%范围内,例如针对中国黄牛的卵裂率分别为87.7%和88.5%;但是卵母细胞体外成熟的成熟率相对于实施例1结果未见有增加,两种情况下对中国黄牛、荷斯坦牛、西门塔尔牛、中国水牛的卵母细胞体外成熟的成熟率分别为73~75%、67~70%、65~66%、55~57%。这表明BY基础培养基中硒化物和硫酸铜的添加与否不会影响卵裂率、桑葚胚率、囊胚率、凋亡率四参数,但是只有同时添加硒化物和硫酸铜时才能有效的提高卵母细胞体外成熟的成熟率。In a supplementary test, with reference to this embodiment 3, sodium selenite is not added (but only the corresponding amount of copper sulfate is supplemented) or copper sulfate is not added (and only the corresponding amount of sodium selenite is supplemented) in the BY basal medium ), in the four kinds of cattle species, the four parameters of cleavage rate, morula rate, blastocyst rate, and apoptosis rate were basically consistent with the results of Example 3 in both cases, and the cleavage rates of the four kinds of cattle species were all In the range of 84-89%, the rate of morula is in the range of 63-65%, the rate of blastocyst is in the range of 52-55%, the rate of apoptosis is in the range of 3-6%, and the blastocyst hatches on the 9th day The rates are all in the range of 70 to 75%. For example, the cleavage rates for Chinese yellow cattle are 87.7% and 88.5% respectively; but the maturation rate of oocyte maturation in vitro is not increased compared with the results of Example 1. In both cases The in vitro maturation rates of oocytes from Chinese Yellow Cattle, Holstein Cattle, Simmental Cattle, and Chinese Buffalo are 73-75%, 67-70%, 65-66%, and 55-57%, respectively. This shows that the addition of selenide and copper sulfate in the BY basal medium will not affect the four parameters of cleavage rate, morula rate, blastocyst rate, and apoptosis rate, but it will be effective only when selenide and copper sulfate are added at the same time. Improves the maturation rate of oocyte maturation in vitro.
实施例4:牛体外受精胚胎的培养方法(活体硒铜)Embodiment 4: the culture method of bovine in vitro fertilization embryo (living body selenium copper)
本实施例与上文实施例2的主要区别是在BY基础培养液中还额外添加0.25mg/L亚硒酸钠和0.075mg/L无水硫酸铜。The main difference between this example and the above example 2 is that 0.25 mg/L sodium selenite and 0.075 mg/L anhydrous copper sulfate are additionally added to the BY basal culture solution.
一、试剂1. Reagents
本发明的具体试验中,如未另外说明,使用的相关试剂详述如下:In the specific test of the present invention, if not otherwise specified, the relevant reagents used are described in detail as follows:
加双抗生理盐水:包含青霉素400IU/mL、链霉素400μg/mL的生理盐水。Add double-antibody normal saline: normal saline containing 400 IU/mL penicillin and 400 μg/mL streptomycin.
洗卵液:添加了3mg/mL牛血清白蛋白的BY基础培养液。Egg washing solution: BY basal culture solution supplemented with 3mg/mL bovine serum albumin.
成熟培养液:添加了100mL/L FBS、10μg/mL FSH、10μg/mL LH、1μg/mL E2、20ng/mLEGF的BY基础培养液。Maturation medium: BY basal medium supplemented with 100 mL/L FBS, 10 μg/mL FSH, 10 μg/mL LH, 1 μg/mL E2, and 20 ng/mL EGF.
HEPES成熟培养液:添加了15mmol/L HEPES、100mL/L FBS、10μg/mL FSH、10μg/mLLH、1μg/mL E2、20ng/mL EGF的BY基础培养液。HEPES maturation medium: BY basal medium supplemented with 15mmol/L HEPES, 100mL/L FBS, 10μg/mL FSH, 10μg/mL LLH, 1μg/mL E2, and 20ng/mL EGF.
其中,EGF——表皮生长因子,FSH——卵泡刺激素,FBS——胎牛血清,E2——雌二醇,LH——促黄体生成素。Among them, EGF—epidermal growth factor, FSH—follicle stimulating hormone, FBS—fetal bovine serum, E2—estradiol, LH—luteinizing hormone.
受精培养液:包含112.0mM氯化钠、4.02mM氯化钾、2.25mM的氯化钙二水合物、0.52mM六水氯化镁、0.83mM磷酸二氢钾、37.0mM碳酸氢钠、1.25mM丙酮酸钠、10μg/ml肝素、4mg/ml牛血清白蛋白(BSA)、100U/ml青霉素、100μg/ml链霉素的水溶液。Fertilization medium: containing 112.0mM sodium chloride, 4.02mM potassium chloride, 2.25mM calcium chloride dihydrate, 0.52mM magnesium chloride hexahydrate, 0.83mM potassium dihydrogen phosphate, 37.0mM sodium bicarbonate, 1.25mM pyruvate Aqueous solution of sodium, 10 μg/ml heparin, 4 mg/ml bovine serum albumin (BSA), 100 U/ml penicillin, 100 μg/ml streptomycin.
精液制备培养液:包含112.0mM氯化钠、4.02mM氯化钾、2.25mM的氯化钙二水合物、0.52mM六水氯化镁、0.83mM磷酸二氢钾、37.0mM碳酸氢钠、1.25mM丙酮酸钠、10μg/ml肝素、4mg/ml牛血清白蛋白(BSA)、10mM咖啡因、100U/ml青霉素、100μg/ml链霉素的水溶液。Semen preparation medium: containing 112.0mM sodium chloride, 4.02mM potassium chloride, 2.25mM calcium chloride dihydrate, 0.52mM magnesium chloride hexahydrate, 0.83mM potassium dihydrogen phosphate, 37.0mM sodium bicarbonate, 1.25mM acetone An aqueous solution of sodium nitrite, 10 μg/ml heparin, 4 mg/ml bovine serum albumin (BSA), 10 mM caffeine, 100 U/ml penicillin, and 100 μg/ml streptomycin.
胚胎培养液:包含:109.5mM氯化钠、3.1mM氯化钾、26.2mM碳酸氢钠、0.8mM六水氯化镁、1.19mM磷酸二氢钾、0.4mM丙酮酸钠、1.5mM葡萄糖、5mM半乳糖酸钙、10v/v%胎牛血清(FBS)、L-谷氨酰胺1mM、2v/v%必需氨基酸、1v/v%非必须氨基酸、3mM的谷胱甘肽、枸橼酸钠0.04w/v%、麦芽糖0.02w/v%的水溶液;所述必需氨基酸为以下氨基酸按重量比例添加:L-盐酸精氨酸6.32g、L-胱氨酸二盐酸盐1.564g、L-盐酸组氨酸一水物2.1g、L-异亮氨酸2.625g、L-亮氨酸2.62g、L-赖氨酸盐酸盐3.625g、L-蛋氨酸0.755g、L-苯丙氨酸1.65g、L-苏氨酸2.38g、L-色氨酸0.51g、L-酪氨酸1.8g和L-缬氨酸2.34g,所述非必须氨基酸为以下氨基酸按重量比例添加:L-丙氨酸0.89g、L-天门冬酰胺一水物1.5g、L-天冬氨酸1.33g、L-谷氨酸1.47g、甘氨酸0.75g、L-脯氨酸1.15g和L-丝氨酸1.05g。Embryo culture medium: contains: 109.5mM sodium chloride, 3.1mM potassium chloride, 26.2mM sodium bicarbonate, 0.8mM magnesium chloride hexahydrate, 1.19mM potassium dihydrogen phosphate, 0.4mM sodium pyruvate, 1.5mM glucose, 5mM galactose calcium carbonate, 10v/v% fetal bovine serum (FBS), L-glutamine 1mM, 2v/v% essential amino acids, 1v/v% non-essential amino acids, 3mM glutathione, sodium citrate 0.04w/ v%, maltose 0.02w/v% aqueous solution; the essential amino acid is the following amino acids added in proportion by weight: L-arginine hydrochloride 6.32g, L-cystine dihydrochloride 1.564g, L-histamine hydrochloride Acid monohydrate 2.1g, L-isoleucine 2.625g, L-leucine 2.62g, L-lysine hydrochloride 3.625g, L-methionine 0.755g, L-phenylalanine 1.65g, L-Threonine 2.38g, L-Tryptophan 0.51g, L-Tyrosine 1.8g and L-Valine 2.34g, described non-essential amino acids are the following amino acids added in proportion by weight: L-Alanine 0.89g, L-asparagine monohydrate 1.5g, L-aspartic acid 1.33g, L-glutamic acid 1.47g, glycine 0.75g, L-proline 1.15g and L-serine 1.05g.
BY基础培养液是包含如下组分的水溶液:氯化钙200mg/L、九水硝酸铁0.72mg/L、氯化钾400mg/L、硫酸镁97.7mg/L、氯化钠6800mg/L、一水磷酸二氢钠140mg/L、碳酸氢钠2200mg/L、醋酸钠50mg/L、L-丙氨酸25mg/L、L-精氨酸盐酸盐70mg/L、L-天冬氨酸30mg/L、L-半胱氨酸盐酸盐一水合物0.11mg/L、L-胱氨酸二盐酸盐26mg/L、L-谷氨酸75mg/L、甘氨酸50mg/L、L-组氨酸盐酸盐一水合物21.88mg/L、L-羟脯氨酸10mg/L、L-异亮氨酸20mg/L、L-亮氨酸60mg/L、L-赖氨酸盐酸盐70mg/L、L-蛋氨酸15mg/L、L-苯丙氨酸25mg/L、L-脯氨酸40mg/L、L-丝氨酸25mg/L、L-苏氨酸30mg/L、L-色氨酸10mg/L、L-酪氨酸二钠二水合物57.66mg/L、L-缬氨酸25mg/L、抗坏血酸0.05mg/L、α-D-生育酚磷酸酯0.01mg/L、生物素0.01mg/L、骨化醇0.1mg/L、D-泛酸钙0.01mg/L、氯化胆碱0.5mg/L、叶酸0.01mg/L、肌醇0.05mg/L、三水合甲萘醌亚硫酸氢钠0.019mg/L、烟酸0.025mg/L、烟酰胺0.025mg/L、p-氨基苯甲酸0.05mg/L、盐酸吡哆辛0.05mg/L、核黄素0.01mg/L、盐酸硫胺素0.01mg/L、维生素A乙酸酯0.14mg/L、硫酸腺嘌呤10mg/L、腺嘌呤0.2mg/L、腺苷三磷酸二钠1mg/L、胆固醇0.2mg/L、2-脱氧-D-核糖0.5mg/L、D-葡萄糖1000mg/L、谷胱甘肽0.05mg/L、盐酸鸟嘌呤0.3mg/L、次黄嘌呤钠0.354mg/L、核糖0.5mg/L、胸腺素0.3mg/L、吐温805mg/L、尿嘧啶0.3mg/L、黄嘌呤钠0.34mg/L、酚红10mg/L、0.25mg/L亚硒酸钠和0.075mg/L无水硫酸铜。BY basic culture solution is an aqueous solution containing the following components: calcium chloride 200mg/L, ferric nitrate nonahydrate 0.72mg/L, potassium chloride 400mg/L, magnesium sulfate 97.7mg/L, sodium chloride 6800mg/L, a Sodium dihydrogen phosphate water 140mg/L, sodium bicarbonate 2200mg/L, sodium acetate 50mg/L, L-alanine 25mg/L, L-arginine hydrochloride 70mg/L, L-aspartic acid 30mg /L, L-cysteine hydrochloride monohydrate 0.11mg/L, L-cystine dihydrochloride 26mg/L, L-glutamic acid 75mg/L, glycine 50mg/L, L-group Amino acid hydrochloride monohydrate 21.88mg/L, L-hydroxyproline 10mg/L, L-isoleucine 20mg/L, L-leucine 60mg/L, L-lysine hydrochloride 70mg/L, L-methionine 15mg/L, L-phenylalanine 25mg/L, L-proline 40mg/L, L-serine 25mg/L, L-threonine 30mg/L, L-tryptophan Acid 10mg/L, L-tyrosine disodium dihydrate 57.66mg/L, L-valine 25mg/L, ascorbic acid 0.05mg/L, α-D-tocopheryl phosphate 0.01mg/L, biotin 0.01mg/L, calcidol 0.1mg/L, D-calcium pantothenate 0.01mg/L, choline chloride 0.5mg/L, folic acid 0.01mg/L, inositol 0.05mg/L, menaquinone trihydrate Sodium bisulfate 0.019mg/L, niacin 0.025mg/L, nicotinamide 0.025mg/L, p-aminobenzoic acid 0.05mg/L, pyridoxine hydrochloride 0.05mg/L, riboflavin 0.01mg/L, hydrochloric acid Thiamine 0.01mg/L, vitamin A acetate 0.14mg/L, adenine sulfate 10mg/L, adenine 0.2mg/L, adenosine triphosphate disodium 1mg/L, cholesterol 0.2mg/L, 2- Deoxy-D-ribose 0.5mg/L, D-glucose 1000mg/L, glutathione 0.05mg/L, guanine hydrochloride 0.3mg/L, hypoxanthine sodium 0.354mg/L, ribose 0.5mg/L, thymus Sodium 0.3mg/L, Tween 805mg/L, Uracil 0.3mg/L, Sodium Xanthine 0.34mg/L, Phenol Red 10mg/L, Sodium Selenite 0.25mg/L and Copper Sulfate Anhydrous 0.075mg/L .
二、牛体外受精和胚胎培养:2. Cattle in vitro fertilization and embryo culture:
步骤(1)、卵母细胞的采集和体外成熟Step (1), collection and in vitro maturation of oocytes
对牛进行活体采卵,将所得卵泡液在体视显微镜下捡出至少含3层卵丘细胞包裹的卵丘-卵母细胞复合体(COCs),放入包含HEPES的成熟培养液中38.8℃、3h内运回实验室;Live bovine eggs were collected, and the obtained follicular fluid was picked out under a stereo microscope to find cumulus-oocyte complexes (COCs) that contained at least 3 layers of cumulus cells, and put them into the mature culture medium containing HEPES at 38.8°C 、Transport back to the laboratory within 3 hours;
将所得COCs在卵母细胞成熟培养液中洗涤1次,再转移到新的成熟培养液中培养22-24h(实际操作24小时),培养条件为38.8℃、5.5-6.5%CO2、饱和湿度;The obtained COCs were washed once in the oocyte maturation medium, and then transferred to a new maturation medium for 22-24 hours (actual operation 24 hours). The culture conditions were 38.8°C, 5.5-6.5% CO2, and saturated humidity;
步骤(2)、体外受精Step (2), in vitro fertilization
将成熟的COCs在受精培养液中洗涤1次,再转移到受精培养液中,放入培养箱中,备用;Wash the mature COCs once in the fertilization medium, then transfer them to the fertilization medium, put them in the incubator, and set aside;
从液氮中取一支冻精细管,37℃水浴解冻;无菌操作剪开细管两端,使精液注入盛有精液制备培养液的15mL离心管中,328×g离心2次,每次5min,离心后弃上清;将300μL精液制备培养液加入上述离心管,重悬精子沉淀,取适当的精子悬液进行精子计数;Take a frozen fine tube from liquid nitrogen and thaw it in a water bath at 37°C; cut both ends of the thin tube aseptically, inject the semen into a 15mL centrifuge tube filled with the semen preparation culture medium, and centrifuge twice at 328×g, each time After centrifuging for 5 minutes, discard the supernatant; add 300 μL of semen preparation culture medium to the above centrifuge tube, resuspend the sperm pellet, and take an appropriate sperm suspension for sperm counting;
将计算好体积的精子悬液加入盛有卵母细胞的受精培养液滴中,并将培养盘放入培养箱,使精卵共孵育16-20h(实际操作18小时),培养条件为38.8℃、5.5-6.5%CO2、饱和湿度;Add the calculated volume of sperm suspension into the fertilization culture drop filled with oocytes, put the culture plate into the incubator, and incubate the sperm and eggs for 16-20 hours (the actual operation is 18 hours), and the culture condition is 38.8°C , 5.5-6.5% CO2, saturated humidity;
步骤(3)、胚胎体外培养及保存Step (3), in vitro culture and preservation of embryos
体外受精操作完毕后,将胚胎周围的颗粒细胞用剥卵针去除干净,放入胚胎培养液中培养,此时记为胚胎培养的第1天,培养条件为38.8℃、6%O2、88%N2、饱和湿度,第3天记录卵裂率;第7天记录囊胚率,至第9天时统计囊胚孵化率(其为孵化囊胚数除以囊胚数所得百分数),并进行质量鉴定;After the in vitro fertilization operation, remove the granulosa cells around the embryo with the egg stripping needle, and put them into the embryo culture medium for culture. At this time, it is recorded as the first day of embryo culture. The culture conditions are 38.8°C, 6% O2, 88% N2, saturated humidity, record the cleavage rate on the 3rd day; record the blastocyst rate on the 7th day, and count the blastocyst hatching rate (it is the percentage obtained by dividing the number of hatched blastocysts by the number of blastocysts) on the 9th day, and carry out quality identification ;
将可用胚胎在保存液中洗涤3次,在平衡液中平衡10min后转移入冷冻液,按5段装液法装入胚胎,做好标记,再放入程序降温仪中按照0.5℃/min的速度降至-35℃后,将胚胎细管迅速取出,置入液氮中冷冻保存。Wash the usable embryos in the preservation solution for 3 times, equilibrate in the balance solution for 10 minutes, transfer to the freezing solution, load the embryos according to the 5-stage liquid filling method, mark them well, and then put them into the programmed cooling device at a temperature of 0.5°C/min. After the speed dropped to -35°C, the embryo straw was quickly taken out and placed in liquid nitrogen for cryopreservation.
三、胚胎差异染色的方法3. Method of Differential Staining of Embryos
1.选取体外培养第7天的囊胚,使用2%多聚甲醛固定20min。1. Select blastocysts on day 7 of in vitro culture and fix them with 2% paraformaldehyde for 20 minutes.
2.使用含0.5%BSA的磷酸盐缓冲液(PBS-BSA)洗两次,放入透化液(50μl Triton、5μl吐温80和9.945ml PBS)中,室温放置30min。2. Wash twice with phosphate buffered saline (PBS-BSA) containing 0.5% BSA, put into permeabilization solution (50 μl Triton, 5 μl Tween 80 and 9.945 ml PBS), and stand at room temperature for 30 min.
3.使用2M盐酸室温处理20min,然后使用100mM的Tris-HCl室温处理10min,使CDX2蛋白能够与一抗结合。3. Use 2M hydrochloric acid to treat at room temperature for 20 minutes, and then use 100 mM Tris-HCl to treat at room temperature for 10 minutes, so that the CDX2 protein can bind to the primary antibody.
4.使用PBS-BSA清洗三次,将囊胚放入封闭液(1ml山羊血清、5μl吐温80和8.995mlPBS)中,室温封闭1h,然后转入4℃冰箱封闭过夜。4. Wash three times with PBS-BSA, put the blastocyst into blocking solution (1ml goat serum, 5μl Tween 80 and 8.995ml PBS), seal at room temperature for 1h, and then transfer to 4°C refrigerator to seal overnight.
5.弃去封闭液,CDX2一抗用封闭液按1:200稀释,室温孵育2h,弃去一抗稀释液,用PBS-BSA清洗3次,每次5min。5. Discard the blocking solution, dilute the CDX2 primary antibody with blocking solution at 1:200, incubate at room temperature for 2 hours, discard the primary antibody dilution, and wash with PBS-BSA 3 times, 5 minutes each time.
6.caspase-3一抗(购自Cell Signaling Technology公司)用封闭液按1:200稀释,室温孵育2h,弃去一抗稀释液,用PBS-BSA清洗3次,每次5min。6. The caspase-3 primary antibody (purchased from Cell Signaling Technology Company) was diluted 1:200 with blocking solution, incubated at room temperature for 2 hours, discarded the primary antibody dilution, and washed 3 times with PBS-BSA, 5 minutes each time.
7.在避光条件下用封闭液按1:200稀释CDX2特异性二抗(购自Sigma公司),室温下避光放置1h。避光条件下弃去二抗稀释液,用PBS清洗3次,每次5min。7. Dilute the CDX2-specific secondary antibody (purchased from Sigma) at a ratio of 1:200 with blocking solution in the dark, and place it in the dark at room temperature for 1 hour. The secondary antibody dilution was discarded under dark conditions, and washed 3 times with PBS, 5 min each time.
8.在避光条件下用封闭液按1:200稀释caspase-3特异性二抗(购自LifeTechnologies公司),室温下避光放置1h。避光条件下弃去二抗稀释液,用PBS清洗3次,每次5min。8. Dilute the caspase-3-specific secondary antibody (purchased from Life Technologies) at a ratio of 1:200 with blocking solution under dark conditions, and place in the dark at room temperature for 1 hour. The secondary antibody dilution was discarded under dark conditions, and washed 3 times with PBS, 5 min each time.
9.加入10μg/mL的Hochest 33342染液染细胞核,室温作用5min,在荧光显微镜下观察并拍照。9. Add 10 μg/mL Hochest 33342 staining solution to stain cell nuclei, react at room temperature for 5 minutes, observe and take pictures under a fluorescent microscope.
10.实验重复三次,每次随机选取10个囊胚,计算凋亡率、ICM细胞数/总细胞数来评估囊胚质量。10. The experiment was repeated three times, and 10 blastocysts were randomly selected each time, and the apoptosis rate, ICM cell number/total cell number were calculated to evaluate the blastocyst quality.
数据统计方法:实验数据采用统计软件SAS V8中的ANOVA程序进行分析,Duncan’smultiple-range检验方法判定处理间的差异显著性,当p<0.05时认为差异显著。Data statistics method: The experimental data was analyzed using the ANOVA program in the statistical software SAS V8, and the Duncan’s multiple-range test method was used to determine the significance of the difference between treatments. When p<0.05, the difference was considered significant.
在本发明中,卵裂率=受精卵裂数/受精卵数。在本发明中,囊胚率=囊胚数/卵裂胚胎数。In the present invention, cleavage rate=number of fertilized cleavage/number of fertilized eggs. In the present invention, the blastocyst rate=the number of blastocysts/the number of cleavage embryos.
四、卵母细胞的体外成熟(IVM)效果——成熟率4. In vitro maturation (IVM) effect of oocytes - maturation rate
在本实施例的步骤(1)中,经体外成熟培养完毕后,在倒置显微镜下观察,将卵母细胞有第一极体释放、保持卵丘细胞间分泌粘稠的基质、细胞层显著膨大,细胞以卵子为中心,大体呈放射状向四周扩散者判定为已成熟,记录成熟的卵母细胞数,计算成熟率。In the step (1) of this embodiment, after in vitro maturation and culture, observe under an inverted microscope, the oocyte has the first polar body released, the viscous matrix secreted between the cumulus cells is maintained, and the cell layer is significantly enlarged. , The cells are centered on the ovum, and the cells that spread radially to the surroundings are judged to be mature, record the number of mature oocytes, and calculate the maturity rate.
五、结果5. Results
本实施例对中国黄牛(南阳牛,役用品种)进行试验。结果,卵裂率88.4%、桑葚胚率为64.7%、囊胚率为50.3%、凋亡率5.1%;另外,在第9天时囊胚孵化率达74.4%。卵母细胞体外成熟的成熟率达89.6%,相对于实施例2方法的成熟率增加约13个百分点。In this example, a test is carried out on Chinese yellow cattle (Nanyang cattle, a service breed). As a result, the cleavage rate was 88.4%, the morula rate was 64.7%, the blastocyst rate was 50.3%, and the apoptosis rate was 5.1%. In addition, the blastocyst hatching rate reached 74.4% on the 9th day. The maturation rate of the in vitro maturation of oocytes reaches 89.6%, which is about 13 percentage points higher than the maturation rate of the method in Example 2.
在一个补充试验中,参照上文实施例4的方法,分别针对荷斯坦牛(乳牛品种)、西门塔尔牛(肉牛品种)、中国水牛(役用品种)三种牛进行试验,结果:卵裂率均在85~90%范围内、桑葚胚率均在62~65%范围内、囊胚率均在51~54%范围内、凋亡率均在4~6%范围内、第9天囊胚孵化率均在71~75%范围内;荷斯坦牛、西门塔尔牛、中国水牛三种牛的卵母细胞体外成熟的成熟率分别为85.2%、79.1%、74.32%,相对于实施例2方法的成熟率均分别增加约14~15个百分点。上述结果,尽管本发明实施例2方法能够获得完全令人满意的结果,然而,出人意料的发现是,当在本发明BY基础培养液中添加微量硒化物和硫酸铜时能够显著增加卵母细胞体外成熟的成熟率,这是非常有意义的,特别是没有任何现有技术教导上述硒化物和硫酸铜的添加能够显著增加卵母细胞体外成熟的成熟率的技术教导。In a supplementary test, with reference to the method in Example 4 above, the tests were carried out on Holstein cattle (dairy breed), Simmental cattle (beef breed), and Chinese buffalo (service breed), and the results: The cleavage rates were all in the range of 85-90%, the morula rates were all in the range of 62-65%, the blastocyst rates were all in the range of 51-54%, and the apoptosis rates were all in the range of 4-6%. The hatching rates of blastocysts were all in the range of 71-75%; the maturation rates of oocytes in vitro maturation of Holstein, Simmental, and Chinese buffalo were 85.2%, 79.1%, and 74.32%, respectively. The maturation rates of the methods in Example 2 both increased by about 14 to 15 percentage points. The above-mentioned results, although the method of Example 2 of the present invention can obtain completely satisfactory results, however, it is unexpectedly found that when traces of selenide and copper sulfate are added to the BY basal culture solution of the present invention, it can significantly increase the oocyte in vitro The maturation rate of maturation, which is very meaningful, especially there is no technical teaching in any prior art that the above-mentioned addition of selenide and copper sulfate can significantly increase the maturation rate of in vitro maturation of oocytes.
在一个补充试验中,参考本实施例4,在BY基础培养基中不添加亚硒酸钠(而仅增补相应量的硫酸铜)或者不添加硫酸铜(而仅增补相应量的亚硒酸钠)时,在四种牛种中,卵裂率、桑葚胚率、囊胚率、凋亡率四参数在两种情况下与实施例4结果基本一致,对四种牛种的卵裂率均在84~89%范围内、桑葚胚率均在63~66%范围内、囊胚率均在53~55%范围内、凋亡率均在3~5%范围内、第9天囊胚孵化率均在70~74%范围内,例如针对中国黄牛的卵裂率分别为88.4%和88.1%;但是卵母细胞体外成熟的成熟率相对于实施例2结果未见有增加,两种情况下对中国黄牛、荷斯坦牛、西门塔尔牛、中国水牛的卵母细胞体外成熟的成熟率分别为72~74%、67~71%、65~67%、55~58%。这表明BY基础培养基中硒化物和硫酸铜的添加与否不会影响卵裂率、桑葚胚率、囊胚率、凋亡率四参数,但是只有同时添加硒化物和硫酸铜时才能有效的提高卵母细胞体外成熟的成熟率。In a supplementary test, with reference to this embodiment 4, in BY basal medium, do not add sodium selenite (but only supplement the corresponding amount of copper sulfate) or do not add copper sulfate (but only supplement the corresponding amount of sodium selenite ), in the four kinds of cattle species, the four parameters of cleavage rate, morula rate, blastocyst rate, and apoptosis rate were basically consistent with the results of Example 4 in both cases, and the cleavage rates of the four kinds of cattle species were all In the range of 84-89%, the rate of morula is in the range of 63-66%, the rate of blastocyst is in the range of 53-55%, the rate of apoptosis is in the range of 3-5%, and the blastocyst hatches on the 9th day The rates are all in the range of 70 to 74%. For example, the cleavage rates for Chinese yellow cattle are 88.4% and 88.1% respectively; but the maturation rate of oocyte maturation in vitro is not increased compared with the results of Example 2. In both cases The in vitro maturation rates of oocytes from Chinese Yellow Cattle, Holstein Cattle, Simmental Cattle, and Chinese Buffalo are 72-74%, 67-71%, 65-67%, and 55-58%, respectively. This shows that the addition of selenide and copper sulfate in the BY basal medium will not affect the four parameters of cleavage rate, morula rate, blastocyst rate, and apoptosis rate, but it will be effective only when selenide and copper sulfate are added at the same time. Improves the maturation rate of oocyte maturation in vitro.
实施例5:牛体外受精胚胎的培养方法(离体无硒)Embodiment 5: the culture method of bovine in vitro fertilization embryo (no selenium in vitro)
参照上文实施例1以及该实施例1中的相应补充试验的方法,在BY基础培养液中不添加硒和铜,不同的仅是,所用的BY基础培养液改用如下配方的水溶液:With reference to the above example 1 and the corresponding supplementary test method in this example 1, selenium and copper are not added in the BY basal culture solution, the only difference is that the BY basal culture solution used is replaced by an aqueous solution of the following formula:
氯化钙180mg/L、九水硝酸铁0.75mg/L、氯化钾380mg/L、硫酸镁100mg/L、氯化钠6500mg/L、一水磷酸二氢钠150mg/L、碳酸氢钠2000mg/L、醋酸钠60mg/L、L-丙氨酸20mg/L、L-精氨酸盐酸盐80mg/L、L-天冬氨酸25mg/L、L-半胱氨酸盐酸盐一水合物0.12mg/L、L-胱氨酸二盐酸盐20mg/L、L-谷氨酸80mg/L、甘氨酸40mg/L、L-组氨酸盐酸盐一水合物25mg/L、L-羟脯氨酸8mg/L、L-异亮氨酸25mg/L、L-亮氨酸50mg/L、L-赖氨酸盐酸盐80mg/L、L-蛋氨酸10mg/L、L-苯丙氨酸30mg/L、L-脯氨酸30mg/L、L-丝氨酸30mg/L、L-苏氨酸25mg/L、L-色氨酸12mg/L、L-酪氨酸二钠二水合物55mg/L、L-缬氨酸30mg/L、抗坏血酸0.04mg/L、α-D-生育酚磷酸酯0.012mg/L、生物素0.008mg/L、骨化醇0.12mg/L、D-泛酸钙0.008mg/L、氯化胆碱0.6mg/L、叶酸0.008mg/L、肌醇0.06mg/L、三水合甲萘醌亚硫酸氢钠0.015mg/L、烟酸0.03mg/L、烟酰胺0.02mg/L、p-氨基苯甲酸0.06mg/L、盐酸吡哆辛0.04mg/L、核黄素0.012mg/L、盐酸硫胺素0.008mg/L、维生素A乙酸酯0.2mg/L、硫酸腺嘌呤8mg/L、腺嘌呤0.25mg/L、腺苷三磷酸二钠0.8mg/L、胆固醇0.25mg/L、2-脱氧-D-核糖0.4mg/L、D-葡萄糖1200mg/L、谷胱甘肽0.04mg/L、盐酸鸟嘌呤0.35mg/L、次黄嘌呤钠0.3mg/L、核糖0.6mg/L、胸腺素0.25mg/L、吐温806mg/L、尿嘧啶0.25mg/L、黄嘌呤钠0.4mg/L、酚红8mg/L。Calcium chloride 180mg/L, ferric nitrate nonahydrate 0.75mg/L, potassium chloride 380mg/L, magnesium sulfate 100mg/L, sodium chloride 6500mg/L, sodium dihydrogen phosphate monohydrate 150mg/L, sodium bicarbonate 2000mg /L, sodium acetate 60mg/L, L-alanine 20mg/L, L-arginine hydrochloride 80mg/L, L-aspartic acid 25mg/L, L-cysteine hydrochloride Hydrate 0.12mg/L, L-cystine dihydrochloride 20mg/L, L-glutamic acid 80mg/L, glycine 40mg/L, L-histidine hydrochloride monohydrate 25mg/L, L -Hydroxyproline 8mg/L, L-isoleucine 25mg/L, L-leucine 50mg/L, L-lysine hydrochloride 80mg/L, L-methionine 10mg/L, L-benzene Alanine 30mg/L, L-proline 30mg/L, L-serine 30mg/L, L-threonine 25mg/L, L-tryptophan 12mg/L, L-tyrosine disodium dihydrate 55mg/L, L-valine 30mg/L, ascorbic acid 0.04mg/L, α-D-tocopheryl phosphate 0.012mg/L, biotin 0.008mg/L, calcidol 0.12mg/L, D- Calcium pantothenate 0.008mg/L, choline chloride 0.6mg/L, folic acid 0.008mg/L, inositol 0.06mg/L, menaquinone sodium bisulfite trihydrate 0.015mg/L, niacin 0.03mg/L, Niacinamide 0.02mg/L, p-aminobenzoic acid 0.06mg/L, pyridoxine hydrochloride 0.04mg/L, riboflavin 0.012mg/L, thiamine hydrochloride 0.008mg/L, vitamin A acetate 0.2mg /L, adenine sulfate 8mg/L, adenine 0.25mg/L, disodium adenosine triphosphate 0.8mg/L, cholesterol 0.25mg/L, 2-deoxy-D-ribose 0.4mg/L, D-glucose 1200mg /L, Glutathione 0.04mg/L, Guanine Hydrochloride 0.35mg/L, Hypoxanthine Sodium 0.3mg/L, Ribose 0.6mg/L, Thymosin 0.25mg/L, Tween 806mg/L, Uracil 0.25mg/L, xanthine sodium 0.4mg/L, phenol red 8mg/L.
结果:各试验参数的结果与上文实施例1以及该实施例1中的相应补充试验的结果基本相同,例如,对中国黄牛,卵裂率88.3%、桑葚胚率为64.2%、囊胚率为51.6%、凋亡率5.3%,在第9天时囊胚孵化率达71.7%,卵母细胞体外成熟的成熟率达74.5%;对荷斯坦牛、西门塔尔牛、中国水牛三种牛的卵母细胞体外成熟的成熟率分别为68.8%、65.9%、57.3%。Result: the result of each test parameter is basically the same as the result of the corresponding supplementary test in the above embodiment 1 and this embodiment 1, for example, for Chinese yellow cattle, the cleavage rate is 88.3%, the morula rate is 64.2%, and the blastocyst rate is 88.3%. The rate of apoptosis was 51.6%, the rate of apoptosis was 5.3%, the hatching rate of blastocyst reached 71.7% on the 9th day, and the maturation rate of in vitro maturation of oocytes reached 74.5%; for Holstein, Simmental and Chinese buffalo The maturation rates of in vitro maturation of oocytes were 68.8%, 65.9%, and 57.3%, respectively.
实施例6:牛体外受精胚胎的培养方法(活体无硒)Embodiment 6: the culture method of bovine in vitro fertilization embryo (living body without selenium)
参照上文实施例2以及该实施例2中的相应补充试验的方法,在BY基础培养液中不添加硒和铜,不同的仅是,所用的BY基础培养液改用如下配方的水溶液:With reference to the method of the above example 2 and the corresponding supplementary test in this example 2, selenium and copper are not added in the BY basal culture solution, the only difference is that the used BY basal culture solution is replaced by an aqueous solution of the following formula:
氯化钙220mg/L、九水硝酸铁0.70mg/L、氯化钾420mg/L、硫酸镁90mg/L、氯化钠7000mg/L、一水磷酸二氢钠130mg/L、碳酸氢钠2500mg/L、醋酸钠40mg/L、L-丙氨酸30mg/L、L-精氨酸盐酸盐60mg/L、L-天冬氨酸35mg/L、L-半胱氨酸盐酸盐一水合物0.10mg/L、L-胱氨酸二盐酸盐30mg/L、L-谷氨酸70mg/L、甘氨酸60mg/L、L-组氨酸盐酸盐一水合物20mg/L、L-羟脯氨酸12mg/L、L-异亮氨酸15mg/L、L-亮氨酸70mg/L、L-赖氨酸盐酸盐60mg/L、L-蛋氨酸20mg/L、L-苯丙氨酸20mg/L、L-脯氨酸50mg/L、L-丝氨酸20mg/L、L-苏氨酸35mg/L、L-色氨酸8mg/L、L-酪氨酸二钠二水合物60mg/L、L-缬氨酸20mg/L、抗坏血酸0.06mg/L、α-D-生育酚磷酸酯0.008mg/L、生物素0.012mg/L、骨化醇0.08mg/L、D-泛酸钙0.012mg/L、氯化胆碱0.4mg/L、叶酸0.012mg/L、肌醇0.04mg/L、三水合甲萘醌亚硫酸氢钠0.025mg/L、烟酸0.02mg/L、烟酰胺0.03mg/L、p-氨基苯甲酸0.04mg/L、盐酸吡哆辛0.06mg/L、核黄素0.008mg/L、盐酸硫胺素0.012mg/L、维生素A乙酸酯0.1mg/L、硫酸腺嘌呤12mg/L、腺嘌呤0.15mg/L、腺苷三磷酸二钠1.2mg/L、胆固醇0.15mg/L、2-脱氧-D-核糖0.6mg/L、D-葡萄糖800mg/L、谷胱甘肽0.06mg/L、盐酸鸟嘌呤0.25mg/L、次黄嘌呤钠0.4mg/L、核糖0.4mg/L、胸腺素0.35mg/L、吐温804mg/L、尿嘧啶0.35mg/L、黄嘌呤钠0.3mg/L、酚红12mg/L。Calcium chloride 220mg/L, ferric nitrate nonahydrate 0.70mg/L, potassium chloride 420mg/L, magnesium sulfate 90mg/L, sodium chloride 7000mg/L, sodium dihydrogen phosphate monohydrate 130mg/L, sodium bicarbonate 2500mg /L, sodium acetate 40mg/L, L-alanine 30mg/L, L-arginine hydrochloride 60mg/L, L-aspartic acid 35mg/L, L-cysteine hydrochloride Hydrate 0.10mg/L, L-cystine dihydrochloride 30mg/L, L-glutamic acid 70mg/L, glycine 60mg/L, L-histidine hydrochloride monohydrate 20mg/L, L -Hydroxyproline 12mg/L, L-isoleucine 15mg/L, L-leucine 70mg/L, L-lysine hydrochloride 60mg/L, L-methionine 20mg/L, L-benzene Alanine 20mg/L, L-proline 50mg/L, L-serine 20mg/L, L-threonine 35mg/L, L-tryptophan 8mg/L, L-tyrosine disodium dihydrate 60mg/L, L-valine 20mg/L, ascorbic acid 0.06mg/L, α-D-tocopheryl phosphate 0.008mg/L, biotin 0.012mg/L, calcidol 0.08mg/L, D- Calcium pantothenate 0.012mg/L, choline chloride 0.4mg/L, folic acid 0.012mg/L, inositol 0.04mg/L, menaquinone sodium bisulfite trihydrate 0.025mg/L, niacin 0.02mg/L, Niacinamide 0.03mg/L, p-aminobenzoic acid 0.04mg/L, pyridoxine hydrochloride 0.06mg/L, riboflavin 0.008mg/L, thiamine hydrochloride 0.012mg/L, vitamin A acetate 0.1mg /L, adenine sulfate 12mg/L, adenine 0.15mg/L, disodium adenosine triphosphate 1.2mg/L, cholesterol 0.15mg/L, 2-deoxy-D-ribose 0.6mg/L, D-glucose 800mg /L, Glutathione 0.06mg/L, Guanine Hydrochloride 0.25mg/L, Hypoxanthine Sodium 0.4mg/L, Ribose 0.4mg/L, Thymosin 0.35mg/L, Tween 804mg/L, Uracil 0.35mg/L, xanthine sodium 0.3mg/L, phenol red 12mg/L.
结果:各试验参数的结果与上文实施例2以及该实施例2中的相应补充试验的结果基本相同,例如,对中国黄牛,卵裂率87.9%、桑葚胚率为64.6%、囊胚率为50.9%、凋亡率5.1%,在第9天时囊胚孵化率达72.2%,卵母细胞体外成熟的成熟率达75.3%;对荷斯坦牛、西门塔尔牛、中国水牛三种牛的卵母细胞体外成熟的成熟率分别为69.5%、65.3%、57.8%。Result: the result of each test parameter is basically the same as the result of the corresponding supplementary test in the above embodiment 2 and this embodiment 2, for example, for Chinese yellow cattle, the cleavage rate is 87.9%, the morula rate is 64.6%, and the blastocyst rate is 87.9%. The rate of apoptosis was 50.9%, the rate of apoptosis was 5.1%, the hatching rate of blastocysts was 72.2% on the 9th day, and the maturation rate of oocytes in vitro was 75.3%. The maturation rates of in vitro maturation of oocytes were 69.5%, 65.3%, and 57.8%, respectively.
实施例7:牛体外受精胚胎的培养方法(离体硒铜)Embodiment 7: the culture method of bovine in vitro fertilization embryo (isolated selenium copper)
参照上文实施例3以及该实施例3中的相应补充试验的方法,在BY基础培养液中添加硒和铜,不同的仅是,所用的BY基础培养液改用如下配方的水溶液:With reference to the method of the corresponding supplementary test in the above embodiment 3 and this embodiment 3, selenium and copper are added in the BY basal culture solution, the only difference is that the used BY basal culture solution is replaced by an aqueous solution of the following formula:
氯化钙180mg/L、九水硝酸铁0.75mg/L、氯化钾380mg/L、硫酸镁100mg/L、氯化钠6500mg/L、一水磷酸二氢钠150mg/L、碳酸氢钠2000mg/L、醋酸钠60mg/L、L-丙氨酸20mg/L、L-精氨酸盐酸盐80mg/L、L-天冬氨酸25mg/L、L-半胱氨酸盐酸盐一水合物0.12mg/L、L-胱氨酸二盐酸盐20mg/L、L-谷氨酸80mg/L、甘氨酸40mg/L、L-组氨酸盐酸盐一水合物25mg/L、L-羟脯氨酸8mg/L、L-异亮氨酸25mg/L、L-亮氨酸50mg/L、L-赖氨酸盐酸盐80mg/L、L-蛋氨酸10mg/L、L-苯丙氨酸30mg/L、L-脯氨酸30mg/L、L-丝氨酸30mg/L、L-苏氨酸25mg/L、L-色氨酸12mg/L、L-酪氨酸二钠二水合物55mg/L、L-缬氨酸30mg/L、抗坏血酸0.04mg/L、α-D-生育酚磷酸酯0.012mg/L、生物素0.008mg/L、骨化醇0.12mg/L、D-泛酸钙0.008mg/L、氯化胆碱0.6mg/L、叶酸0.008mg/L、肌醇0.06mg/L、三水合甲萘醌亚硫酸氢钠0.015mg/L、烟酸0.03mg/L、烟酰胺0.02mg/L、p-氨基苯甲酸0.06mg/L、盐酸吡哆辛0.04mg/L、核黄素0.012mg/L、盐酸硫胺素0.008mg/L、维生素A乙酸酯0.2mg/L、硫酸腺嘌呤8mg/L、腺嘌呤0.25mg/L、腺苷三磷酸二钠0.8mg/L、胆固醇0.25mg/L、2-脱氧-D-核糖0.4mg/L、D-葡萄糖1200mg/L、谷胱甘肽0.04mg/L、盐酸鸟嘌呤0.35mg/L、次黄嘌呤钠0.3mg/L、核糖0.6mg/L、胸腺素0.25mg/L、吐温806mg/L、尿嘧啶0.25mg/L、黄嘌呤钠0.4mg/L、酚红8mg/L、亚硒酸钠0.3mg/L、硫酸铜(以无水物计)0.05mg/L。Calcium chloride 180mg/L, ferric nitrate nonahydrate 0.75mg/L, potassium chloride 380mg/L, magnesium sulfate 100mg/L, sodium chloride 6500mg/L, sodium dihydrogen phosphate monohydrate 150mg/L, sodium bicarbonate 2000mg /L, sodium acetate 60mg/L, L-alanine 20mg/L, L-arginine hydrochloride 80mg/L, L-aspartic acid 25mg/L, L-cysteine hydrochloride Hydrate 0.12mg/L, L-cystine dihydrochloride 20mg/L, L-glutamic acid 80mg/L, glycine 40mg/L, L-histidine hydrochloride monohydrate 25mg/L, L -Hydroxyproline 8mg/L, L-isoleucine 25mg/L, L-leucine 50mg/L, L-lysine hydrochloride 80mg/L, L-methionine 10mg/L, L-benzene Alanine 30mg/L, L-proline 30mg/L, L-serine 30mg/L, L-threonine 25mg/L, L-tryptophan 12mg/L, L-tyrosine disodium dihydrate 55mg/L, L-valine 30mg/L, ascorbic acid 0.04mg/L, α-D-tocopheryl phosphate 0.012mg/L, biotin 0.008mg/L, calcidol 0.12mg/L, D- Calcium pantothenate 0.008mg/L, choline chloride 0.6mg/L, folic acid 0.008mg/L, inositol 0.06mg/L, menaquinone sodium bisulfite trihydrate 0.015mg/L, niacin 0.03mg/L, Niacinamide 0.02mg/L, p-aminobenzoic acid 0.06mg/L, pyridoxine hydrochloride 0.04mg/L, riboflavin 0.012mg/L, thiamine hydrochloride 0.008mg/L, vitamin A acetate 0.2mg /L, adenine sulfate 8mg/L, adenine 0.25mg/L, disodium adenosine triphosphate 0.8mg/L, cholesterol 0.25mg/L, 2-deoxy-D-ribose 0.4mg/L, D-glucose 1200mg /L, Glutathione 0.04mg/L, Guanine Hydrochloride 0.35mg/L, Hypoxanthine Sodium 0.3mg/L, Ribose 0.6mg/L, Thymosin 0.25mg/L, Tween 806mg/L, Uracil 0.25mg/L, sodium xanthine 0.4mg/L, phenol red 8mg/L, sodium selenite 0.3mg/L, copper sulfate (calculated as anhydrous substance) 0.05mg/L.
结果:各试验参数的结果与上文实施例3以及该实施例3中的相应补充试验的结果基本相同,例如,对中国黄牛,卵裂率87.4%、桑葚胚率为64.9%、囊胚率为51.6%、凋亡率5.4%,在第9天时囊胚孵化率达72.5%,卵母细胞体外成熟的成熟率达89.1%;对荷斯坦牛、西门塔尔牛、中国水牛三种牛的卵母细胞体外成熟的成熟率分别为85.6%、80.2%、73.6%。Result: the result of each test parameter is basically the same as the result of the corresponding supplementary test in the above embodiment 3 and this embodiment 3, for example, for Chinese yellow cattle, the cleavage rate is 87.4%, the morula rate is 64.9%, and the blastocyst rate is 87.4%. The rate of apoptosis was 51.6%, the rate of apoptosis was 5.4%, the hatching rate of blastocysts reached 72.5% on the 9th day, and the maturation rate of in vitro maturation of oocytes reached 89.1%; for Holstein, Simmental and Chinese buffalo The maturation rates of in vitro maturation of oocytes were 85.6%, 80.2%, and 73.6%, respectively.
实施例8:牛体外受精胚胎的培养方法(活体硒铜)Embodiment 8: the culture method of bovine in vitro fertilization embryo (living body selenium copper)
参照上文实施例4以及该实施例4中的相应补充试验的方法,在BY基础培养液中添加硒和铜,不同的仅是,所用的BY基础培养液改用如下配方的水溶液:With reference to the method of the above Example 4 and the corresponding supplementary test in this Example 4, selenium and copper are added in the BY basal culture solution, the only difference is that the BY basal culture solution used is changed to the aqueous solution of the following formula:
氯化钙220mg/L、九水硝酸铁0.70mg/L、氯化钾420mg/L、硫酸镁90mg/L、氯化钠7000mg/L、一水磷酸二氢钠130mg/L、碳酸氢钠2500mg/L、醋酸钠40mg/L、L-丙氨酸30mg/L、L-精氨酸盐酸盐60mg/L、L-天冬氨酸35mg/L、L-半胱氨酸盐酸盐一水合物0.10mg/L、L-胱氨酸二盐酸盐30mg/L、L-谷氨酸70mg/L、甘氨酸60mg/L、L-组氨酸盐酸盐一水合物20mg/L、L-羟脯氨酸12mg/L、L-异亮氨酸15mg/L、L-亮氨酸70mg/L、L-赖氨酸盐酸盐60mg/L、L-蛋氨酸20mg/L、L-苯丙氨酸20mg/L、L-脯氨酸50mg/L、L-丝氨酸20mg/L、L-苏氨酸35mg/L、L-色氨酸8mg/L、L-酪氨酸二钠二水合物60mg/L、L-缬氨酸20mg/L、抗坏血酸0.06mg/L、α-D-生育酚磷酸酯0.008mg/L、生物素0.012mg/L、骨化醇0.08mg/L、D-泛酸钙0.012mg/L、氯化胆碱0.4mg/L、叶酸0.012mg/L、肌醇0.04mg/L、三水合甲萘醌亚硫酸氢钠0.025mg/L、烟酸0.02mg/L、烟酰胺0.03mg/L、p-氨基苯甲酸0.04mg/L、盐酸吡哆辛0.06mg/L、核黄素0.008mg/L、盐酸硫胺素0.012mg/L、维生素A乙酸酯0.1mg/L、硫酸腺嘌呤12mg/L、腺嘌呤0.15mg/L、腺苷三磷酸二钠1.2mg/L、胆固醇0.15mg/L、2-脱氧-D-核糖0.6mg/L、D-葡萄糖800mg/L、谷胱甘肽0.06mg/L、盐酸鸟嘌呤0.25mg/L、次黄嘌呤钠0.4mg/L、核糖0.4mg/L、胸腺素0.35mg/L、吐温804mg/L、尿嘧啶0.35mg/L、黄嘌呤钠0.3mg/L、酚红12mg/L、亚硒酸钠0.2mg/L、硫酸铜(以无水物计)0.1mg/L。Calcium chloride 220mg/L, ferric nitrate nonahydrate 0.70mg/L, potassium chloride 420mg/L, magnesium sulfate 90mg/L, sodium chloride 7000mg/L, sodium dihydrogen phosphate monohydrate 130mg/L, sodium bicarbonate 2500mg /L, sodium acetate 40mg/L, L-alanine 30mg/L, L-arginine hydrochloride 60mg/L, L-aspartic acid 35mg/L, L-cysteine hydrochloride Hydrate 0.10mg/L, L-cystine dihydrochloride 30mg/L, L-glutamic acid 70mg/L, glycine 60mg/L, L-histidine hydrochloride monohydrate 20mg/L, L -Hydroxyproline 12mg/L, L-isoleucine 15mg/L, L-leucine 70mg/L, L-lysine hydrochloride 60mg/L, L-methionine 20mg/L, L-benzene Alanine 20mg/L, L-proline 50mg/L, L-serine 20mg/L, L-threonine 35mg/L, L-tryptophan 8mg/L, L-tyrosine disodium dihydrate 60mg/L, L-valine 20mg/L, ascorbic acid 0.06mg/L, α-D-tocopheryl phosphate 0.008mg/L, biotin 0.012mg/L, calcidol 0.08mg/L, D- Calcium pantothenate 0.012mg/L, choline chloride 0.4mg/L, folic acid 0.012mg/L, inositol 0.04mg/L, menaquinone sodium bisulfite trihydrate 0.025mg/L, niacin 0.02mg/L, Niacinamide 0.03mg/L, p-aminobenzoic acid 0.04mg/L, pyridoxine hydrochloride 0.06mg/L, riboflavin 0.008mg/L, thiamine hydrochloride 0.012mg/L, vitamin A acetate 0.1mg /L, adenine sulfate 12mg/L, adenine 0.15mg/L, disodium adenosine triphosphate 1.2mg/L, cholesterol 0.15mg/L, 2-deoxy-D-ribose 0.6mg/L, D-glucose 800mg /L, Glutathione 0.06mg/L, Guanine Hydrochloride 0.25mg/L, Hypoxanthine Sodium 0.4mg/L, Ribose 0.4mg/L, Thymosin 0.35mg/L, Tween 804mg/L, Uracil 0.35mg/L, sodium xanthine 0.3mg/L, phenol red 12mg/L, sodium selenite 0.2mg/L, copper sulfate (calculated as anhydrous substance) 0.1mg/L.
结果:各试验参数的结果与上文实施例4以及该实施例4中的相应补充试验的结果基本相同,例如,对中国黄牛,卵裂率87.8%、桑葚胚率为65.5%、囊胚率为51.2%、凋亡率4.4%,在第9天时囊胚孵化率达73.8%,卵母细胞体外成熟的成熟率达90.2%;对荷斯坦牛、西门塔尔牛、中国水牛三种牛的卵母细胞体外成熟的成熟率分别为84.7%、80.5%、73.8%。Result: the result of each test parameter is basically the same as the result of the corresponding supplementary test in the above embodiment 4 and this embodiment 4. For example, for Chinese yellow cattle, the cleavage rate is 87.8%, the morula rate is 65.5%, and the blastocyst rate is 87.8%. The rate of apoptosis was 51.2%, the rate of apoptosis was 4.4%, the hatching rate of blastocyst reached 73.8% on the 9th day, and the maturation rate of in vitro maturation of oocytes reached 90.2%; for Holstein, Simmental and Chinese buffalo The maturation rates of in vitro maturation of oocytes were 84.7%, 80.5%, and 73.8%, respectively.
虽然上文中已经用一般性说明及具体实施方案对本发明作了详尽的描述,但在本发明基础上,可以对之作一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。Although the present invention has been described in detail with general descriptions and specific embodiments above, it is obvious to those skilled in the art that some modifications or improvements can be made on the basis of the present invention. Therefore, the modifications or improvements made on the basis of not departing from the spirit of the present invention all belong to the protection scope of the present invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810576764.3A CN108728401B (en) | 2018-06-07 | 2018-06-07 | Method for culturing bovine oocyte in vitro fertilization embryo and used culture medium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810576764.3A CN108728401B (en) | 2018-06-07 | 2018-06-07 | Method for culturing bovine oocyte in vitro fertilization embryo and used culture medium |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108728401A true CN108728401A (en) | 2018-11-02 |
CN108728401B CN108728401B (en) | 2021-09-10 |
Family
ID=63932550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810576764.3A Active CN108728401B (en) | 2018-06-07 | 2018-06-07 | Method for culturing bovine oocyte in vitro fertilization embryo and used culture medium |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108728401B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111019997A (en) * | 2019-11-11 | 2020-04-17 | 浙江卫未生物医药科技有限公司 | Cell activity detection simulated physiological environment buffer |
CN111254109A (en) * | 2020-02-06 | 2020-06-09 | 天津博裕力牧科技有限公司 | Method for in vitro fertilization and embryo culture of bovine oocytes and transport culture solution |
CN114836373A (en) * | 2022-05-30 | 2022-08-02 | 上海洲康医疗器械有限公司 | Oocyte activation culture medium and culture method and application thereof |
CN119307441A (en) * | 2024-12-17 | 2025-01-14 | 内蒙古大学 | A culture medium for bovine cloned embryos and its application |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101225373A (en) * | 2008-01-23 | 2008-07-23 | 北京锦绣大地农业股份有限公司 | Bovine oocyte in vitro maturation serum-free medium |
CN103898046A (en) * | 2014-02-28 | 2014-07-02 | 中国农业科学院北京畜牧兽医研究所 | Cow in-vitro fertilization embryo culture fluid and culture method thereof |
CN107034173A (en) * | 2017-06-09 | 2017-08-11 | 英科博雅基因科技(天津)有限公司 | The method of ox IVF Embryos culture and the nutrient solution used |
CN107142239A (en) * | 2017-06-09 | 2017-09-08 | 英科博雅基因科技(天津)有限公司 | The method for improving ox IVF Embryos culture efficiency |
-
2018
- 2018-06-07 CN CN201810576764.3A patent/CN108728401B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101225373A (en) * | 2008-01-23 | 2008-07-23 | 北京锦绣大地农业股份有限公司 | Bovine oocyte in vitro maturation serum-free medium |
CN103898046A (en) * | 2014-02-28 | 2014-07-02 | 中国农业科学院北京畜牧兽医研究所 | Cow in-vitro fertilization embryo culture fluid and culture method thereof |
CN107034173A (en) * | 2017-06-09 | 2017-08-11 | 英科博雅基因科技(天津)有限公司 | The method of ox IVF Embryos culture and the nutrient solution used |
CN107142239A (en) * | 2017-06-09 | 2017-09-08 | 英科博雅基因科技(天津)有限公司 | The method for improving ox IVF Embryos culture efficiency |
Non-Patent Citations (1)
Title |
---|
WAEL A. KHALIL等: "Protective effects of antioxidants on linoleic acid–treated bovine oocytes during maturation and subsequent embryo development", 《THERIOGENOLOGY》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111019997A (en) * | 2019-11-11 | 2020-04-17 | 浙江卫未生物医药科技有限公司 | Cell activity detection simulated physiological environment buffer |
CN111254109A (en) * | 2020-02-06 | 2020-06-09 | 天津博裕力牧科技有限公司 | Method for in vitro fertilization and embryo culture of bovine oocytes and transport culture solution |
CN111254109B (en) * | 2020-02-06 | 2022-07-08 | 天津力牧生物科技有限公司 | Method for in vitro fertilization and embryo culture of bovine oocytes and transport culture solution |
CN114836373A (en) * | 2022-05-30 | 2022-08-02 | 上海洲康医疗器械有限公司 | Oocyte activation culture medium and culture method and application thereof |
CN114836373B (en) * | 2022-05-30 | 2023-11-10 | 上海洲康医疗器械有限公司 | Egg cell activation culture medium and cultivation method and application thereof |
CN119307441A (en) * | 2024-12-17 | 2025-01-14 | 内蒙古大学 | A culture medium for bovine cloned embryos and its application |
Also Published As
Publication number | Publication date |
---|---|
CN108728401B (en) | 2021-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111254109B (en) | Method for in vitro fertilization and embryo culture of bovine oocytes and transport culture solution | |
Paramio et al. | Recent advances in in vitro embryo production in small ruminants | |
Paramio et al. | Current status of in vitro embryo production in sheep and goats | |
Long et al. | In vitro production of pig embryos: comparisons of culture media and boars | |
CN113201484B (en) | Method for improving cryopreservation and thawing of bovine in vitro fertilization blastocysts | |
CN111269876A (en) | Method for collecting bovine oocytes in vivo for in vitro fertilization and embryo culture | |
CN109943522A (en) | A kind of mammalian in vitro fertilization embryo culture method | |
CN112501114B (en) | Method for improving cattle in-vitro fertilization efficiency | |
CN107034173B (en) | Method for culturing bovine in vitro fertilized embryo and culture solution used in method | |
CN107142239B (en) | Method for improving culture efficiency of bovine in vitro fertilization embryos | |
Tibary et al. | Update on reproductive biotechnologies in small ruminants and camelids | |
Paramio et al. | Assisted reproduction technologies in goats | |
CN108728401A (en) | The method of IVF of Oocyte in Bovine Embryo Culture and culture medium used | |
CN103898046A (en) | Cow in-vitro fertilization embryo culture fluid and culture method thereof | |
CN110066763A (en) | Promote the method for ox embryo in vitro culture development of fertilized ova | |
Herrick et al. | Effect of macromolecule supplementation during in vitro maturation of goat oocytes on developmental potential | |
CN108728404A (en) | Ox live body or the method for in vitro oocyte collection IVF Embryos culture | |
De et al. | In vitro development of goat (Capra hircus) embryos following cysteamine supplementation of the in vitro maturation and in vitro culture media | |
CN108753689A (en) | The method of ox IVF Embryos culture | |
CN112980778B (en) | Methods of culturing and cryopreserving bovine in vitro fertilization embryos | |
CN112322579B (en) | Culture solution for cattle in-vitro fertilization and method for improving cattle in-vitro fertilization | |
CN110066764A (en) | Promote the method for ox embryo in vitro culture oocyte in vitro maturation | |
CN113151160B (en) | Method for improving the efficiency of bovine in vitro fertilization and cryopreservation and thawing solutions used | |
CN112914784B (en) | Bovine embryo segmentation method | |
Gupta et al. | Recent advances in reproductive biotechnologies in small ruminants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190916 Address after: 300457 A building, Alexander center, 3 Haitong street, Tianjin Binhai New Area. Applicant after: Tianjin Bo Yu Li Husbandry Technology Co., Ltd. Address before: 300457 Tianjin Binhai New Area Development Zone Haitong Street No. 3 Alexander A building - Boya company Applicant before: Tianjin Bo Yu Li Husbandry Technology Co., Ltd. Applicant before: Tianjin Zhongke Boya biological Breeding Research Co Ltd Applicant before: Tianjin Li Mu Ding Feng Biotechnology Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 300457 building a, Alexandria, No.3 Haitong street, Binhai New Area Development Zone, Tianjin Boya company Patentee after: Tianjin Limu Biotechnology Co.,Ltd. Address before: 300457 A building, Alexander center, 3 Haitong street, Tianjin Binhai New Area. Patentee before: TIANJIN BOYU LIMU TECHNOLOGY CO.,LTD. |
|
CP03 | Change of name, title or address |